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Projects 1,2: Palladium and platinum are widely used precious metals that play a pivotal role in 
energy, materials and drugs. In collaboration with Dr. Fengling Song, a highly sensitive 
fluorescent detection method has been developed for these metals based upon the Tsuji-Trost 
reaction. A key aspect of this method is the amplification of fluorescence signal directly through 
a catalytic process, which is conceptually new for metal sensors. Using this method, sub-ppb 
levels of both palladium and platinum can be detected. Importantly, detection of palladium in 
synthetic samples and detection of cisplatin in serum and crude samples are demonstrated, which 
have vast applications in the pharmaceutical industry, hospitals and pharmacies. Lastly, selective 
detection of palladium in the presence of platinum is demonstrated.  
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Project 3: Palladium- and platinum-catalyzed reactions are powerful reactions in synthetic 
organic chemistry. As such, each requires the metal in a specific oxidation state. A convenient 
fluorogenic probe capable of determining the oxidation state of palladium and platinum has been 
developed based on the Claisen rearrangement. This probe can fluorescently distinguish Pd0 
from PdII/IV and Pt0 from PtIV in both organic and aqueous solvents. Detection in functionalized 
organic compounds, reaction mixtures and a spiked platinum drink are demonstrated. 
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Project 4: Ozone exposure is a significant global health problem, especially in urban areas. 
While ozone in the stratosphere protects the earth from damaging ultraviolet light, tropospheric 
or ground level ozone is toxic, resulting in damage to the respiratory tract. The exact mechanism 
by which ozone damages the respiratory system is poorly understood. It has recently been shown 
that ozone may be produced endogenously in inflammatory and antibacterial responses of the 
immune system; however, these results have sparked controversy due to the use of a non-specific 
colorimetric probe. A fluorescent sensor capable of unambiguously detecting ozone has been 
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developed. Although many methods exist for ozone detection, this sensor is the first that is 
specific for ozone and can be used in both biological and atmospheric samples.  
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Project 5: Solid-phase organic synthesis is an enabling technology and its automation has 
profoundly impacted the scientific community and society in general. To date, however, the 
structural diversity of the molecules that can be synthesized by this technology is limited, partly 
because current solid-phase organic synthesis relies on linear approaches. Described here are 
efforts toward the development of an enabling resin-to-resin transfer technology that unites two 
functionalized fragments to form highly complex small molecules in a convergent manner. Such 
technology would allow for the synthesis of small molecules possessing natural product- and 
drug-like functionalities that are not readily accessible by conventional linear approaches. 
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Olefin cross-metathesis couples two alkenes to form complex molecules and has been widely 
used in solution phase organic synthesis. This powerful method has rarely been used in solid-
phase organic synthesis, however. Herein it is reported that olefin cross-metathesis is a 
synthetically viable method, particularly when a traceless, longer linker is inserted between solid 
support and reacting olefins. 
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 1 
1.0  INTRODUCTION: SMALL MOLECULE-BASED FLUORESCENT 
CHEMOSENSORS 
Fluorescence spectroscopy is a powerful method used to image otherwise invisible molecules.1−4 
A desirable probe interacts specifically with an analyte and fluoresces or changes color to 
indicate its presence. Fluorescent probes provide accessibility to real-time imaging in live cells, 
respond to a wide variety of biological signals and events, target sub-cellular compartments in a 
broad range of tissues and intact organisms and rarely cause photodynamic toxicity.1 While 
many fluorescent sensors are based on green fluorescent protein (GFP) and its variants, small 
molecule-based fluorescent chemosensors are superior in that they are stable, easier to tune and 
change emission wavelength, provide faster rates of labeling and are available in large quantities. 
Thus, such fluorescent chemosensors are indispensable tools in biology.  
Small molecule-based fluorescent sensors have provided novel approaches for the 
detection of metal ions, small organic compounds and biomolecules. These chemosensors are 
typically derived from a core group of well-known fluorophores, such as coumarin, fluorescein, 
rhodamine and BODIPY (Figure 1), each emitting in different regions of the electromagnetic 
spectrum.4  
 2 
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CO2
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F F
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Figure 1. Well-known small molecule fluorophores 
 
Practical fluorescent sensors must possess a few key properties: (1) produce a viable signal with 
high quantum yield upon selective interaction with the desired analyte; (2) exhibit an excitation 
wavelength (λex) exceeding 340 nm to prevent UV-induced cell damage and an emission 
wavelength (λem) approaching 500 nm to avoid autofluorescence issues from species native to 
the cell; and (3) cell-permeability.5 As described in Figure 1, the photophysical properties of the 
fluorophores depicted make them excellent platforms for fluorescent sensor development. 
1.1 CHEMICAL PRINCIPLES OF “TURN-ON” FLUORESCENT SENSORS 
Fluorescent probes are designed by chemically manipulating the fluorophore scaffold through 
the addition of side chains specific for the analyte of interest. As such, a variety of chemosensors 
can be designed simply by changing the attached group. Such modularity has given rise to 
diverse mechanisms of fluorescence induction, which are derived from two main chemical 
principles: molecular recognition and chemical reactivity. Descriptions of each principle with 
key examples follow below. 
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1.1.1 Molecular Recognition-Based Fluorescent Sensors −  Photoinduced Electron 
Transfer 
e-
analyte
+
e-
nonfluorescent fluorescent
KD
 
Figure 2. Generic scheme of fluorescent sensors based on a host that serves as a quencher 
 
Many fluorescent sensors rely on molecular recognition whereby a fluorescent compound is 
covalently linked to a host moiety that also serves as a quencher (blue; Figure 2). In fact, one of 
the first fluorescent sensors, quin2, was based on this design principle for Ca2+ sensing (Figure 
3).6 This type of sensor generates virtually no fluorescence signal when free, while producing 
strong fluorescence signal when bound to its respective analyte. 
N
CO2
quin2
N
H3CO
O OCH3
NO2C
O2C
CO2
 
Figure 3. Ca2+ sensor based on molecular recognition 
Weak
Fluorescence
Strong
Fluorescence
LUMO
HOMO
HOMO
e-
LUMO
HOMO
HOMO
Analyte
excited
chromophore
unbound
quencher
excited
chromophore
quencher
bound to
analyte  
Figure 4. Photoinduced electron transfer (PeT) mechanism 
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The chemical principle by which these fluorescent off-on switches operate is the 
photoinduced electron transfer (PeT) mechanism shown in Figure 4.7 In the weak fluorescence 
state, the fluorescence emission is quenched via an electron transfer process from the unbound 
quencher to the excited chromophore. For this electron transfer to occur, the HOMO energy level 
of the quencher must be higher than that of the chromophore but below the LUMO and in 
reasonable proximity. If the electrons of the quenchers are used for binding to an analyte, the 
energy of the quencher is then lowered. This energy lowering suppresses the electron transfer 
from the quencher to the excited chromophore, thereby restoring fluorescence. Thus, the 
efficiency of such PeT processes is attributed to the difference in the oxidation potential(s)8,9 of 
the quencher(s) (electron donor) and the fluorophore (electron acceptor) and the distance10 
between the two. This principle is well established and numerous studies have been reported on 
the elucidation of PeT processes. 
OO O
CO2
OO O
CO2
NH2 HN
O
Ph
1
! = 0.015
2
! = 0.79  
Figure 5. Reversible quenching via oxidation potential 
 
In 1990, the Walt group reported one of the first studies examining the electronic impact 
on the quenching mechanism;11 they studied the effect of intramolecular fluorescence self-
quenching of fluoresceinamine 1 via covalent bond formation (Figure 5). Compound 1 exhibited 
a quantum yield (Φ) of 0.015 in pH 7.5 buffer, indicating significant quenching; however, upon 
amide bond formation to form compound 2, a considerable increase in fluorescence intensity was 
 5 
observed (Φ = 0.79), which is likely due to the change in the oxidation potential of the aniline 
unit (quencher). Thus, this study validates the electronic component of the PeT switch 
mechanism through π-bonds in the biologically useful fluorescein system. 
Other PeT sensors consist of a quencher covalently linked to a fluorophore by a spacer of 
a certain length, which should also impact the PeT process through space.7 The kinetics of 
distance-dependent quenching is expressed as:  
k(r) = ka   e
^
r-a
re
-
 
where k(r) is the rate of quenching at distance r, ka is the rate of reaction at distance a, and re is 
the characteristic distance (distance where the probability of electron transfer is 50%). Distance a 
is the distance of closest approach, typically 5−7 Å. The characteristic distance, re, is typically 
1−2 Å. Thus, as the distance between the quencher and the fluorophore is decreased, the rate of 
quenching (electron transfer) should increase exponentially. Santa examined this principle and 
reported a systematic study on the distance-dependent quenching of benzofurazan compounds 3 
with linkers ranging from 2 to 12 carbons (Figure 6).12  
 
N
O
N
NO2
NMe2
n
!n=2 = 0.0016
!n=12 = 0.17
3  
Figure 6. Trend in distance-dependent quenching 
 
Not surprisingly, they found that when the quencher was located in closer proximity to the 
fluorophore (n = 2−4) increased quenching was observed, and when the quencher was located 
 6 
farther away (n = 5−12) quenching was decreased. A similar trend was also observed in the rate 
of electron transfer (ket). 
Using this PeT process, many practical fluorescent chemosensors have been developed 
for a number of biologically relevant analytes. PeT sensors have been extensively reviewed.13−16 
A few examples of PeT sensors based on some common design strategies are highlighted below. 
For fluorescent sensors to exhibit the greatest signal-to-background ratios in sensing 
analytes, the fluorescence signals of unbound sensors must be minimized. As a result, many PeT 
sensors include fluorophores attached to multiple electron donors, typically free amines, in order 
to achieve this goal. Some examples of sensors designed to include multiple amine quenchers are 
shown in Figure 7. 
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Figure 7. Examples of PeT sensors with multiple electron donors  
 
Zinpyr-1 (4) is a fluorescent sensor for intracellular Zn2+ and contains two di-(2-
picolyl)amine moieties as quenchers.17,18 This sensor displays an approximate two-fold increase 
in fluorescence intensity with a Φfree of 0.39 and ΦZn of 0.89 and is known to form a 1:1 
Zn2+:Zinpyr-1 complex. Czarnik developed anthracyl sensor 5 containing protonated polyamine 
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quenchers, which serves as a sensor for negatively charged phosphate oxygens.19 The Koide 
group reported DCF-based sensor 6 using N-(p-methoxyphenyl)piperazine quenchers, which was 
used to image specific RNA aptamers.20−22 Of the aptamers isolated, the best aptamer showed a 
13-fold fluorescence enhancement upon binding. 
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Figure 8. Examples of selective PeT fluorescent sensors 
 
In addition to attaining good signal-to-background and sensitivity, selectivity for the 
respective analyte is also important in designing a useful PeT sensor. In order to gain selectivity 
for one analyte over another, a quenching ligand specific for that analyte is required. Three 
sensors that nicely emulate this concept are Mercuryfluor-1 (7),23 Mercurygreen-1 (8)24 and 
Coppersensor-1 (9),25 all developed by the Chang group (Figure 8). Each of these sensors 
possesses thioether ligands selective for Hg2+ and Cu+. Sensor 9 is the first fluorescent sensor 
that is specific for Cu+ over Cu2+. Sensors 7 and 8 both selectively and sensitively detect Hg2+ in 
water, cells and tissue; and sensor 8 displays less quenching due to Hg2+ and a quantum yield of 
0.72.  
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1.1.2 Molecular Recognition-Based Fluorescent Sensors −  Restricted Conformation  
nonfluorescent
+
analyte
fluorescent  
Figure 9. Generic scheme of fluorescent sensors based on conformational rigidity 
 
While PeT sensors induce fluorescence by lowering the energy of the quenching moiety, another 
class of molecular recognition-based fluorescent sensors operates by affecting the conformation 
of the probe to produce a fluorescence signal. When free in solution, this type of binding-based 
sensor emits very low fluorescence due to vibrational deexcitation. Upon binding the analyte, the 
probe becomes rigid, prohibiting such nonradiative decay and a fluorescence signal is emitted 
(Figure 9).26 This type of sensor is frequently used in DNA- and RNA-binding assays and a few 
examples are shown in Figure 10. 
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Figure 10. Examples of sensors that fluoresce via restricted conformation 
 
Hoechst 33258 (10) is a widely used DNA staining reagent.27 Malachite Green (11) was 
recently utilized as a sensor for a specific RNA aptamer and showed a ~2360-fold enhancement 
upon binding its specific aptamer.28 Interestingly, the Tsien group was able to isolate RNA 
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aptamers specific for Malachite Green and a sulfonated triphenylmethane dye, and this is the first 
reported example of such specificity. Dimethylindole Red (12), an example of an unsymmetrical 
Cy dye, was recently reported by the Armitage group and is another example of an RNA 
sensor.29 An RNA aptamer raised against this fluorophore showed a 60-fold fluorescence 
enhancement upon binding. 
1.1.3 Reactivity-Based Fluorescent Sensors 
There are many examples of successful fluorescent sensors based on molecular recognition; 
however, the binding activity is reversible. An alternative and more effective means of 
fluorescence induction would utilize the analyte to perform an irreversible chemical reaction that 
converts a nonfluorescent molecule to a fluorescent molecule. This approach has been used for 
the detection of metal ions, anions and reactive oxygen species among others, and these sensors 
have demonstrated enhanced selectivity as compared to their binding counterparts as shown 
below.  
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Figure 11. Generic scheme of reactivity-based sensor using a masking group 
 
A common approach of masking a fluorophore (red in Figure 11) is by capping the 
phenol of fluorescein or coumarin or by forming the nonfluorescent fluorescein lactone by 
doubly substituting both xanthene oxygen substituents (Figure 12). This chemical principle is 
well known and originally derived from fluorometric enzyme assays developed in the early 
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1960’s.30−33 The earliest examples relied on each of these methods and were used to study β-
galactosidase and lipase- and esterase-catalyzed hydrolysis reactions (Figure 12), and also 
applied to release fluorescence immunoassays34 to study antibody-antigen binding. 
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Figure 12. Examples of early fluorometric enzyme assays 
 
Because of the success of this approach, it is still widely used today in biology in reporter gene 
assays (alkaline phosphatase, luciferase, β-galactosidase),35 enzyme activity assays36−38 and cat-
ELISA.39,40 Some more recent examples are shown in Figure 13. 
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Figure 13. Recent examples of fluorometric enzyme assays 
 
The Raines groups used this chemical principle to design latent rhodamine 13 based on 
the “trimethyl lock”.41,42 They reasoned that unfavorable steric interactions between the methyl 
substituents on the reactive side chain would encourage lactonization upon ester hydrolysis to 
form fluorescent rhodamine. This same “trimethyl lock” approach was recently utilized by the 
Kiessling group for visualizing the cellular internalization of multivalent ligands for biological 
analytes.43 The Nagano group also utilized this approach to design mono-substituted fluorescein 
14 based on their Tokyo Green fluorophore scaffold.44 They demonstrated that this mono-
substituted sensor showed many advantages over the di-substituted version in terms of sensitivity 
and in real-time imaging in live cells.  
A key benefit of these fluorometric enzyme assays is the catalytic nature of the analyte, 
and thus the signal will be amplified dependent upon the efficiency of the catalyst. Most current 
reactivity-based sensors, however, use the analyte as a stoichiometric reagent, and the signal 
output for each is dependent upon the effectiveness of the chemical transformation. Examples of 
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reactivity-based sensors modeled after these similar chemical principles are described below: 
Figure 14 shows sensors based on the nonfluorescent lactone scaffold and Figure 15 shows 
sensors based on the phenolic capping scaffold. 
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Figure 14. Examples of reactivity-based sensors with nonfluorescent lactone scaffold 
 
Czarnik designed rhodamine hydrazide sensor 15 based on the affinity of Cu2+ for α-
amino esters, which is the first example utilizing the power of Cu2+ to promote hydrolysis 
reactions.45 In this case, although the Cu2+-catalyzed ring opening is catalytic, the hydrolysis 
reaction was dependent upon the hydrazide concentration and nonintegral stoichiometry was 
observed. This concept has been used in several other more recent Cu2+ sensors.46 Chang 
recently reported a selective, cell-permeable fluorescent probe for detecting hydrogen peroxide 
in living cells.47,48 Sensor 16 is based on the ability of hydrogen peroxide to convert aryl 
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boronates to phenols, in this case to fluorescent fluorescein, and was recently followed up with a 
second-generation hydrogen peroxide sensor that specifically targets the mitochondria.49 A 
selective probe for Hg2+ was developed by the Tae group, which takes advantage of the 
thiophilicity of this metal ion.50,51 In this example, Hg2+ promotes the conversion of the 
thiosemicarbazide moiety in 17 to the 1,3,4-oxadiazole with subsequent ring opening and 
liberation of mercury sulfide to yield a fluorescent compound. This sensor is highly selective and 
can detect below 2 ppb Hg2+ in aqueous solution. In addition, the Kool group recently utilized 
this approach for fluorescent detection of nucleic acids.52 
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Figure 15. Examples of reactivity-based sensors with phenolic masking group 
 
The Nagano group developed two fluorescein-based fluorescent sensors 18 (Figure 15) to 
distinguish various reactive oxygen species (ROS).53 For example, hydroxyl radical can be 
distinguished from nitric oxide and peroxynitrite can be distinguished from nitric oxide and 
superoxide, each of which cannot be accomplished with other ROS fluorescent sensors.  A 
 14 
second example is from the Hong group for detecting fluoride.54 Sensor 19 is based on the 
resorufin fluorophore and uses fluoride’s ability to cleave silylethers to produce a fluorescence 
signal. 
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Figure 16. Generic scheme of reactivity-based sensors that operate by modifying a quenching group 
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Figure 17. First example of reactivity-based sensor developed by Czarnik 
 
Another principle in which reactivity-based sensors are designed is converting a 
quenching group (red; Figure 16) to a non-quenching group. In fact, Czarnik designed the first 
reactivity-based fluorescent sensor for metal ions using this concept in the early 1990’s (Figure 
17).55 Anthracene-based sensor 20 showed selectivity toward mercury (87% reaction yield) and 
to a lesser extent for silver (73% reaction yield). Although the selectivity is lacking, this sensor 
represents the first example of rational fluorescent sensor design that converts a quenching 
moiety to a non-quenching moiety. Other examples are shown in Figure 18. 
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Figure 18. Examples of reactivity-based sensors that convert and quenching group to a non-quenching group 
 
Each one of the sensors depicted in Figure 18 was carefully designed based on PeT to 
ensure quenching of the parent fluorophore and reactivity to ensure selectivity for the respective 
analyte by the Nagano group. Sensor 21 was designed to selectively detect nitric oxide based on 
the reactivity of aromatic amines with nitric oxide in the presence of dioxygen to produce 
triazenes.56,57 Thus, by converting quenching adjacent primary amines to an aromatic triazene 
ring, they are able to selectively and sensitively detect nitric oxide even in living cells. Sensor 
22, which contains a quenching anthracyl moiety as the benzoic acid portion of fluorescein, was 
designed for selective detection of singlet oxygen.58,59 The addition of singlet oxygen across the 
anthracene ring was effective in lowering the HOMO energy to produce a fluorescence signal; 
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and this sensor was capable of detecting singlet oxygen in both aqueous media and cells. Another 
mechanism-based probe was developed to detect nitrative stress by peroxynitrite.60 BODIPY dye 
1-23 was shown to selectively detect peroxynitrite by nitrating the di-methoxyphenyl substituent 
of the sensor to lower the HOMO energy of this quencher. This is the first example of a 
fluorescent sensor that can monitor aromatic nitration. 
1.1.4 Catalytic Signal Amplification via Signal Transduction 
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Figure 19. Generic scheme of sensors based on amplification via signal transduction 
 
While the sensitivity of the reactivity-based sensors discussed above is impressive, the emitted 
signal is stoichiometric with respect to the analyte. To overcome this, the Anslyn group 
developed an approach for amplifying fluorescence signal (Figure 19).61 In this approach, a 
ligand (= host; shown in blue) binds to a catalyst (shown in purple) to mask its reactivity; when 
an analyte binds to and replaces the catalyst in the ligand host, this complex formation releases 
the catalyst, which converts fluorogenic molecules to fluorescent molecules and amplifies 
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fluorescence signal. One drawback, however, is the fact that the binding is inevitably reversible, 
which generates active catalyst in the absence of the analyte, resulting in amplification of the 
background fluorescence signal. Additionally, more parameters must be optimized in this 
approach than in other approaches, presumably requiring laborious work. Although this does not 
match the catalytic power of fluorometric enzyme assays, it is a clever method of amplifying 
fluorescence signal. Some examples of sensors based on this principle are shown in Figure 20. 
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Figure 20. Examples of sensors based on catalytic signal amplification 
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The first reported example of this approach was a detection method for Cu2+ using the 
Pd-catalyzed Heck reaction shown in Figure 20a.61 In this case, a cyclam ligand is used to 
preferentially bind Cu2+ to free Pd2+, which after reduction catalyzes the ring closing of 
compound 24 to form fluorescent indole 25. The detection limit of this method was 30 nM Cu2+ 
in 1.5 h. Another example from the same group used the copper-catalyzed Huisgen cycloaddition 
to detect Zn2+ and Pb2+ (Figure 20b).62 In this case, the analyte displaces Cu2+ from the EDTA 
ligand for subsequent reduction by L-ascorbate. This Cu+ species then catalyzes the 
cycloaddition reaction between 26 and 27 to produce a ratiometric fluorescence signal (28). 
Although not shown, this system has also been utilized to detect small molecules (ketones and 
aldehydes)63 and biomolecules (DNA).64,65 
1.2 CONCLUSION 
A survey of the literature reveals two main chemical principles in which fluorescent sensors are 
designed: molecular recognition and chemical reactivity. Using these principles, fluorescent 
sensors for metal ions, biomolecules, small molecules and reactive oxygen species have been 
designed. Although binding-based sensors and stoichiometric reactivity-based sensors are useful, 
a more effective method of fluorescence detection would utilize the analyte in catalysis for 
fluorescence signal amplification. While initial efforts dedicated to this goal are promising, much 
more work remains to obtain similar signal amplification observed in fluorometric biological 
assays for metal ion sensing. 
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2.0  DESIGN AND SYNTHESIS OF DICHLOROFLUORESCEIN DERIVATIVES 
2.1 RESEARCH DESIGN 
The Koide lab has been interested in developing a new series of 2’,7’-dichlorofluorescein (DCF)-
based fluorescence sensors. DCF was chosen as the fluorophore for several reasons: (1) cell-
permeable DCF derivatives are known including Zinpyr-11 and Fluo-32, (2) the fluorescence is 
nearly pH-independent under physiological conditions (explanation below) and (3) the 
fluorescein chromophore exhibits appropriate λex and λem.3  
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Figure 21. Structures of DCF 
 
DCF, and fluorescein in general, is known to exist in three major forms, shown in Figure 
21.4 At physiological pH, the phenolic OH is largely deprotonated and DCF2--II predominates 
because of the pKa lowering effect due to the presence of the chloride substituents (phenol pKa 
(fluorescein) = 6.7; phenol pKa (DCF) = 5.0).5 Only in acidic aqueous solution and organic 
solvent does DCF exist as the non-fluorescent DCF-lactone-III. As a result, the fluorescence 
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intensity of DCF is greatest under physiological conditions and should exhibit a large signal-to-
background ratio necessary for a useful sensor. A similar fluorophore containing 2’- and 7’-
fluoride substituents (Oregon Green) has also been developed with similar physical properties 
(phenol pKa = 4.8).6  
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Figure 22. Importance of the carboxyl group presence and position 
 
While DCF and Oregon Green are valuable fluorophore scaffolds, the negatively charged 
carboxyl group that each contains may cause nonspecific interactions with positively charged 
moieties of biomolecules. Additionally, the carboxyl group may be responsible when inherently 
cell-permeable molecules become impermeable following conjugation to fluorescein.7 However, 
the Lindqvist group reported that this carboxyl group is indispensable for fluorescence emission 
because removal of this group caused a reduction in fluorescence quantum yield (Figure 22).8 
Furthermore, an additional study showed that movement of the carboxyl group to the 3-position 
of the phenyl ring caused a similar reduction in fluorescence emission.9  
The necessity for the carboxyl group was speculated to be primarily due to structural 
rigidity, which is a common feature used to explain the high fluorescence emission of conjugated 
aromatic dyes.8,9 Radiationless transfer from the excited state to the ground state via internal 
conversion is less likely for rigid structures because they experience less vibrational dissipation. 
More specifically to fluorescein, it was speculated that an ordered structure of water molecules 
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surrounds the negatively charged carboxyl group in alkaline pH, which increases the rigidity of 
the molecular structure.8 In addition, only fluorescein is capable of the electronic overlap 
necessary to form the nonfluorescent lactone (DCF-lactone-III in Figure 21), further 
demonstrating its potential rigidity. These hypotheses were further corroborated by the fact that 
all three molecules exhibit the same fluorescence emission in acidic pH. 
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Figure 23. Examples of fluorescein-based derivatives 
 
The Nagano group recently demonstrated that the carboxyl group can be replaced with a 
methyl group with no decrease in fluorescence intensity, and gave the compound the name 
Tokyo Green (Figure 23).10  Based on these results, it was hypothesized that the substituent in 
this position simply keeps the benzene moiety and the fluorophore orthogonal to each other and 
restricts rotation. A similar methyl substitution was carried out by the Peterson group to produce 
Pennsylvania Green (Figure 23).11 In live human cells, Pennsylvania Green was more fluorescent 
than Tokyo Green due to its lower pKa value. Despite these successes, the addition of a methyl 
group may cause nonspecific hydrophobic interactions and poor water solubility.12 
To overcome the potential fallbacks with the above fluorophores, it was hypothesized 
that the replacement of the carboxyl group of DCF with a hydroxymethyl group would prove to 
be superior is those instances in which nonspecific hydrophobic interactions and poor water 
solubility are detrimental. Moreover, such compounds could be synthetically more accessible 
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than Tokyo Green or Pennsylvania Green, and conjugation ready via the primary hydroxy group. 
The synthetic plan for these new sensors is shown in Figure 24. 
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Figure 24. Synthetic plan for Pittsburgh Green and Pittsburgh Yellowgreen 
 
The synthesis of Pittsburgh Green was envisioned to begin with the bis-allylation of 
DCF, which was previously reported by Drs. Sparano and Shahi in the Koide group.13 Reduction 
of the resulting allyl ester would give the allyl-hydroxymethyl DCF intermediate, which 
following deallylation would yield Pittsburgh Green. This allyl-hydroxymethyl DCF 
intermediate could also be subjected to Claisen rearrangement conditions to obtain allyl-DCF 
fluorophore, Pittsburgh Yellowgreen, which is also conjugation-ready via its terminal alkene 
(olefin cross-metathesis and oxidative cleavage/coupling for example). The Koide group 
previously reported a similar Claisen rearrangement of DCF for the synthesis of DCF derivatives 
containing one quenching group.13 Thus, the proposed scheme provides scalable access to two 
conjugation-ready DCF-derivatives with a valuable hydroxymethyl substituent in place of the 
carboxyl or methyl group on the benzene moiety of DCF. 
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2.2 RESULTS AND DISCUSSION 
2.2.1 Synthesis of Pittsburgh Green and Pittsburgh Yellowgreen 
The synthesis of the Pittsburgh Green began with the bis-allylation of DCF. Although this 
transformation was previously reported13, the purification method for this compound has been 
improved; this deserves comment here. Commercially available DCF was treated with allyl 
bromide and K2CO3 in DMF (Figure 26). Upon reaction completion, excess water was added to 
the reaction mixture to precipitate the bis-allyl DCF derivative 29 in excellent purity. Because of 
the ease of purification, this transformation is routinely performed in multiple gram scale (>25 
g). 
 With successful preparation of compound 29, attention was next turned to the reduction 
step. Lithium borohydride14 was examined as a mild reducing agent, but these conditions 
consistently yielded a product with incorrect NMR and MS data. From these data, it was 
speculated that this hydride reagent, in fact, does not reduce the allyl ester, but reduces the 
xanthene ring either directly (30) or through initial reduction of the ketone followed by 
aromatization (30→31) (Figure 25). This side reaction provided insight into reactivity of the 
xanthene moiety in the presence of reducing agents. 
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Figure 25. Results of unsuccessful lithium borohydride reduction 
 
With the unsuccessful results with lithium borohydride, diisobutylaluminum hydride 
(DIBALH)15 was next examined as a reducing agent. Although treatment of the 29 with 
DIBALH was successful in reducing the ester, a similar reduction of the xanthene chromophore 
as with lithium borohydride was noticed. It was speculated that 29 is initially reduced to form 
putative intermediate 32, which then presumably isomerizes to the more stable intermediate 33. 
To oxidize the chromophore, the excess DIBAL-H was first quenched with aqueous NH4Cl and 
the putative intermediate 33 was oxidized with DDQ16 in one pot to afford compound 34 in 80%  
yield as crystalline (Figure 26).17 
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Figure 26. Synthetic scheme for the synthesis of Pittsburgh Green 
 
 The final step in the synthesis of Pittsburgh Green is the deallylation of the phenolic 
ether. A common approach in the deprotection of such allyl aryl ethers is to use a variant of the 
Pd-catalyzed allylic alkylation, or Tsuji-Trost reaction.18,19 This reaction will be discussed in 
detail in the following chapter. As such, Pd0-catalyzed deallylation was employed with the use of 
catalytic Pd(PPh3)4, sodium borohydride20 and morpholine.21 The reaction proceeded efficiently 
to yield Pittsburgh Green (35) in 80% as a crystalline solid.17 In addition to Pd0 species, the same 
efficient conversion could also be achieved with PdII reagents.17 
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 The overall synthetic scheme for Pittsburgh Green is shown above in Figure 26. Thus, 
this new DCF derivative is efficiently synthesized in two steps from commercially available 
compounds. Since all steps yield crystalline solids, this synthesis is highly scalable and multiple 
gram to kilogram quantities can be easily prepared.  
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Figure 27. Synthetic scheme for the synthesis of Pittsburgh Yellowgreen 
 
The above synthetic scheme also provides efficient access to a second DCF derivative, 
Pittsburgh Yellowgreen 36 (Figure 27).22 This compound was synthesized via Claisen 
rearrangement of compound 34. Dr. Shahi in the Koide group previously reported a similar 
rearrangement of DCF.13 The terminal alkene of Pittsburgh Yellowgreen provides a useful 
handle for coupling via the ruthenium-catalyzed olefin cross-metathesis reaction.22 Despite 
numerous attempts on my part to couple this olefin to other alkenes, such as alkenyl maleimides, 
the only successful example was with but-3-en-1-ol to form compound 37, which was performed 
by Dr. Song.  
2.2.2 Spectroscopic Properties of Pittsburgh Green and Pittsburgh Yellowgreen 
To compare the fluorescence emission of these new fluorophores to the parent fluorescein 
scaffold, Dr. Song measured the quantum yield of each compound in pH 10 buffer.22 The 
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quantum yields of 35 and 36 were 0.89 and 0.82, respectively. Thus, these compounds exhibit 
similar fluorescence emission properties to other fluorescein derivatives (Φfluorescein = 0.85 in pH 
13 buffer; ΦTokyoGreen = 0.85 in pH 13 buffer). The emission maxima for 35 and 36 were 
determined as 523 and 535 nm, respectively. Thus, the two sensors are easily distinguishable by 
this red shift in the fluorescence emission. 
 
Figure 28. Fluorescence intensity of Pittsburgh Green at 523 nm as a function of pH  
 
For usefulness in biological applications, pH sensitivity under physiological conditions 
(pH 4−7.4) is a major concern. To address this, Dr. Song measured the fluorescence intensity of 
35 at 523 nm from pH 1−12.22 As Figure 28 shows, the fluorescence intensity is relatively 
constant from pH 5.5−9.5, indicating its robustness around physiological pH. However, above 
and below this pH range, the intensity significantly drops.  
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Figure 29. Structure of Pittsburgh Green as a function of pH 
 33 
300 350 400 450 500 550 600
0.0
0.1
0.2
0.3
0.4
0.5
f
a
A
b
s
o
rb
a
n
c
e
Wavelength /nm
a: pH = 0.95
b: pH = 2.67
c: pH = 4.08
d: pH = 5.18
e: pH = 6.40
 f: pH = 7.52
a
f
300 350 400 450 500 550
0.0
0.1
0.2
0.3
0.4
0.5
Wavelength /nm
A
b
s
o
rb
a
n
c
e g: pH = 8.03
h: pH = 9.01
 i: pH = 10.41
 j: pH = 11.02
k: pH = 11.62
 l: pH = 12.47
g
l
l
g
 
Figure 30. UV absorption spectra of Pittsburgh Green as a function of pH 
 
The weaker fluorescence above pH 10 could be due to deprotonation of the 
hydroxymethyl group followed by subsequent cyclization to form a cyclic ether, which is 
analogous to the nonfluorescent, cyclic lactone structure of DCF (Figure 29).4 To confirm this 
hypothesis, Dr. Song measured the UV absorption spectrum as a function of pH.22 As Figure 30 
shows, as the pH is raised, the peak at 506 nm decreases and a new peak at 302 nm emerges, 
which could be an indication of such a cyclic structure. As the pH is decreased, the peak at 506 
nm also decreases with a subsequent increase in a new peak at 457 nm. This new peak could be 
indicative of a fully protonated, non-cyclic form of 35. In fact, a similar peak is also known for 
DCF at 440−450 nm. Dr. Song also measured the pKa of the phenolic hydroxy group and found it 
to be nearly identical to that of DCF (pKa  (35) = 4.27).22  
2.2.3 Biological Applications of Pittsburgh Green and Pittsburgh Yellowgreen 
Zebrafish are becoming increasing popular as a model animal in drug screenings and as a 
research tool.23−25 This is partly because they exhibit high fecundity, small embryo size and are 
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transparent in their early developmental stages, enabling visual inspection in detail. However, a 
drawback of using zebrafish in bioimaging is that zebrafish are not permissive to many 
fluorescent probes, and neither rhodamine nor DCF can penetrate zebrafish embryos.  
In collaboration with the Hukriede group at the University of Pittsburgh Department of 
Microbiology and Molecular Genetics, we set out to determine the permeability of 35 and 36 in 
zebrafish embryos.22 Dechorionated zebrafish embryos were incubated with either compound (25 
µM) for 1 hour and visualized using confocal microscopy to determine compound distribution. 
To our delight, both derivatives were permeable and distributed throughout the embryos 
compared to BODIPY TR Methyl Ester, which was used as a control (Figure 31A-C).26 In fact, 
35, 36 and BODIPY TR Methyl Ester each penetrate the embryos to similar extents (Figure 32D-
L). A further description of this figure follows below. 
 
 35 
 
Figure 31. Pseudocolored images of stained zebrafish embryos  
35 = green panels (A, D, G, H), 36 = yellow panels (B, E, I, J) or BODIPY TR Methyl Ester = red panels (C, F, K, 
L). Scale bars = 100 mm. K. Koide, F. Song, E. D. de Groh, A. L. Garner, V. D. Mitchell, L. A. Davidson, N. A. 
Hukriede: Scalable and Concise Synthesis of Dichlorofluorescein Derivatives Displaying Tissue Permeation in Live 
Zebrafish Embryos. ChemBioChem. 2008, 9, Pages 214−218. Copyright Wiley-VCH Verlag GmbH & Co. KGaA. 
Reproduced with permission. 
 
Figure 31A-C shows representative examples from a group of 20 stained embryos 
showing the labeling consistency of the compounds. In all cases, the compounds are more highly 
concentrated in the yolk sac and yolk extension than in the embryo itself, which is likely the 
result of compound accumulation within the lipidic yolk platelets that comprise almost the entire 
volume of the yolk.27 Figure 31D-F shows 80 mm confocal Z projections of the head region 
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demonstrating that compound penetration extends to the embryonic interior. Structures 
containing little organic material, such as the calcified otoliths (indicated by arrows) are not 
labeled. Figure 31G, I, K shows 80 mm Z projections of the tail region taken just above the 
posterior end of the yolk sac (anterior to the left). Figure 31H, J, L shows 1 mm slices from the 
tail projections illustrating that the compounds label the notochord sheath and surrounding tissue, 
but are not found in notochord vacuoles.  
 The toxicity of the fluorophores was next examined because possible signs of toxicity 
were detected at 25 µM, including narrowing of the yolk extension and ventral curling of the tail. 
22 Embryos were exposed to either compound (25−0.25 µM) from 3.5 h post fertilization (hpf) to 
48 hpf. While 35 showed limited toxicity at 8 µM, 36 showed limited toxicity only at 2.5 µM 
indicating that it could potentially impact zebrafish development to a greater extent. These data 
are consistent with observations from the staining experiments. Nonetheless, these results 
strongly indicate the potential for these compounds as useful tools in bioimaging.  
2.3 CONCLUSION 
In collaboration with Dr. Song, two new DCF derivatives, Pittsburgh Green (35) and Pittsburgh 
Yellowgreen (36), have been developed each of which contain a hydroxymethyl group in place 
of the carboxyl group of the fluorescein scaffold. These compounds possess desirable properties 
for bioimaging in terms of fluorescence emission and pH insensitivity, and also provide access to 
further functionalization. The synthesis of these new fluorophores requires only three steps, all of 
which are scalable. Furthermore, these compounds exhibited desirable staining and permeation 
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in zebrafish embryos. Thus, these fluorophores should find many applications as new fluorescent 
sensors. 
2.4 EXPERIMENTAL 
2.4.1 General Information 
All reactions were carried out under a nitrogen atmosphere with freshly distilled solvents under 
anhydrous conditions, unless otherwise noted. Tetrahydrofuran (THF) was distilled from 
sodium-benzophenone, and methylene chloride (CH2Cl2) was distilled from calcium hydride. 
Yields refer to chromatographically and spectroscopically (1H NMR) homogenous materials, 
unless otherwise stated. 
All reactions were monitored by thin-layer chromatography (TLC) carried out on 0.25-
mm EMD silica gel plates (60F-254) using UV light (254 nm). TSI silica gel (230−400 mesh) 
was used for flash column chromatography. 
NMR spectra were recorded on AM300 (Bruker) instruments and calibrated using a 
solvent peak or tetramethylsilane as an internal reference. The following abbreviations are used 
to indicate the multiplicities: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad. 
Mass spectra were obtained from a Micromass Autospec double focusing instrument. 
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2.4.2 Synthesis 
Compound 29. A 1.0-L round bottom flask was charged with 2’,7’-dichlorofluorescein (20.7 g, 
51.9 mmol), DMF (175 mL), K2CO3 (21.5 g, 155 mmol) and allyl bromide (13.5 mL, 155 mmol) 
at 24 °C. The reaction mixture was stirred at 24 °C for 16 h under laboratory atmosphere and 
then poured into 2.0 L water. The resulting precipitate was collected via vacuum filtration, 
washed with water and dried in vacuo to yield 29 as a red-orange solid (24.8 g; quantitative 
yield). 
 
Compound 34.  A solution of compound 29 (4.80 g, 10.0 mmol) in 
CH2Cl2 (40 mL) was treated with DIBALH (48 mL, 1.0 M in hexanes, 
48.0 mmol) dropwise over 15 min at -78 °C under a nitrogen 
atmosphere. The mixture was stirred for 5 min at the same temperature and then was warmed to 
24 °C. After 2 h, Et2O (90 mL) was added and the reaction mixture was quenched with saturated 
aqueous NH4Cl (15 mL) at 0 °C. This mixture was warmed to 24 °C again and stirred for 1 h. A 
second portion of Et2O (180 mL) was added to the mixture followed by DDQ (2.50 g, 11.0 
mmol) at 0 °C.  After stirring 1 h at 24 °C, the mixture was filtered through Celite® and washed 
with EtOAc. The filtrate was dried over Na2SO4 and the solvents were evaporated under reduced 
pressure. Silica gel flash chromatography of the residue (5 → 10 % EtOAc in hexanes) afforded 
compound 34 as a pink solid (3.43 g, 80%).  
Data for 34: mp = 167−168 °C; Rf = 0.69 (50% EtOAc in hexanes); IR (in CH2Cl2): 3385 
(br, OH), 3077, 2923, 2855, 1608, 1486, 1410, 1266, 1191, 1032, 875, 725 cm-1; 1H NMR (300 
MHz, CDCl3, 293K): δ 7.37−7.40 (m, 2H, Ar), 7.26−7.30 (m, 1H, Ar), 6.89 (s, 1H, Ar), 6.87 (s, 
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1H, Ar), 6.84 (m, 1H, Ar), 6.83 (s, 1H, Ar), 6.73 (s, 1H, Ar), 6.05 (ddt, J = 17.4, 10.2, 5.1 Hz, 
1H, 2′′-H), 5.47 (ddt, J = 17.4 , 3.0, 1.5 Hz, 1H, 3′′-Htrans), 5.32 (ddt, J = 10.2, 3.0, 1.5 Hz, 1H, 
3′′-Hcis), 5.28 (s, 2H, 1′′′-H), 4.63 (ddt, J = 5.1, 1.5, 1.5 Hz, 2H, 1′′-H); 13C NMR (75 MHz, 
CDCl3, 293K): δ 154.6, 152.1, 150.1, 149.5, 143.6, 138.6, 132.1, 129.6, 128.7 (two carbons), 
128.6, 123.7, 121.0, 118.2, 118.1, 118.0, 117.2, 115.6, 103.7, 101.5, 83.1, 72.3, 69.8;  HRMS 
(ESI) m/z calcd. for C23H17Cl2O4 [M+H]+ 427.0504, found 427.0519. 
 
Compound 35.  A solution of compound 34 (214 mg, 0.50 mmol) in THF 
(6 mL) was treated morpholine (48 µL, 0.55 mmol), sodium borohydride 
(22.7 mg, 0.60 mmol) and Pd(PPh3)4 (2.9 mg, 0.0025 mmol) at 24 °C. After 
3 h, 3 N HCl (1 mL) was added to quench the reaction. The mixture was extracted with EtOAc, 
dried over Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified 
by silica gel flash chromatography (3% MeOH in CH2Cl2) to afford compound 35 as an orange 
solid (180 mg, 93%).  
Data for 35: mp > 270 °C; Rf = 0.18 (50% EtOAc in hexanes); IR (in CH2Cl2): 3174 (br, 
OH), 2930, 1634, 1593, 1584, 1521, 1347, 1273, 1043, 839 cm-1; 1H NMR (300 MHz, CD3OD, 
293K): δ 7.42−7.47 (m, 2H, Ar), 7.32−7.37 (dd, J = 7.5, 7.5 Hz, 1H, Ar), 6.85 (d, J = 7.5 Hz, 1H, 
Ar), 6.78 (s, 2H, Ar), 6.74 (s, 2H, Ar), 5.28 (s, 2H, 1′′-H). 13C NMR (75 MHz, CD3OD, 293K): δ 
155.5, 151.3, 145.5, 140.3, 130.7, 129.9, 124.7, 122.4, 118.2, 117.6, 104.5, 84.8, 73.2 (Although 
20 peaks expected, only 13 peaks detected); HRMS (EI) m/z calcd. for C20H12Cl2O4 M+· 
386.0113, found 386.0108. 
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Compound 36. A solution of compound 34 (1.43 g, 3.35 mmol) in Ph2O (5 
mL) was stirred at 150 °C for 12 h. After cooled to 24 °C, the reaction 
mixture was transferred directly to a silica gel column. The column 
chromatography was performed with 10 % isopropyl alcohol in hexanes to 
afford compound 36 as a red-orange solid (1.15 g, 80%).  
Data for 36: mp = 186−188 °C; Rf = 0.59 (50% EtOAc in hexanes); IR (in CH2Cl2): 3305 
(br, OH), 3074, 2923, 2855, 1635, 1598, 1482, 1446, 1356, 1278, 1213, 737 cm-1; 1H NMR (300 
MHz, CDCl3, 293K): δ 7.42−7.35 (m, 2H, Ar), 7.30−7.28 (m, 1H, Ar), 6.89−6.87 (m, 3H, Ar; 
overlap of two singlets and one doublet), 6.77 (s, 1H, Ar), 6.01 (ddt, J = 17.4, 9.9, 6.3 Hz, 1H, 
2′′-H), 5.29 (br s, 2H, 1′′-H), 5.14 (dd, J = 17.4, 1.7 Hz, 1H, 3′′-Htrans), 5.05 (dd, J = 9.9, 1.5 Hz, 
1H, 3′′-Hcis), 3.63 (br d, J = 6.3 Hz, 2H, 1′′-H); 13C NMR (75 MHz, CD3OD, 293K): δ 155.3, 
152.5, 151.2, 149.2, 145.3, 140.1, 138.7, 130.4, 129.8 (two carbons), 127.6, 124.6, 122.2, 118.6, 
118.1, 117.5, 117.3, 117.1, 115.6, 104.4, 85.0, 73.0, 29.0; HRMS (EI) m/z calcd. for C23H16Cl2O4 
M+· 426.0426, found 426.0419. 
2.4.3 UV and Fluorescence Spectroscopy 
UV-visible spectroscopy. Absorption spectra were acquired on a Pekin Elmer Lambda 19 UV-
Visible spectrometer under the control of a Windows-based PC running the manufacturers’ 
supplied software.  
 
Fluorescence spectroscopy. Fluorescence spectra were recorded in a 1 × 1-cm quartz cuvette on 
a Jobin Yvon FluoroMax-3 spectrometer under the control of a Windows-based PC running 
FluorEssence software. The samples were excited at 497 nm and the emission intensities were 
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collected at 523 or 535 nm. All spectra were corrected for emission intensity using the 
manufacturer supplied photomultiplier curves. 
 
Relative Quantum Yields. To determine quantum yields relative to fluorescein, stock solutions 
of 35 and 36 were prepared in DMSO (1 mM) and diluted in borate buffer (pH = 10) to OD490 = 
0.12. The samples were excited at 490 nm and the integrated emission spectra were compared. 
The quantum yields of all compounds were referenced to fluorescein in 0.1 N NaOH (Φ = 
0.95).28 
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3.0  FLUOROMETRIC DETECTION OF PALLADIUM 
3.1 RESEARCH DESIGN 
In the synthesis of Pittsburgh Green (35), the final step involves a Pd-catalyzed deprotection of 
the allyl ether (Figure 26).1 Since it is known that such protection of the phenolic moiety 
prohibits fluorescence emission,2 it was envisioned that this transformation could serve as a 
novel detection method for palladium. More specifically, by deprotecting the allyl ether of 
compound 34, a nonfluorescent compound is coverted to a fluorescent compound 35 (Pittsburgh 
Green) (Figure 32). The proposed approach is conceptually new for metal detection because the 
metal analyte amplifies fluorescence signal directly through a catalytic process, which is 
analogous to the fluorometric enzyme assays previously described. 
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Figure 32. Pd-catalyzed transformation from a nonfluorescent to a fluorescent molecule  
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3.1.1 Tsuji-Trost Reaction 
The chemical principle in which this palladium sensing method is based is a variant of the Pd-
catalyzed allylic alkylation chemistry independently reported by Tsuji and Trost in the late 
1960’s−early 1970’s.3−9 The mechanism of this transformation is shown below in Figure 
33.6,10−12 
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Figure 33. Mechanism of Tsuji-Trost reaction 
 
 The reaction mechanism begins with the reduction of PdII by a ligand to form Pd0L4. If a 
Pd0 catalyst, such as Pd(PPh3)4, is used, then this reduction step will be eliminated. Since this 
species is a stable 18-electron species, it must first dissociate from the ligand to form reactive 
Pd0L2 with available d-orbitals (14-electrons on palladium). It is important to note that the 
potential for formation of this 18-electron species is highly dependent upon the electron density 
of the ligand; electron-rich phosphines such as Ph3P are more likely to promote formation of this 
unreactive complex than electron-poor ligands.6 This active Pd0 catalyst will then oxidatively 
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insert into the C−X bond to form a π-allyl palladium intermediate. Typical leaving groups (X) 
include acetate, halides, sulfones, carbonates, epoxides and phenoxides.9 The reaction is then 
speculated to take place through a cationic π-allyl palladium species.4,6,13−15 Formation of this 
intermediate was initially proposed by Trost because of the requirement of excess Ph3P and the 
finding that only soft nucleophiles were successful.4,5 In one case it has been shown that such a 
cationic species was 100 times more reactive than a neutral π-allyl palladium species towards 
nucleophilic substitution.12 Nucleophilic addition to the cationic complex then occurs and 
substitution is favored at one of the allylic termini in the presence of an appropriate nucleophile. 
Typical nucleophiles include malonate anion, nitrogen nucleophiles, sulfur nucleophiles, oxygen 
nucleophiles and organometallics (dialkylzincs, Grignards, organoaluminum reagents, etc.).9 
Dissociation from the product regenerates the active Pd0 species to turnover another substrate 
molecule. 
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Figure 34. Pd-catalyzed deallylation in the Roche synthesis of Tamiflu 
  
 Although this reaction was initially developed as a method of carbon-carbon or carbon-
heteroatom bond formation, it quickly found application in the deprotection of allyl carboxylates 
and allyl ether moieties.16 For example, the synthesis of the influenza drug, Tamiflu, includes a 
Pd-catalyzed deallylation as a final synthetic step where allylamine 38 is converted to the free 
amine salt in 39 (Figure 34).17 In the case of deprotection, the nucleophilic moiety is used as a 
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scavenger to release the leaving group, which in this case is the product. Common scavengers 
include nitrogen nucleophiles such as morpholine,18 hydride sources (formic acid, tributyltin 
hydride and sodium borohydride)19 and sulfur nucleophiles such as 2-thiobenzoic acid.20  
 This same mechanistic principle can be applied to fluorometric palladium detection 
(Figure 35). In this case, Pd0 catalyzes the oxidative insertion to cleave the allylic C−O bond of 
the nonfluorescent allylic ether 34 to form the palladium complex 40. This complex then reacts 
with a nucleophile to form the fluorescent compound 35 and an allylated nucleophile. Since this 
process is catalytic with respect to Pd0, the analyte (palladium) amplifies fluorescence signal. 
This is the first example of a system where the metal analyte amplifies fluorescence signal 
directly through a catalytic process. 
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Figure 35. Mechanism of fluorometric palladium detection method 
 
A similar ruthenium-catalyzed allylcarbamate cleavage to yield fluorescent rhodamine was 
previously reported by the Meggers group although not for ruthenium detection (Figure 36).21 
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Figure 36. Ruthenium-catalyzed allylcarbamate cleavage to yield rhodamine 
3.1.2 Importance of Palladium Detection 
Palladium is a widely used precious metal in materials and chemistry. With respect to materials, 
palladium is found in electronics, dental amalgams, catalytic converters, fuel cells and jewelry. 
However, despite the importance of palladium in such materials, a major downfall is the 
subsequent pollution of the environment that comes with the frequent use of this metal.22 One of 
the major sources of palladium pollution is the particulate palladium that is emitted due to 
automobile catalytic converter attrition.23−27 While the palladium concentration in the earth’s 
crust is estimated as 0.4 µg/kg, palladium contamination found in the environment is estimated 
as 2−400 times this amount.22 For example, studies have shown the following amounts of 
palladium in environmental samples:  road dust = 20−146 µg/kg; soil = <0.7−47 µg/kg; sewage 
sludge = 18−260 µg/kg; and fresh water = 0.5−22 ng/L.22 These sources of palladium are often 
attributed to the presence of this metal in human bodies.28,29 
 With respect to chemistry, the benefits of palladium are quite expansive and numerous 
compounds, including active pharmaceutical ingredients (API), can be synthesized using Pd-
catalyzed cross-coupling reactions such as the Buchwald-Hartwig, Heck, Sonogashira and 
Suzuki-Miyaura reactions.30,31 Some examples of APIs synthesized using Pd-catalyzed cross-
coupling chemistry are shown in Figure 37.31 The carbon-carbon bond formed using a Pd-
catalyzed reaction is indicated in red. 
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Figure 37. Examples of APIs synthesized using Pd-catalyzed cross-coupling chemistry 
 
Refecoxib is a COX-II inhibitor, which was prepared using a Suzuki-Miyaura cross-coupling 
reaction as a key step. Eniluracil is a widely used anticancer agent, which was synthesized using 
Sonogashira chemistry. Cefprozil, an orally active antibiotic, was synthesized via a tin-mediated 
Stille cross-coupling reaction.  
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Figure 38. Pd contamination problem in the pharmaceutical and synthetic communities 
 
 Despite the frequent and fruitful use of such reactions in the synthetic community, one 
major setback to these reactions is the high level of palladium that is often found in the resultant 
synthetic compounds.32−34 Although there is little known about the specific biological effects of 
palladium, the metal, particularly in its cationic forms, has potential to bind proteins, DNA or 
other biomolecules, and thus may be a health hazard.22,33 As a result, the proposed dietary intake 
is <1.5−15 µg/day per person and the threshold for palladium in APIs is 5−10 ppm.33 Because 
compounds synthesized via Pd-catalyzed reactions often contain much more palladium than this 
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threshold limit (typically 300−1000 ppm), extensive purifications are required to remove these 
impurities (Figure 38).34−38 This quality control process can be quite time-consuming and the 
streamlining of such methods could greatly aid in getting new drugs to market. 
3.1.3 Current Detection Methods for Palladium 
Current techniques of quantifying palladium typically rely on spectroscopic methods such as 
atomic absorption spectroscopy, x-ray fluorescence and inductively-coupled plasma emission 
spectroscopy. Further descriptions of each of these methods follow below including their 
detection limit for palladium. 
Atomic absorption spectroscopy (AAS) is a method in which a small volume of a sample 
(~20 µL) or a small amount of solid (0.1−1.0 mg) is atomized at very high temperature, typically 
by a graphite furnace, and the element is detected by its unique absorption spectrum.39 The 
samples are then analyzed by measuring the amount of light emitted, which directly correlates to 
the amount of the metal in the sample. Although this method is sensitive (detection limit for Pd = 
1−3 ng/mL),40 there are a number of drawbacks with this spectroscopic technique.39 Most 
importantly, AAS is extremely sensitive to the matrix of the sample, which makes analysis of 
field samples difficult. For example, many heavy metals (Pb, Co, Ni, Zn, Cu, Fe, K, Mn) cause 
spectral interference in palladium detection. In addition, many reagents used in sample 
preparation and the presence of chloride can also negatively impact signal through non-spectral 
interference. 
X-ray fluorescence (XRF) is a method in which samples are bombarded with high energy 
x-rays and emission of fluorescence radiation from elemental ions is detected.39 Although this 
method requires less sample preparation and preconcentration and is typically faster, it is less 
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sensitive than other spectroscopic techniques for quantifying palladium. The detection limit 
using energy-dispersive XRF is 2 ppm for palladium.41 
The most sensitive method for detecting trace quantities of palladium is inductively-
coupled plasma emission spectroscopy (ICP-MS). In ICP-MS, a sample (solid, liquid or gaseous) 
is ionized by a high temperature (~6000 °C) ICP torch and directed to a quadrupole mass 
spectrometer for detection.39 Using this method, as low as 1−10 ppt of Pd can be detected, but 
more typically quantities between 30−200 ppb.40 Similar to AAS, ICP-MS also suffers from 
spectral and non-spectral interferences.39,40,42 Known spectral interferences (overlapping m/z) for 
palladium are Cu, Zn, Ge, Se, Mo, Zr and Cd among others. Non-spectral interferences are 
typically due to sample preparation or the sample matrix. Such interferences can also be due to 
the instrument itself (transport into the plasma source, problems in the ionization or ion transport 
into the quadrupole). Despite these drawbacks, ICP-MS is the most commonly employed 
spectroscopic technique for quantifying palladium in environmental, biological and chemical 
samples. 
 In general, each of these methods require large and expensive instruments and highly 
skilled individuals to operate. In addition, such operations require great caution because the 
electrode can be cross-contaminated.43 Due to the linear nature of these analyses, such 
techniques are not amenable to high throughput analysis. A fluorescent method would be more 
desirable because the measurement requires a far less expensive bench-top or hand-held 
fluorometer or even a simple laser pen. Moreover, the samples in fluorescent methods are not 
cross-contaminated because disposable cuvettes (~10 cents/cuvette; 340−800 nm) and multi-well 
plates are readily available, facilitating high throughput analysis. Therefore, a more desirable 
approach would rely on high-throughput fluorescent detection. 
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3.1.4 Fluorescent Sensors for Palladium 
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Figure 39. Other fluorescent detection methods for palladium 
 
 In addition to our fluorescent sensor for palladium based on the Tsuji-Trost allylic 
oxidative insertion mechanism1, two other palladium sensors have been developed and are 
depicted in Figure 34. In 2004, the Tang group developed sensor 41 based on the salicyladehyde 
furfuralhydrazone scaffold (SAFH) (Figure 39a).44 In this method, PdII catalyzes the oxidation of 
41 to an unknown compound, which emits fluorescence at 460 nm. The sensitivity of this 
method is in the 0−120 ng/mL range with a detection limit of 0.060 ng/mL, and proved to be 
specific for palladium even in the presence of various metal ions and anions. As applications of 
this technique, they demonstrated detection in synthetic and mineral samples; however, one 
potential drawback is the requirement of aqua regia in sample preparation prior to analysis. 
    More recently, the Anslyn group developed colorimetric chemodosimeter 42 for PdII 
detection (Figure 39b).45 In this system, PdII scavenges the thiol of colorless 42 to form a color 
“turn-on” signal from the parent squaraine 43. The detection limit for this method was estimated 
as 0.5 ppm using “naked-eye” detection and 0.1 ppm using instrument-based detection. This 
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technique was then applied to the detection of PdII in samples synthesized via Suzuki-Miyaura 
cross-coupling reactions; however, these samples are must be treated with nitric acid in order to 
convert all Pd species (Pd0 and PdII) to a uniform Pd(NO3)2 species. 
3.2 RESULTS AND DISCUSSION  
3.2.1 First Generation Palladium Sensing Method: Initial Report 
Our first generation palladium sensing method was published in the Journal of the American 
Chemical Society in 2007.1 The key experiments from this publication are discussed below. 
 In order to develop a fluorescent method for palladium, it was desirable to perform the 
conversion of 34 to 35 in aqueous media. More specifically, pH 10 buffer was chosen because a 
442-fold fluorescence enhancement is observed in this solvent. As an initial method, the 
conversion of 34 (10 µM) to 35 was attempted using Ph3P (250 µM) as a reducing agent and 
ligand. As Figure 40a shows, this method was successful and selective for palladium, regardless 
of the metal oxidation state (Figure 40b). It is important to note that this method also exhibited 
modest specificity for platinum (~40%) (see Chapter 4 for a follow-up on this observation). 
Interestingly, other π-electrophilic metals such as Ag, Ni, Au, Rh, Co, Hg and Ru did not afford 
this transformation.  
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                                                      (a)       
 
   (b)                         (c)                        (d) 
  
Figure 40. Fluorescence analysis of Pd  
In these graphs, the y-axis is fluorescence intensity (a. u. × 105) at 523 nm. In all cases, [34] = 10 µM and [Ph3P] = 
100 µM, and the assays were performed for 1 h at 24 °C. (a) Metal specificity of Pd sensing method. A = no metal, 
B = PdCl2, C = PtCl2, D = FeCl3, E = AgNO3, F = NiCl2, G = Pb(NO3)2, H = MnCl2, I = CdCl2, J = AuCl3, K = 
Rh(Ph3P)3Cl, L = CuCl2, M = MgSO4, N = KCl, O = CrCl3, P = CoCl2, Q = HgCl2, R = RuCl3. (b) Fluorescence 
induction with various Pd oxidation states. (c) Correlation between fluorescence intensity and [Pd(PPh3)4] (y = 
0.0443x + 4.46; R2 = 0.994); (d) Proof of concept for Pd detection in drugs. 
 
With this successful palladium detection method, the detection limit of this method was 
determined. As Figure 40c shows, after 1 h incubation at 24 °C the fluorescence intensity is 
correlated to the concentration of palladium in the 3−300 nM (300 ppt−30 ppb) range. Thus, this 
method should prove amenable for detecting palladium in various samples. 
The applicability of this sensor system for palladium analyses in APIs was next 
examined. As a proof of concept, Dr. Song spiked a solution containing a commercially available 
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aspirin tablet (1.0 mg) with palladium (10 ppm final concentration). As Figure 40d shows, the 
fluorescence signal for the palladium in the aspirin tablet was nearly that of the positive control, 
which supports the use of this fluorescent method in determining palladium contamination in 
APIs. 
 
                      (a)     (b)    (c) 
 
 
 
Figure 41. Applications of Pd sensing method  
(a) Detection of Pd contamination in a reaction flask. (b) Detection of Pd in rock samples (A = no metals; B = Pd/Pt, 
120 ppm; C = Au/Ag; Rock D = Pd/Pt, 35 ppm). (c) Detection of Pd with the naked eyes (1 = PdCl2 (9.4 µmol), 
dimethylglyoxime; 2 = PdCl2 (9.4 µmol), Sensor, NaBH4; 3 = PdCl2 (30 nmol), dimethylglyoxime; 4 = PdCl2 (30 
nmol), Sensor, NaBH4). 
 
An additional concern with Pd-catalyzed cross-coupling reactions is the potential 
contamination of the reaction vessels in which the reaction was performed. This is especially 
controversial since in recent years many “Pd-free” cross-coupling reactions have been reported, 
which have since come into question.46,47 To test whether this method could detect residual 
palladium in a reaction flask, a THF solution of a Pd0 catalyst, Pd2(dba)3, was stirred in a flask 
for 1 h at 24 °C. After standard washing procedures (brushing with detergent, washing with 
water and acetone), fluorescent detection was attempted in the flask. As Figure 41a shows, after 
1 h at 24 °C Dr. Song was successful at detecting palladium contamination in the flask, which 
provides an application for this sensing method in the quality control of reactors. 
Rock         A      B     C      D  1        2           3      4 
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Current methods of discovering Pd/Pt-containing rock samples typically involve the 
spectroscopic methods previously described, which cannot be performed at the mining site. As a 
result, this method may find application in such processes, which can be employed on site with 
the use of a hand-held fluorometer. Rock samples were obtained from Stillwater Mining 
Company, each containing either no metal, Pd/Pt or Au/Ag. As Figure 41b shows, only rocks 
containing Pd/Pt exhibited fluorescence signal demonstrating the viability of our sensor in Pd/Pt 
detection at mining sites. 
As a final application, palladium detection with the naked eyes was attempted. This 
potential was noted with the first Pd-catalyzed deallylation reaction performed because the THF 
solution goes from colorless to red/pink nearly instantaneously to signal reaction progress. Dr. 
Song then compared this method with the well-known spot test for palladium using 
dimethylglyoxime. The results are shown in Figure 41c where vials 1 and 3 are the spot test 
results and vials 2 and 4 are the results with our sensor. As Figure 41c indicates, only those 
solutions containing sensor 34 exhibited a color change detectable with the naked eyes even at 
30 nmol further the demonstrating the utility of this sensing method. 
3.2.2 First Generation Palladium Sensing Method: Further Studies 
 Following the initial report describing the palladium sensing method, I wished to further 
study this transformation. Described below are more in-depth studies concerning 34. 
 While the initial experiments were performed in 100% pH 10 buffer, DMSO was added 
as a co-solvent to aid in the solubility of organic compounds that may be tested using this 
method. As Figure 42a shows, the addition of DMSO has some effect on the fluorescence 
intensity of 35; however, this effect is minor. With respect to 34, the fluorescence intensity 
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appears to slightly increase as a function of DMSO content. As a result of these experiments, it 
was concluded that 5−20% DMSO would be ideal for testing synthetic compounds, and all 
remaining experiments were conducted using 20% DMSO/buffer as a solvent.  
     
         (a)          (b)              (c) 
   
                   (d)             (e) 
  
Figure 42. Fluorescence analysis of Pd  
In these graphs, the y-axis is fluorescence intensity (a. u. × 105) at 525 nm. In all cases, [34] = 12.5 µM and [Ph3P] = 
250 µM, and the assays were performed for 1 h at 24 °C. (a) Effect of % DMSO on fluorescence intensity of 
sensors, black = 34, gray = 35. (b) pH-dependent deallylation of 34 in the presence of PdCl2 (625 nM) in 1:4 
DMSO/buffer. (c) Initial rate analysis for deallylation of 34 in the presence of PdCl2 (1 mol %) in 1:1 DMSO/buffer. 
♦ = pH 4; y = 2.26x + 0.400; R2 = 0.999.  = pH 7; y = 2.73x + 2.25; R2 = 0.999.  = pH 10; y  = 3.13x + 2.75; R2 
= 0.986. (d) Correlation between fluorescence intensity and [PdCl2] in 1:4 DMSO/pH 7 buffer. (e) Fluorescence 
induction by various Pd species and oxidation states. In all cases, [Pd] = 5.0 µM. A = no Pd, B = Pd(PPh3)4, C = 
PdCl2, D = Pd(OAc)2, E = Pd(acac)2, F = Pd(PPh3)2Cl2, G = Pd(MeCN)2Cl2, H = Pd2(dba)3, I = K2PdCl6. 
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 To determine the optimal pH of the palladium-catalyzed deallylation reaction pH 
dependence in the optimal range for 35 (pH = 4−10) was examined.48 As Figure 42b shows, the 
ideal pH with respect to fluorescence intensity lies between pH 6−9. The pH dependence results 
were then followed up with kinetic assessment. The initial rates were measured at pH 4, 7 and 10 
(1:1 DMSO/buffer) using PdCl2 as a catalyst (1 mol %). As Figure 42c shows, reaction occurs at 
all pHs tested and the rate at pH 10 is fastest although the intensity is lower at this pH due to 
nonfluorescent cyclic ether formation. The rate at pH 7 was only ~10% slower. From these data, 
it was deduced that pH 7 is best for palladium fluorescence analysis because it allows for optimal 
fluorescence intensity and rate.  
 Using these conditions, the catalytic efficiency and sensitivity of this method was next 
examined. The turnover frequency (TOF) for palladium in pH 7 buffer under the high dilution 
and salt conditions ([34] = 12.5 µM; [Pd] = 50 nM; [PO43-] = 50 mM) was determined as 3.1 h-1. 
In terms of the quantitative nature of this method for palladium, the fluorescence intensity 
correlated to the concentration of palladium in the 10 nM–500 nM (1–50 ppb) range after 4 h at 
24 °C (Figure 42d). 
 Although excess Ph3P is used to fully reduce the palladium species present, other ligands 
may initially be coordinated to the metal. As such, the generality of this method using a variety 
of palladium reagents with oxidation states of 0, +2 and +4 was tested. As Figure 42e shows, this 
method is general for many different palladium species, and thus is successful at effectively 
converting all palladium to reactive Pd(PPh3)n species regardless of other ligands present in the 
solution. A similar experiment involving various ligands surrounding palladium would be 
difficult with ICP-MS because it is extremely sensitive to the chemistry within the coordination 
sphere of the metal.40 As such, all samples are required to undergo rigorous pre-treatment with 
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concentrated acid, typically hydrochloric acid, which is necessary to stabilize the chloro-
complexes of the metal to obtain a uniform signal. Additionally, the presence of other non-halide 
ligands may cause undesired spectral interferences. 
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Figure 43. Pd detection in a synthetic sample 
(a) Synthetic transformation of Pd-contaminated sample. (b) In this graph, the y-axis is fluorescence intensity (a. u. 
× 105) at 525 nm. The Pd assay was performed in the presence of 34 (12.5 µM) and Ph3P  (250 µM) for 1 h at 24 °C. 
Left = no Pd; Middle = standard (PdCl2; 5 µM); Right = synthetic sample. 
 
 The palladium sensing method was next used to detect palladium content in an actual 
sample. This method was tested on a purified, indole derivative prepared by a Pd(PPh3)4-
catalyzed Suzuki cross-coupling reaction by Sami Osman. A solution of the purified synthetic 
sample (5.0 mg) in 1:4 DMSO/pH 7 buffer was treated with 34 and Ph3P to promote the Pd0-
catalyzed deallylation (Figure 43). The content of Pd was estimated as 14 µM (1200 ppm; 1200 
ng/mg) based on relative fluorescent intensities compared to the standard (PdCl2, 5.0 µM). Thus, 
this method is successful even in the presence of a potentially chelating nitrogen ligand and 
should find broad application for palladium analysis in pharmaceuticals. From the strong signal 
with the 5-mg sample, we propose that 0.1−1.0 mg of samples should be sufficient. 
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3.2.3 Second Generation Palladium Sensing Method 
Despite the successes of the first generation palladium sensing method, this method has 
limitations with respect to sensitivity and catalytic turnover. To enhance these features, a number 
of different phosphine and phosphite ligands were screened. In addition, the combination of each 
reagent with NaBH4 was also examined in attempt to further enhance each ligand’s reducing 
capacity.  
 
        (a)                             (b)          (c) 
  
Figure 44. Examination of alternative phosphine ligands  
In these graphs, the y-axis is fluorescence intensity (a. u. × 105) at 525 nm. In all cases, [34] = 12.5 µM, [phosphine] 
= 250 µM, [NaBH4] = 1.25 mM and [Pd] = 100 nM, and the assays were performed for 1 h at 24 °C. (a) Phosphine 
screening. Black = phosphine only, gray = phosphine and NaBH4. A = no Pd, B = (1R, 2R)-(+)-1,2-
diaminocyclohexane-N,N’-bis(2’-diphenylphosphinobenzoyl), C = tris(2-carboxyethyl)-phosphine, D = bis(2-
diphenylphosphinophenyl)ether, E = 1,1’-bis(diphenylphosphino)ferrocene, F = tris(2,4-di-tbutylphenyl)phosphite, 
G = tri-o-tolylphosphine, H = 1,3-bis(diphenylphosphino)propane, I = 1,2-bis(diphenylphosphino)ethane, J = PPh3, 
K = JohnPhos, L = TFP.  (b) Effect of % DMSO on phosphines. Black = Ph3P, gray = TFP, dark gray = JohnPhos. 
(c) Effect of % DMSO on phosphines and NaBH4. Black = Ph3P, gray = TFP, dark gray = JohnPhos. 
 
 From the phosphine ligand screening, two phosphines in addition to Ph3P were identified 
that promoted the deallylation reaction, tri-2-furylphosphine (TFP) and 2-(di-
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tbutylphosphino)biphenyl (JohnPhos). In the absence of NaBH4 (black in Figure 44a), TFP was 
~3.5 times more efficient than Ph3P and JohnPhos was ~3.2 times more efficient than Ph3P. 
However, in the presence of NaBH4 (gray in Figure 44a), TFP was ~4.1 times more efficient 
than Ph3P and JohnPhos was ~1.9 times more efficient than Ph3P.  
 The effect of DMSO on the reaction with these new phosphine ligands was also 
examined in the absence and presence of NaBH4. As is shown in Figure 44b and 44c, overall the 
reaction is less efficient as the DMSO content is increased; however, TFP with NaBH4 showed 
relatively constant fluorescence intensity from 0−10% DMSO.  
 Interestingly, in organic solvent DMSO is known to take the place of phosphine in its role 
of reducing agent and ligand to ensure formation of the reactive cationic π-allyl palladium 
species.49−51 In this system, the negative impact of DMSO could be the product of a few 
possibilities. Firstly, aqueous solutions of DMSO are known to exist as highly ordered structures, 
particularly upon increasing the mole fraction of DMSO, which is primarily due to hydrophobic 
and hydrophilic hydration of the DMSO molecule.52 This rigidity in the water molecules could 
decrease their likelihood of participating as a nucleophile to turnover palladium in the catalytic 
cycle, which would significantly damper the reaction efficiency.  Secondly, there is the potential 
for increased formation of the cyclic ether form of 35, which may be less reactive than the open 
form, and is a common phenomenon for the fluorescein scaffold (see Figure 21).53 From these 
results, it was concluded that TFP with NaBH4 was the optmal reducing agent/ligand 
combination and 5% DMSO was ideal for maximizing reaction efficiency and fluorescence 
intensity (see Figure 42a). 
 TFP is a well-studied ligand in the organometallics field, and an article in Chemical 
Reviews is dedicated wholly to this ligand and its utility in organic synthesis.54 While this ligand 
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was first discovered to enhance the Stille reaction,55 it has since been applied to a wide variety of 
Pd-, Ni-, Rh- and Ru-catalyzed cross-coupling reactions. For the Stille reaction, the key property 
of TFP is its low electron donating ability, which is proposed to enhance the rate of 
transmetallation into the C−Sn bond. Interestingly, TFP was found to be a poor ligand in allylic 
alkylation chemistry unless a substrate capable of undergoing fast oxidative addition was used;56 
however, in another study, TFP was found to enhance the rate of oxidative addition into aryl-
halide bonds in comparison to Ph3P when DMF was employed as a solvent.57 Although the exact 
mechanism with which TFP enhances the Pd-catalyzed Tsuji-Trost type reaction in aqueous 
solution is not known, it may be speculated that TFP helps to promote the formation of the 
reactive cationic π-allyl palladium intermediate by serving as a weak electron donor, which 
activates it toward nucleophilic attack by either water or phosphate in the buffer. Additionally, 
because it is a weaker ligand, it is less likely to form the stable and unreactive Pd(TFP)4 species.  
 
(a)          (b)             (c) 
      
Figure 45. Optimization studies with TFP  
In these graphs, the y-axis is fluorescence intensity (a. u. × 105) at 525 nm. In all cases, [34] = 12.5 µM, [NaBH4] = 
1.25 mM and [Pd] = 100 nM, and the assays were performed for 1 h at 24 °C. (a) Correlation between fluorescence 
intensity and [TFP]. (b) pH-dependent deallylation of 34 in the presence TFP (500 µM) in 5:95 DMSO/buffer. (c) 
pH-dependent deallylation of 34 in the presence of TFP (500 µM) and NaBH4 in 5:95 DMSO/buffer.  
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 The reaction was first screened to determine the optimal TFP concentration, and as 
Figure 45a shows 400−500 µM is the ideal TFP concentration range. The optimal pH of the Pd-
catalyzed deallylation reaction with TFP in the presence and absence of NaBH4 was next 
examined. Similar to the results with Ph3P (see Figure 42b), the ideal pH in the absence of 
NaBH4 was pH 7 (Figure 45b). In fact, the fluorescence intensity dropped at ± 1 pH unit 
indicating that reaction with this ligand seems to be more sensitive to changes in pH. This is 
mostly likely due to the fact that it is a less electron donating ligand. In the presence of NaBH4, 
however, the ideal pH ranges from pH 6−9 (Figure 45c). From these results, the optimal 
conditions are TFP (500 µM) and NaBH4 (1.25 mM) in 5:95 DMSO/pH 7 buffer. 
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Figure 46. Role of NaBH4 as a nucleophile 
 
 The role of hydride reagents is three-fold: first to reduce PdII to Pd0 to reinitiate the 
catalytic cycle, second to act as a nucleophile to directly attack the allyl group (Figure 46) and 
third to form a highly reactive Pd−H species.58 In addition to NaBH4, formic acid, tributyltin 
hydride and silicon hydrides are known to act in the same capacity.19  
 The sensitivity and catalytic efficiency of the Pd-catalyzed deallylation reaction with the 
new TFP/NaBH4 conditions was next determined. The fluorescence intensity correlated to the 
concentration of palladium in the 1.0 nM−1.0 µM (0.1−100 ppb) range with signal-to-
background (S/B) of 1.1−14 after 4 h at 24 °C (Figure 47a). The detection limit with S/B of 3 is 
42 nM (4.5 ppb) after 1 h and 24 nM (2.6 ppb) after 4 h, which is a 8-fold enhancement 
compared to our previous method (Figure 47c). As this Figure shows, this new method is far 
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superior to the originally reported method with respect to sensitivity (see Figures 40c and 42d).  
The initial rate using these conditions ([Pd] = 100 nM; Figure 47b) was measured and the 
reaction is ~4.8 times greater than that with the previous conditions (see Figure 42c). The TOF 
for Pd using the TFP/NaBH4 method was determined as 14.1 h-1, which is also ~4.5 times greater 
than the previous method. To further demonstrate the robustness of this sensing method, Pd-
catalyzed deallylation of 34 was attempted in coffee (Figure 47d).  
       
                           (a)         (b)                         (c) 
 
         (d)        (e)                                              (f) 
 
Figure 47. Fluorescence analysis of Pd  
In these graphs, the y-axis is fluorescence intensity (a. u. × 105) at 525 nm. In all cases, [34] = 12.5 µM, [TFP] = 500 
µM and [NaBH4] = 1.25 mM, and the assays were performed for 1 h at 24 °C. (a) Correlation between fluorescence 
intensity and [Pd] in 5:95 DMSO/pH 7 buffer. ♦ = 1 h; y = 0.0888x + 1.87; R2 = 0.997.  = 2 h; y = 0.134x + 1.88; 
R2 = 0.997.  = 4 h; y  = 0.165x + 2.01; R2 = 0.993. (b) Comparison of Pd detection methods after 4 h. [Pd] = 100 
nM. A = TFP in 5:95 DMSO/pH 7 buffer, B = TFP/NaBH4 in 5:95 DMSO/pH 7 buffer, C = Ph3P in 1:4 DMSO/pH 
7 buffer, D = Ph3P/NaBH4 in 5:95 DMSO/pH 7 buffer. (c) Initial rate analysis for deallylation of 34 in the presence 
of Pd (100 nM) in 5:95 DMSO/pH 7 buffer. y = 3.50x + 8.5; R2 = 0.942. (d) Pd detection in coffee. A = no Pd, B = 
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100 nM Pd, C = 1.0 µM Pd. (e) Fluorescence induction by various Pd species and oxidation states. In all cases, [Pd] 
= 100 nM. A = no Pd, B = PdCl2, C = Pd(OAc)2, D = Pd(acac)2, E = Pd(PPh3)2Cl2, F = Pd(MeCN)2Cl2, G = 
Pd2(dba)3, H = Pd standard. (f) Fluorescence induction by Pd black (<1.0 mg). Black = with TFP/NaBH4, gray = no 
reducing agents. 
 
 The generality of this method was examined, and it is general for many palladium 
sources (Figure 47e). In addition to soluble palladium species, detection of Pd black was also 
examined (Figure 47f). In the presence of reducing agents (TFP with NaBH4; black in Figure 
47f), detection of the metal is successful; however, in the absence of reducing agents (gray in 
Figure 47f), no detection was observed. Thus, sensor 34 is capable of detecting both soluble and 
insoluble Pd0 species. 
3.2.4 Palladium Detection in Synthetic Samples 
While the previous method was successful in detecting palladium contamination in synthetic 
samples with limited functionality (see Figures 40d and 43), it could not detect palladium in 
compounds containing potentially chelating functional groups such as sulfides. This task is 
extremely difficult for two reasons: (1) there is a very large excess of synthetic compound 
relative to palladium (~100000-fold excess in a 10-ppm Pd contaminated sample), and thus, 
there is greater chance for palladium to remain bound to the synthetic compound rather than 
participate in catalysis; and (2) because palladium is bound to these compounds, each palladium 
species is ligated differently and may react differently. As such, it is important to find a method 
that will not only break the palladium-synthetic compound complexes but will also effectively 
convert all palladium contamination to a uniform species that will react in a predictable manner.  
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 In ICP-MS, these requirements are achieved via sample preparation with concentrated 
nitric acid, typically 1 mg/mL, and in some cases microwave digestion.59−61 This often time-
consuming step is necessary because ICP-MS is extremely sensitive to the chemistry within the 
coordination sphere of the metal. In addition, because of its linearity and time per sample (15−30 
min per sample including instrument washing), analytical laboratories are often overloaded with 
samples and the analyses are significantly delayed (Dr. Christopher Welch, Merck; personal 
communication). Thus, although this method is sensitive (detection limit: 10−100 ppb), a high 
throughput method is greatly needed. 
 Described below are the best conditions to date to accomplish this challenging feat. 
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      (d)             (e) 
 
Figure 48. Pd detection in spiked synthetic compounds  
In these graphs, the y-axis is fluorescence intensity (a. u. × 105) at 525 nm. In all cases, [34] = 12.5 µM, [TFP] = 500 
µM, [NaBH4] = 1.25 mM and [Pd] = 8.5 ppm with respect to the synthetic compound, and the assays were 
performed for 1 h at 24 °C. The error bars in (b)−(d) represent the average standard deviation of the compounds 
from triplicate experiments. (a) Structures of synthetic compounds that were spiked with Pd. (b) Detection of Pd 
contamination in 5:95 DMSO/pH 10 buffer after pretreatment with concentrated HCl (60 mM). A = no Pd, B = 
positive control, C = 44, D = 45, E = 46, F = 47, G = 48, H = 49, I = 50, J = 51, K = 52, L = 53, M = 54, N = 55, O = 
56, P = 57, Q = 58, R = 59, S = 60, T = 61. (c) Detection of Pd contamination in 5:95 DMSO/pH 7 buffer (150 mM) 
after pretreatment with concentrated HCl (60 mM). A = no Pd, B = positive control, C = 44, D = 45, E = 46, F = 47, 
G = 48, H = 49, I = 50, J = 51, K = 52, L = 53, M = 54, N = 55, O = 56, P = 57, Q = 58, R = 59, S = 60, T = 61. (d) 
Pd detection in the presence of 62 or 63 ([Pd] = 100 nM; [62/63] = 500 nm). A = no Pd, B = positive control, C = Pd 
+ 62, D = Pd + 63. Black = pH 10 method, gray = pH 7 method. (e) Pd detection in the presence of equimolar Ph3P 
or dba (64) ([Pd] = 100 nM; [Ph3P/64] = 100 nM). Black = no 54, gray = Pd + 54, dark gray = Pd + 54 + Ph3P/64. A 
= no Pd, B = Ph3P, C = 64.  
 
Toward this goal, a pretreatment method was developed that met both of the criteria 
described above. Using ampicillin (55; Figure 48a) as a model compound since it is an example 
of a highly functionalized, drug-like compound, many different pretreatment methods (not 
shown) were examined, and it was found that treatment of 5 mg of compound in DMSO (200 
µL) with 12N HCl (20 µL) was successful in consistently recovering fluorescence signal. This 
method was then used to examine palladium detection in a variety of functionalized organic 
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compounds (Figure 48a). To my delight, treatment of solutions of Pd-spiked samples ([Pd] = 8.5 
ppm in the compound) in DMSO with 12N HCl followed by dilution with pH 10 buffer and 
addition of TFP, NaBH4 and 34 led to successful recovery of fluorescent signal (31−153%) for a 
variety of molecular structures (Figure 48b) after 1 h incubation at 24 °C. These molecules 
include potentially chelating atoms found in many privileged structures and drug-like 
compounds (nitrogen, sulfur), potentially reactive groups (bromobenzene, 2-butyn-1-ol, 2-
hydroxycinnamic acid) and other fluorophores (carboxyumbelliferone). The fact that quantitative 
recovery can be obtained even in the presence of such a large excess of compound implies 
limited interferences from differences in sample matrix, which is a known problem in ICP-MS. 
One potential problem with this method, however, became apparent after examination of 
the unsuccessful compounds. Amines are largely unprotonated at pH 9−10, and this should 
enhance their ability to chelate to palladium. In order to mask amines, the Pd-spiked samples in 
DMSO were treated with 12N HCl followed by dilution with pH 7 buffer ([PO43-] = 150 mM) to 
ensure overall pH 7 in the final solution. TFP, NaBH4 and 34 were then added and the samples 
were incubated for 1 h at 24 °C. As Figure 48c shows, this method was successful in recovering 
fluorescence signal in the presence of amines. However, signal was lost with sulfur and 
carboxylic acid-containing compounds. Thus, through the choice of the two pHs, palladium 
contamination can be determined in a variety of functionalized small molecules.  
In order to remove palladium from synthetic samples, many methods utilize sulfur-based 
reagents such as thiourea and N-acetylcysteine.33,34,36 Residual amounts of these reagents can 
also be found in samples after removal operation. Thus, it is important for this method to be able 
to detect palladium even in the presence of these reagents. Although the method failed to detect 
palladium in the presence of 85000 equivalents of 62 and 63, as Figure 48d shows palladium can 
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successfully be detected in the presence of 5 equivalents of each of these reagents, which is a 
more realistic content. In addition to S-based ligands, other potentially chelating ligands (not the 
actual synthetic compound) may also be present; and as Figure 48e shows, ligands such as Ph3P 
and dba (64) (1 equivalent) do not interfere. 
3.3 CONCLUSION 
In collaboration with Dr. Song, a highly sensitive and robust fluorescent sensor (34) has been 
developed for palladium based upon the Tsuji-Trost allylic oxidative insertion mechanism. This 
method allows for the detection of total quantities of palladium at sub-ppb levels. Importantly, 
fluorescent detection of palladium in synthetic samples has been demonstrated. This sensor 
technology should change the paradigm of palladium analyses and find broad applications in 
materials, energy and human health. 
3.4 EXPERIMENTAL 
3.4.1 General Information 
PdCl2, PdCl2(PPh3)4, Pt(PPh3)4, PtCl2 and H2PtCl6•6H2O were purchased from Alfa Aesar and 
used as received. Pd(PPh3)4, Pd(acac)2, PdCl2(MeCN)2 and K2PdCl6 were purchased from Strem 
and used as received. Pd(OAc)2 was purchased from TCI and used as received. Aspirin is a 
product of BAYER Co. Buffers were purchased and used as received (pH 4, potassium 
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biphthalate ([biphthalate] = 49.8−50.2 mM), J. T. Baker, Catalog Number 5606-01; pH 7, 
phosphate ([PO43-] = 46−50 mM, [K+] = 23−25 mM, [Na+] = 50−56 mM), J. T. Baker, Catalog 
Number 5608-01; pH 10, borate ([K+] = 94−114 mM), J. T. Baker, Catalog Number 5609-01). 
3.4.2 First Generation Palladium Sensing Method: Initial Report 
Preparation of parent stock solutions used for this study. 
Entry Reagent Quantity Solvent (10 mL) Conc. of stock 
solution 
A compound 34 42.7 mg (0.10 mmol) DMSO 10.0 mM 
B PPh3 262.3 mg (1.00 mmol) DMSO 100 mM 
C PdCl2 9.0 mg (50 µmol) 3:1 Brine/MeOH 5.0 mM 
D Pd(PPh3)4 57.7 mg (50 µmol) DMSO 5.0 mM 
E Aspirin 500 mg pH 10 buffer 10 mg/mL 
Notes:  
(1) All the solutions were stored at 24 °C. 
(2) Solution A was stored in the dark as a precautionary measure. 
(3) Solution B was freshly prepared every 2 weeks. We found that 2 month-old solution of 
PPh3 was not effective presumably due to air-oxidation. 
(4) Each of these stocks with the respective solvent was further diluted to prepare 1.0 
mM−1.0 µM stock solutions. 
 
Fluorescence spectroscopy. Fluorescence spectra were recorded in a 1 × 1-cm quartz cuvette on 
a Jobin Yvon FluoroMax-3 spectrometer under the control of a Windows-based PC running 
FluorEssence software. The samples were excited at 497 nm and the emission intensities were 
collected at 523 nm. All spectra were corrected for emission intensity using the manufacturer 
supplied photomultiplier curves.   
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First generation Pd sensing method. Varying amounts of Pd solution and solution B (5 µL, 
[PPh3]final = 100 µM) were added to pH 10 buffer solution (4.0 mL). Solution A (5 µL, [34]final = 
10 µM) was then added to the mixture, and the samples were incubated for 1 h at 24 °C before 
fluorescence measurement. 
3.4.3 First Generation Palladium Sensing Method: Further Studies 
Preparation of parent stock solutions used for this study. 
Entry Reagent Quantity Solvent (10 mL) Conc. of stock 
solution 
A compound 34 42.7 mg (0.10 mmol) DMSO 10.0 mM 
B PPh3 262.3 mg (1.00 mmol) DMSO 100 mM 
C PdCl2 9.0 mg (50 µmol) 3:1 Brine/MeOH 5.0 mM 
D Pd(OAc)2 2.2 mg (10 µmol) 3:1 Brine/MeOH 1.0 mM 
E Pd(acac)2 3.0 mg (10 µmol) DMSO 1.0 mM 
F PdCl2(PPh3)4 7.0 mg (10 µmol) DMSO 1.0 mM 
G PdCl2(MeCN)2 2.6 mg (10 µmol) 3:1 Brine/MeOH 1.0 mM 
H K2PdCl6 19.9 mg (50 µmol) 3:1 Brine/MeOH 5.0 mM 
I Pd(PPh3)4 57.7 mg (50 µmol) DMSO 5.0 mM 
Notes: See previous experimental 
 
Fluorescence spectroscopy. Fluorescence spectra were recorded in a 1 × 1-cm disposable 
cuvette (VWR; catalog number 58017-880) on a Jobin Yvon FluoroMax-3 spectrometer under 
the control of a Windows-based PC running FluorEssence software. The samples were excited at 
497 nm and the emission intensities were collected at 525 nm. All spectra were corrected for 
emission intensity using the manufacturer supplied photomultiplier curves. 
 
Palladium: buffer screening. PdCl2 solution (25.0 µL of 100.0 µM stock, 625 nM final 
concentration) and solution B (10.0 µL, [PPh3]final = 250 µM) were added to DMSO/pH X buffer 
(1:4) solution (X = 4.0−10.0) (4.0 mL). Solution A (5.0 µL, [34]final = 12.5 µM) was then added 
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to the mixture, and the samples were incubated for 1 h at 24 °C before fluorescence 
measurement.  
 
Palladium: initial rate analysis. PdCl2 stock solution C (50.0 µL, 250 nmol), PPh3 (4.8 mg, 
2.34 µmol) and 34 (10.0 mg, 23.4 µmol) were added to DMSO/pH X buffer (1:1) solution (X = 
4.0, 7.0, 10.0) (20 mL) at 24 °C. The experiment was performed in triplicate. At t = 0.5, 1 and 2 
h, 100 µL aliquots were taken from each reaction mixture and diluted to 4.0 mL with DMSO/pH 
7.0 buffer (1:4) for fluorescence measurement.  
 
Palladium: TOF. To determine the turnover frequency, a solution containing PdCl2 solution 
([PdCl2]final =  50 nM), solution B (10.0 µL, [PPh3]final = 250 µM) and solution A (5.0 µL, [34]final 
= 12.5 µM) was prepared in DMSO/pH 7.0 buffer (1:4). The intensity of this sample was 
compared to a standard solution containing Pittsburgh Green 35 ([35]final = 50 nM) in DMSO/pH 
7.0 buffer (1:4). The intensity of the Pd2+-containing sample was 1.9 × 106 after 7 h at 24 °C and 
the intensity of the standard solution of 35 was 8.8 × 104. The turnover frequency is 1.9 × 106 
/8.8 × 104 = 21.6/7 h = 3.1 h-1. 
 
Palladium: concentration dependence. Varying amounts of Pd solution and solution B (10.0 
µL, [PPh3]final = 250 µM) were added to DMSO/pH 7.0 buffer solution (1:4; [PO43-] = 5 mM) 
(4.0 mL). Solution A (5.0 µL, [34]final = 12.5 µM) was then added to the mixture, and the 
samples were incubated for 4 h at 24 °C before fluorescence measurement.  
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Dependence on palladium reagents. Pd solutions (20.0 µL of 1.0 mM stock, [Pd]final = 5.0 µM) 
and solution B (10.0 µL, [PPh3]final = 250 µM) were added to DMSO/pH 7.0 buffer (1:4) solution 
(4.0 mL). Solution A (5.0 µL, [34]final = 12.5 µM) was then added to the mixture, and the 
samples were incubated for 1 h at 24 °C before fluorescence measurement.  
 
Palladium detection in synthetic sample. The synthetic sample (5.0 mg) was dissolved in 800 
µL of DMSO and pH 7.0 buffer was added (3.2 mL; total volume = 4.0 mL). Solution B (10.0 
µL, [PPh3]final = 250 µM) and solution A (5.0 µL, [34]final = 12.5 µM) were then added to the 
mixture. A positive control was also prepared (PdCl2; [Pd]final = 5.0 µM) and the samples were 
incubated for 1 h at 24 °C before fluorescence measurement.  
3.4.4 Second Generation Palladium Sensing Method 
Preparation of parent stock solutions used for this study. 
Entry Reagent Quantity Solvent (10 mL) Conc. of stock 
solution 
A compound 34 42.7 mg (0.10 mmol) DMSO 10.0 mM 
B TFP 232.17 mg (1.00 mmol) DMSO 100 mM 
C NaBH4 943 mg (25 mmol) 10 M NaOH 2.5 M 
D Pd standard 10.6 mL (100 µmol) 1% HNO3 1.0 mM 
E PdCl2 9.0 mg (50 µmol) 3:1 Brine/MeOH 5.0 mM 
F Pd(OAc)2 2.2 mg (10 µmol) 3:1 Brine/MeOH 1.0 mM 
G Pd(acac)2 3.0 mg (10 µmol) DMSO 1.0 mM 
H PdCl2(PPh3)4 7.0 mg (10 µmol) DMSO 1.0 mM 
I PdCl2(MeCN)2 2.6 mg (10 µmol) 3:1 Brine/MeOH 1.0 mM 
Notes:  
(1) Solution A – see previous experimentals 
(2) Solution B was freshly prepared every 2 weeks.  
(3) Solution C – Further dilution with pH 9 buffer was done to prepare a 100 mM 
solution. 
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(4) Solution D - This Pd stock was prepared from a commercial Pd standard (1000 ± 3 
µg/mL in 10% HNO3 (product of High-Purity Standards (Cat. # 100038-1, Lot # 
632601). 
 
Fluorescence spectroscopy. Fluorescence spectra were recorded in a 1 × 1-cm disposable 
cuvette (VWR; catalog number 58017-880) on a Jobin Yvon FluoroMax-3 spectrometer under 
the control of a Windows-based PC running FluorEssence software. The samples were excited at 
497 nm and the emission intensities were collected at 525 nm. All spectra were corrected for 
emission intensity using the manufacturer supplied photomultiplier curves. 
 
Palladium: buffer screening. Pd standard (40.0 µL of 10.0 µM stock, [Pd]final = 100 nM), 
solution B (20.0 µL, [TFP]final = 500 µM), and solution C (50.0 µL, [NaBH4]final = 1.25 mM) 
were added to DMSO/pH X buffer (5:95) solution (X = 4.0−10.0) (4.0 mL). After shaking, 
solution A (5.0 µL, [34]final = 12.5 µM) was added, and the samples were incubated for 1 h at 24 
°C before fluorescence measurement.  
 
Palladium: Turnover frequency. To determine the turnover frequency, a solution containing 
Pd standard ([Pd]final =  100 nM), solution B (20.0 µL, [TFP]final = 500 µM), solution C (50.0 µL, 
[NaBH4]final = 1.25 mM) and solution A (5.0 µL, [34]final = 12.5 µM) was prepared in DMSO/pH 
7.0 buffer (5:95). The intensity of this sample was compared to a standard solution containing 
Pittsburgh Green 35 ([35]final = 100 nM) in DMSO/pH 7.0 buffer (5:95). The intensity of the 
Pd2+-containing sample was 1.2 × 106 after 1 h at 24 °C and the intensity of the standard solution 
of 35 was 8.2 × 104. The turnover frequency is (1.2 × 106 /8.2 × 104)/1 h = 14.1 h-1. 
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Palladium: concentration dependence. Varying amounts of Pd solution, solution B (20.0 µL, 
[TFP]final = 500 µM) and solution C (50.0 µL, [NaBH4]final = 1.25 mM) were added to DMSO/pH 
7.0 buffer solution (5:95) (4.0 mL). After shaking, solution A (5.0 µL, [34]final = 12.5 µM) was 
added, and the samples were incubated for 4 h at 24 °C before fluorescence measurement.  
 
Dependence on palladium reagents. Pd solutions (40.0 µL of 10 µM stock, [Pd]final = 100 nM), 
solution B (20.0 µL, [TFP]final = 250 µM) and solution C (50.0 µL, [NaBH4]final = 1.25 mM) 
were added to DMSO/pH 7.0 buffer (5:95) solution (4.0 mL). After shaking, solution A (5.0 µL, 
[34]final = 12.5 µM) was added, and the samples were incubated for 1 h at 24 °C before 
fluorescence measurement.  
 
Palladium detection in compounds: pH 10 method. A solution of compound (5.0 mg) was 
prepared in DMSO (200 µL) and spiked with Pd standard solution (40 µL of 10 µM solution in 
1% HNO3; [Pd]sample = 8.5 ppm) and the sample was allowed to sit on a bench for 30 min. 
Following incubation, the sample was treated with 12N HCl (20 µL, [HCl]final = 60 mM) and 
allowed to incubate at 24 °C for 10 min. The sample solution was then diluted with pH 10 buffer 
([K+] = 114 mM; 3.8 mL) and treated with solution B (20.0 µL, [TFP]final = 250 µM) and 
solution C (50.0 µL, [NaBH4]final = 1.25 mM). After shaking and 5 min incubation at 24 °C, 
solution A (5.0 µL, [34]final = 12.5 µM) was added, and the samples were incubated for 1 h at 24 
°C before fluorescence measurement.  
 
Palladium detection in compounds: pH 7 method. A solution compound (5.0 mg) was 
prepared in DMSO (200 µL) and spiked with Pd standard solution (40 µL of 10 µM solution in 
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1% HNO3; [Pd]sample = 8.5 ppm) and the sample was allowed to sit on a bench for 30 min. 
Following incubation, the sample was treated with 12N HCl (20 µL, [HCl]final = 60 mM) and 
allowed to incubate at 24 °C for 10 min. The sample solution was then diluted with pH 7 buffer 
([PO43-] = 150 mM; prepared by diluting pH 7 buffer concentrate ([PO43-] = 1.25 M; Fisher 
Scientific, Cat. # SB109-500, Lot # 065758) with Aristar® ULTRA Water; 3.8 mL) and treated 
with solution B (20.0 µL, [TFP]final = 250 µM) and solution C (50.0 µL, [NaBH4]final = 1.25 
mM). After shaking and 5 min incubation at 24 °C, solution A (5.0 µL, [34]final = 12.5 µM) was 
added, and the samples were incubated for 1 h at 24 °C before fluorescence measurement.  
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4.0  FLUOROMETRIC DETECTION OF PLATINUM 
4.1 RESEARCH DESIGN 
During screening of the metal specificity for the conversion of nonfluorescent compound 34 to 
the brightly green fluorescent compound 35, platinum was approximately 40% as effective as 
palladium at pH 10 (see Figure 40a).1 Because of the importance of analytical techniques for 
quantifying platinum in various samples, the Pt-catalyzed deallylation chemistry was explored to 
find optimal conditions for platinum sensing (Figure 49). This provides a second example of a 
metal ion amplifying fluorescence signal via a catalytic process. 
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Figure 49. Pt-catalyzed deallylation to produce a fluorescence signal 
4.1.1 Importance of Platinum Detection 
Platinum, like palladium, is a widely used precious metal in various materials including those 
involving energy and human health. With respect to energy, platinum is an integral component in 
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automobile catalytic converters, fuel cells and oil refining. Because of increasing usage and 
South Africa’s production crisis, there has been a marked platinum deficit in recent years.2 
Similar to the palladium problem, platinum pollution in the environment is an emerging 
problem.3 Platinum intake occurs frequently because significant amounts of the metal are emitted 
from automobiles (0.8−1.2 µg/km/car),4 and such pollution products may account for the metal's 
presence in human bodies.5−7 In addition, studies have shown the following amounts of platinum 
in environmental samples: road dust = 60−250 ng/g; soil = 23−112 ng/g; river water = 155 ng/g; 
and grasses = 17−96 ng/g.8  
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Figure 50. Pt-based anticancer drugs 
 
 With respect to human health, platinum-containing drinking water and skin-care products 
are sold for potential benefits in human health.9,10 In addition, cisplatin and its analogues are 
widely used as anticancer drugs, and additional platinum-based compounds are emerging (Figure 
50).11,12 Despite such medical benefits of platinum compounds, other forms of platinum, like 
palladium, are considered potential health hazards.3 Moreover, although controversial,13−15 
platinum residue in silicone-based artificial tissues may leach into blood.16  
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4.1.2 Current Detection Methods for Platinum 
Similar to palladium, the current techniques for detecting and quantifying platinum are 
spectroscopic (AAS, XRF, ICP-MS) with similar limitations. The detection limit for platinum 
using each of these methods is: AAS = 2−10 ppm; XRF = 3 ppm; ICP-MS = 0.01−0.1 ppm.17,18 
For further discussion of each of the methods, please see 3.1.3. 
4.2 RESULTS AND DISCUSSION 
4.2.1 Platinum Detection 
In the palladium method, the oxidative insertion step appeared to be the rate-determining step, 
resulting in the correlation between the fluorescence intensity of the reaction solution and the 
palladium concentration. However, it would be premature to expect a similar correlation between 
the fluorescence signal and platinum concentrations because these metals are different with 
respect to rate of ligand substitution and affinity for phosphine (size difference), and as such 
should have different reactivities.19,20 Additionally, there is no precedence for a generalizable 
platinum-catalyzed Tsuji-Trost reaction.21 Thus, these questions warranted independent and 
rigorous studies on the Pt-catalyzed Tsuji-Trost reaction.  
Toward this end, compound 34 was subjected to Pt(PPh3)4 and PtCl2 (0.5 mol % for each 
reaction) and morpholine (1.1 equiv) at 24 °C in THF. After 10 min, the reaction with Pt(PPh3)4 
was complete (Figure 49), while that with PtCl2 did not proceed, showing that the conversion of 
34 to 35 can be catalyzed by Pt0 but not by PtII. The reaction with PtCl2 was driven to completion 
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by the addition of a reducing agent such as Ph3P or NaBH4, indicating that this method can be 
applied to sensing platinum in various oxidation states upon in situ reduction. 
 
      (a)              (b)      (c) 
  
         (d)                (e) 
  
Figure 51. Fluorescence analysis of Pt  
In these graphs, the y-axis is fluorescence intensity (a. u. × 105) at 525 nm. In all cases, [34] = 12.5 µM and [Ph3P] = 
250 µM and the assays were performed for 1 h at 24 °C. (a) The pH-dependent deallylation of 34 in the presence of 
PtCl2 (625 nM) in 1:4 DMSO/buffer. (b) Fluorescence induction by Pt at various oxidation states and in Pt drink in 
1:4 DMSO/pH 7 buffer. In A−E, [Pt] = 625 nM. A = no Pt, B = Pt(PPh3)4, C = PtCl2, D = H2PtCl6, E = cisplatin, F = 
platinum nanocolloid (50 ppm).  (c) Initial rate analysis for deallylation of 34 in the presence of PdCl2 (1 mol %) in 
1:1 DMSO/buffer.  = pH 4; y = 0.0143x + 1.15; R2 = 0.0357.  = pH 7; y = 2.80x + 2.00; R2 = 1.00.  = pH 10; y 
= 0.786x + 6.55; R2 = 0.991; (d) Phosphine ligand screening with PtCl2 (625 nM). A = no Pt, B = DPEphos, C = 
JohnPhos, D = (o-Tol)3P, E = TFP, F = Ph3P. (e) Correlation between fluorescence intensity and [PtCl2] in 1:4 
DMSO/pH 7 buffer.   = 24 °C: y = 0.0136x + 0.255; R2 = 0.999. The intensity continued to be linear to 625 nM 
(125 ppb). = 37 °C.  
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 In order to develop a fluorescent method for platinum, 34 was converted to 35 in aqueous 
media in the presence of PtCl2 (625 nM; 125 ppb) and Ph3P as a ligand and reducing agent. 
Buffers were screened in the pH 4−10 range, and the platinum-catalyzed deallylation was most 
effective in pH 7–9 buffers (Figure 51a) (cf. pH 6−9 for palladium). Excess Ph3P allowed for 
generation nearly the same fluorescence signal regardless of the initial oxidation states of 
platinum (0, +2, and +4) (Figure 51b). 
 Initial rate studies were performed to verify the pH dependence results. For all Pt species 
tested (Pt(PPh3)4, PtCl2, H2PtCl6, cisplatin) in the presence of Ph3P, reaction at pH 7 was 
approximately 3.5 times faster than that at pH 10 and little reaction occurred at pH 4 (Figure 
51c). Similar to palladium, reaction was optimal at pH 7. The TOF for Pt in pH 7 buffer under 
the high dilution and salt conditions ([34] = 12.5 µM; [Pt] = 50 nM; [PO43-] = 50 mM) was 
determined to be 4.5 h-1. 
 Because platinum has a higher reduction potential than palladium,22 a number of different 
phosphines and phosphites were also tested to determine if Ph3P was the optimal reducing agent. 
As Figure 51d shows, Ph3P was the most effective reducing agent. Borohydride reducing agents 
(NaBH4 and NaBH(OAc)3) were examined, but inconsistent results were observed possibly due 
to side reduction of the xanthene ring of the sensor (not shown). 
 The quantitative nature of this method for platinum was next determined. The 
fluorescence intensity is linear with respect to the concentration of platinum in the 625 pM–625 
nM (125 ppt–125 ppb) range at 24 °C (Figure 51e). Further sensitivity in the 125 pM–625 nM 
(25 ppt–125 ppb) range was obtained by heating to 37 °C (Figure 51e). 
 With the successful detection method for platinum in hand, attention was next turned 
toward platinum detection in real samples. As an initial example, the platinum concentration was 
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confirmed in a commercially available platinum-drink with 50-ppm platinum. As Figure 51b (F) 
shows, platinum was detected in this drink. It is important to note that the platinum is in 
nanocolloid form, indicating that this method may be used for the quality control of catalytic 
converters and fuel cells. 
4.2.2 Platinum Detection in Biological Media 
Although this platinum sensing method was effective in the presence of various salts in buffers, 
it was not certain whether it could be applied to platinum monitoring in serum because serum 
contains many proteins at high concentration (total concentration: 60 mg/mL = 6 × 104 ppm) and 
sulfur-containing residues (e.g., Cys, Met, glutathione). Approximately 80% of cisplatin in blood 
is known to be bound to proteins such as albumin, and free cisplatin is of interest for those who 
need to ensure the effective dose of this drug.23 Since the pharmacokinetics of drugs varies 
among individuals, the monitoring of cytotoxic drugs is of paramount importance in medicine. 
As an initial examination, human serum was spiked with various cisplatin concentrations and the 
resulting samples were tested with this fluorescent method. As Figure 52a shows, despite the 
presence of many sulfur-containing proteins and other components in serum, this fluorescent 
method was robust enough to detect cisplatin easily at 100 nM (20 ppb; free cisplatin: ~20 nM = 
4 ppb). With the total concentration of cisplatin at 100 nM in human serum, the fluorescence 
intensity (2.7 × 105; intensity without cisplatin = 1.0 × 105) corresponded to 20 nM of cisplatin in 
pH 7 buffer (2.8 × 105), which is consistent with the literature about free vs. protein-bound 
cisplatin in serum.23  
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Figure 52. Applications of Pt sensing method  
In these graphs, the y-axis is fluorescence intensity (a. u. × 105) at 525 nm. In all cases, [34] = 300 µM and [Ph3P] = 
6.0 mM and the assays were performed for 1 h at 24 °C. (a) Correlation between the concentration of cisplatin in 
immunopure human serum and fluorescence intensity. (b) Correlation between the concentration of cisplatin in 
sheep serum and fluorescence intensity. (c) Kimwipes® in pH 7 buffer solution containing 34 and Ph3P. Left = clean 
Kimwipe®. Right = Kimwipe® from cisplatin-doped floor sample. 
 
 This method was then tested in sheep serum samples containing immunoglobulins. Sheep 
serum was used in this case to ensure the purity of the serum samples and human serum samples 
may contain palladium or platinum impurities depending on the source. Although detection was 
not observed using the previous method, after initial treatment of serum/cisplatin mixtures with 
5% HNO3, cisplatin was detected to 50 nM (10 ppb) (Figure 52b). Many other additives were 
tested such as electrophiles (CH3I, maleimide, epoxides);24 however, sensitivity was not 
improved. Further optimizations for sample preparations may be needed, but these results 
provide a proof of concept that the concentration of free cisplatin can be monitored 
fluorometrically in serum. Thus far, this method appears to be superior to ICP-MS, whose 
detection limit in serum is typically 0.1—10 ppm, and our method requires only 50 µL of 
serum.25,26  
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 Next, the utility of this fluorescent platinum sensing method in hospitals and pharmacies, 
where platinum-based anticancer drugs are handled and contaminations in the working 
environment are considered to be occupational hazards, was examined.27,28 A solution of cisplatin 
was intentionally spilled on a laboratory floor and wiped with a wet paper towel. Subsequently, a 
piece of Kimwipe® soaked with 1% hydrochloric acid was used to wipe the spill area, and the 
resulting paper towel was tested for possible residual platinum. As Figure 52c shows, this 
fluorescent method can detect cisplatin contamination even in such crude samples. 
4.2.3 Selective Detection of Palladium in the Presence of Platinum 
After examining the kinetic data from both palladium and platinum, it became apparent that the 
palladium-catalyzed deallylation of 34 is 158 times faster than the platinum-catalyzed reaction at 
pH 4 (see Figures 42b and 51c). As such, selective detection of palladium in the presence of 
platinum at pH 4 was attempted. The reaction with a 1:1 mixture of palladium and platinum (100 
nM each) in 1:4 DMSO/pH 7 buffer was first performed to confirm that the metals react 
independently of one another in such a mixture. As Figure 53a shows, in fact this is the case and 
the fluorescence intensity in the 1:1 mixture is approximately additive with respect to the 
intensity of each metal alone. The reaction was then performed in 1:4 DMSO/pH 4 buffer. As 
Figure 53b and 53c show, in this solution palladium was selectively detected in the presence of 
platinum, even in the presence of excess platinum (10:1 platinum/palladium). 
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 (a)       (b)       (c)          (d) 
    
Figure 53. Selective detection of Pd in the presence of Pt  
In these graphs, the y-axis is fluorescence intensity (a. u. × 105) at 525 nm. In all cases, [34] = 12.5 µM and [PPh3] = 
250 µM, and the assays were performed for 1−4 h at 24 °C. (a) Detection of 1:1 PdCl2/PtCl2 (100 nM each) in 1:4 
DMSO/pH 7 buffer compared to positive controls. (b) Detection of 1:1 PdCl2/PtCl2 (5 µM each) in 1:4 DMSO/pH 4 
buffer compared to positive controls. (c) Detection of 1:10 PdCl2/PtCl2 (500 nM Pd / 5 µM Pt) in 1:4 DMSO/pH 4 
buffer compared to positive controls. (d) Detection of soil spiked with 1:1 PdCl2:PtCl2 (5 µM each) in 1:4 
DMSO/pH 4 buffer compared to positive controls. 
 
To demonstrate the potential application of this palladium-specific method, the following 
proof-of-concept experiment was performed. Soil (heated in an oven at >100 °C for 24 h prior to 
this experiment; presumably this process can be accelerated by the use of microwave) was 
suspended in 1:4 DMSO/pH 4 buffer (final: 10 mg/mL). The resulting mixture was spiked with a 
1:1 mixture of palladium and platinum and left on a bench for 30 min. After filtering to remove 
insoluble materials, the solution was then treated with Ph3P (final concentration = 250 µM) and 
34 (final concentration = 12.5 µM) and incubated for 4 h at 24 °C. As Figure 53d shows, even 
without rigorous sample pretreatment, palladium was specifically detected in this crude sample. 
Thus, although this experiment is somewhat artificial, this method could have potential 
application in platinum/palladium manufacturing because these metals are found together in 
mining sites (ores) and spectroscopic analyses of the individual metals typically require a 
complex series of purifications to eliminate molecular interferences.17 Environmental samples, 
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especially those collected from roadsides, contain both metals and this method will allow the 
metals to be quantified differentially. 
4.3 CONCLUSION 
In conclusion, the first experimental evidence for the use of a fluorescent sensor as a quantitative 
platinum sensor has been provided. This method allows for the detection of total quantities 
platinum at nanomolar levels, even in heterogenous samples such as human serum. In addition, it 
was also demonstrated that palladium can be selectively detected in the presence of platinum. 
This sensor technology should find broad applications in materials, energy and human health.  
4.4 EXPERIMENTAL 
4.4.1 General Information 
All reactions were monitored by thin-layer chromatography (TLC) carried out on 0.25-mm EMD 
silica gel plates (60F-254) using a hand-held UV lamp (254 nm or 365 nm). 
 Pt(PPh3)4, PtCl2 and H2PtCl6•6H2O were purchased from Alfa Aesar and used as 
received. Cisplatin was purchased from Sigma-Aldrich and used as received. WaterOz Platinum 
is a product of Kornax Superior Nutrition L.L.C. (Houston, Texas). ImmunoPure normal human 
serum was purchased from Thermo Scientific and used after restoration with 2.0 mL distilled 
water. Sheep serum was obtained from Luminos, LLC. Kimwipes® are a product of Kimberly-
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Clark. Buffers were purchased (pH 4, potassium biphthalate ([biphthalate] = 49.8−50.2 mM), J. 
T. Baker, Catalog Number 5606-01; pH 7, phosphate ([PO43-] = 46−50 mM, [K+] = 23−25 mM, 
[Na+] = 50−56 mM), J. T. Baker, Catalog Number 5608-01; pH 10, borate ([K+] = 94−114 mM), 
J. T. Baker, Catalog Number 5609-01) and used as received. 
4.4.2 Platinum Detection in Organic Solvent 
Determination of reactive oxidation state for platinum.  A solution of compound 34 (5.0 mg, 
12 µmol) in THF (150 µL) was treated with morpholine (2 µL, 13 µmol), and Pt(PPh3)4 (1.0 mg, 
0.6 µmol) at 24 °C. The reaction was stirred for 10 min and TLC analysis (50% EtOAc in 
hexanes) showed formation of 35.    
A solution of compound 34 (5.0 mg, 12 µmol) in THF (150 µL) was treated with 
morpholine (2 µL, 13 µmol), and PtCl2 (1.0 mg, 0.6 µmol) at 24 °C. The reaction was stirred for 
10 min and TLC analysis (50% EtOAc in hexanes) showed no reaction (i.e. only starting 
material). Following addition of NaBH4 (5 mg, 0.13 mmol), the reaction fully proceeded to form 
35. 
4.4.3 Fluorescence Spectroscopy 
Preparation of parent stock solutions used for this study. 
Entry Reagent Quantity Solvent (10 mL) Conc. of stock 
solution 
A compound 34 42.7 mg (0.10 mmol) DMSO 10.0 mM 
B PPh3 262.3 mg (1.00 mmol) DMSO 100 mM 
C PtCl2 13.3 mg (50 µmol) DMSO 5.0 mM 
D Pt(PPh3)4 62.6 mg (50 µmol) DMSO 5.0 mM 
E H2PtCl6•6H2O 25.9 mg (50 µmol) 1% HNO3 in H2O 5.0 mM 
F cisplatin 14.5 mg (50 µmol) pH 7.0 buffer 5.0 mM 
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Notes: See previous experimentals  
 
Fluorescence spectroscopy. Fluorescence spectra were recorded in a 1 × 1-cm disposable 
cuvette (VWR; catalog number 58017-880) on a Jobin Yvon FluoroMax-3 spectrometer under 
the control of a Windows-based PC running FluorEssence software. The samples were excited at 
497 nm and the emission intensities were collected at 525 nm. All spectra were corrected for 
emission intensity using the manufacturer supplied photomultiplier curves.  
 
Platinum: buffer screening. PtCl2 solution (25.0 µL of 100.0 µM stock, [Pt]final = 625 nM) and 
solution B (10.0 µL, [PPh3]final = 250 µM) were added to DMSO/pH X buffer (1:4) solution (X = 
4.0−10.0) (4.0 mL). To the mixture was added solution A (5.0 µL, [34]final = 12.5 µM), and the 
resulting mixtures were incubated for 1 h at 24 °C before fluorescence measurement.  
 
Platinum: initial rate analysis. PtCl2 stock solution C (50.0 µL, 250 nmol), PPh3 (4.8 mg, 2.34 
µmol) and 34 (10.0 mg, 23.4 µmol) were added to DMSO/pH X buffer (1:1) solution (X = 4.0, 
7.0, 10.0) (20 mL) at 24 °C. 1:1 DMSO/buffer was used in this case for the solubility of the 
sensor and PPh3. The experiment was performed in triplicate. At t = 0.5, 1 and 2 h, 100 µL 
aliquots were taken from each reaction mixture and diluted to 4.0 mL with DMSO/pH 7.0 buffer 
(1:4) for fluorescence measurement.   
 
Platinum: Turnover frequency. To determine the turnover frequency, a solution containing 
PtCl2 ([PtCl2]final =  50 nM), solution B (10.0 µL, [PPh3]final = 250 µM) and solution A (5.0 µL, 
[34]final = 12.5 µM) was prepared in DMSO/pH 7.0 buffer (1:4). The intensity of this sample was 
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compared to a standard solution containing Pittsburgh Green 35 ([35]final = 50 nM) in DMSO/pH 
7.0 buffer (1:4). The intensity of the Pt2+-containing sample was 2.8 × 106 after 7 h at 24 °C and 
the intensity of the standard solution of 35 was 8.8 × 104. The turnover frequency is 2.8 × 106 
/8.8 × 104 = 31.8/7 h = 4.5 h-1. 
 
Platinum: concentration dependence. Varying amounts of Pt solution and solution B (10.0 µL, 
[PPh3]final = 250 µM) were added to DMSO/pH 7.0 buffer solution (1:4) (4.0 mL). Solution A 
(5.0 µL, [34]final = 12.5 µM) was added to the mixture, and the samples were incubated for 
20−24 h at 24 °C or 37 °C before fluorescence measurement. Each experiment was performed in 
triplicate. 
 
Pt detection in WaterOz Platinum. WaterOz Platinum (4.4 mL, 750 nM final concentration) 
and solution B (20.0 µL, [PPh3]final = 140 µM) were added to DMSO/ pH 7.0 buffer solution 
(1:4) (10.0 mL). Solution A (10.0 µL, [34]final = 7.0 µM) was added to the mixture, and the 
samples were incubated for 1 h at 24 °C before fluorescence measurement. 
 
Cisplatin detection in human serum. Varying amounts of cisplatin in pH 7.0 buffer and pH 7 
buffer (total volume of pH 7.0 buffer = 100.0 µL) was added to immunopure human serum (50.0 
µL). Solution B (10.0 µL, [PPh3]final = 6.0 mM) and solution A (5.0 µL, [34]final = 300.0 µM) 
were added to the mixture, and the samples were incubated for 24 h at 24 °C before fluorescence 
measurement. The experiment was performed in triplicate. 
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Cisplatin detection in sheep serum. Varying amounts of cisplatin in pH 7.0 buffer and 5% 
HNO3 (50 µL) were added to sheep serum (50.0 µL). The samples were allowed to sit for 5 min 
and then heated in a water bath at 100 °C to evaporate the acid. The samples were then diluted 
with pH 7.0 buffer (total volume of pH 7.0 buffer = 500.0 µL) and treated with solution B (10.0 
µL, [PPh3]final = 6.0 mM) and solution A (5.0 µL, [34]final = 300.0 µM). The samples were 
incubated for 24 h at 24 °C before fluorescence measurement. The experiment was performed in 
triplicate. 
 
Detection of cisplatin contamination. Cisplatin solution in pH 7.0 buffer (500 µL, 1.0 mM 
stock solution) was spilled on an uncleaned floor tile. After 5 min, the spilled area was wiped 
with a wet paper towel (with water) and subsequently with a Kimwipe® containing a 1% HCl 
solution. The HCl-soaked Kimwipe® was placed into a 20-mL scintillation vial and additional 
1% HCl (2.0 mL) was added. After 10 min, the solution was basified to pH 9.0 with 1.0 N NaOH 
(<1.0 mL) and diluted to 10.0 mL with DMSO/pH 7.0 buffer (1:4). Solution B (20.0 µL, 
[PPh3]final = 200 µM) and the compound 2 solution A (10.0 µL, [34]final = 10.0 µM) were then 
added to the mixture, and the samples were incubated for 3 h at 24 °C before visualization under 
a UV lamp at 365 nm wavelength. The experiment was performed in triplicate.  
4.4.4 Detection of Palladium in the Presence of Platinum 
Pd/Pt mixtures. PdCl2 solution (10.0 µL of 100.0 µM stock; [Pd]final = 100 nM), PtCl2 solution 
(10.0 µL of 100.0 µM stock; [Pt]final = 100 nM) or a 1:1 mixture of Pd/Pt ([Pd/Pt]final = 100 nM 
each) and solution B (10.0 µL, [Pd]final = 250 µM) were added to DMSO/pH 7.0 buffer solution 
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(1:4) (4.0 mL). Solution A (5.0 µL, [34]final = 12.5 µM) was added to the mixture, and the 
samples were incubated for 1 h at 24 °C before fluorescence measurement. 
PdCl2 solution (20.0 µL of 1.0 mM stock; [Pd]final = 5.0 µM), PtCl2 solution (20.0 µL of 
1.0 mM stock; [Pt]final = 5.0 µM) or a 1:1 mixture of Pd/Pt ([Pd/Pt]final = 5.0 µM each) and 
solution B (10.0 µL, [Pd]final = 250 µM) were added to DMSO/pH 4.0 buffer solution (1:4) (4.0 
mL). Solution A (5.0 µL, [34]final = 12.5 µM) was added to the mixture, and the samples were 
incubated for 1 h at 24 °C. Concentrated pH 7 buffer ([PO43-] = 1.25 M) (1.0 mL) was added 
before fluorescence measurement to maximize fluorescence signal. 
PdCl2 solution (20.0 µL of 1.0 mM stock; [Pd]final = 5.0 µM), PtCl2 solution (20.0 µL of 
1.0 mM stock; [Pt]final = 5.0 µM) or a 1:10 mixture of Pd/Pt ([Pd]final = 500 nM; [Pt]final = 5.0 
µM) and solution B (10.0 µL, [Pd]final = 250 µM) were added to DMSO/pH 4.0 buffer solution 
(1:4) (4.0 mL). Solution A (5.0 µL, [34]final = 12.5 µM) was added to the mixture, and the 
samples were incubated for 4 h at 24 °C. Concentrated pH 7 buffer ([PO43-] = 1.25 M) (1.0 mL) 
was added before fluorescence measurement to maximize fluorescence signal. 
Soil was heated in an oven at 133 °C for 24 h prior to use. A solution of this soil (10 
mg/mL) was prepared in 1:4 DMSO/pH 4.0 buffer solution (1:4) and spiked with PdCl2 solution 
(20.0 µL of 1.0 mM stock; [Pd]final = 5.0 µM), PtCl2 solution (20.0 µL of 1.0 mM stock; [Pt]final = 
5.0 µM) or a 1:1 mixture of Pd/Pt ([Pd/Pt]final = 5.0 µM each), and left on a bench for 30 min at 
24 °C. The samples were then filtered through cotton and treated with solution B (10.0 µL, 
[Pd]final = 250 µM) and solution A (5.0 µL, [34]final = 12.5 µM), and the samples were incubated 
for 4 h at 24 °C. Concentrated pH 7 buffer ([PO43-] = 1.25 M) (1.0 mL) was added before 
fluorescence measurement to maximize fluorescence signal. 
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5.0  OXIDATION STATE-SPECIFIC FLUORESCENT METHOD FOR PALLADIUM 
AND PLATINUM BASED ON THE AROMATIC CLAISEN REARRANGEMENT 
5.1 RESEARCH DESIGN 
In the synthesis of Pittsburgh Yellowgreen (36), the final step is an aromatic Claisen 
rearrangement, which proceeds under thermal conditions (150 °C).1 Since it is known that many 
metal ions, including PdII and PtIV, can catalyze this rearrangement,2,3 it was envisioned that this 
transformation could serve as a detection method for these metals and would be oxidation state 
dependent. More specifically, by promoting the Claisen rearrangement of 34, a nonfluorescent 
compound is converted to a fluorescent compound 36 (Pittsburgh Yellowgreen) (Figure 54). The 
proposed approach is novel for detection of oxidation state in a metal. 
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Figure 54. Pdn+/Ptm+-catalyzed aromatic Claisen rearrangement to produce a fluorescent molecule 
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5.1.1 Palladium- and Platinum-Catalyzed Claisen Rearrangement 
One known mechanism of the metal-catalyzed Claisen rearrangement, which proceeds through a 
cyclization-induced rearrangement pathway, is shown below in Figure 55.4−7 
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Figure 55. Pathway of the metal-catalyzed Claisen rearrangement 
 
Although many metals are known to promote this transformation (Al, Cr, Mn, Fe, Cu, Ag, Au), 
typically through a Lewis acid-catalyzed pathway, the examples of Pd- and Pt-catalyzed 
rearrangement are few. One explanation for this is due to irreversible binding of the electrophilic 
metal catalyst to the strongly nucleophilic vinyl ether moiety instead of the allyl ether moiety. 
However, with substrates that contain alkyl-protected vinyl moieties (such as is found in the 
aromatic Claisen rearrangement), successful rearrangement can occur. As such, several examples 
have been reported on the PdII-catalyzed2 rearrangement and one example with PtIV.3  
 The same mechanistic principle can be applied to fluorescent detection of the oxidation 
state of palladium and platinum (Figure 56). In this case, Pdn+/Ptn+ induces cyclization of 34 to 
yield putative intermediate 65. This complex then rearranges with elimination of Pdn+/Ptn+ to 
form 66, which rearomatizes to form Pittsburgh Yellowgreen 36. Since this process is catalytic 
with respect to Pdn+/Ptn+, similar to the Pd0/Pt0 sensor, the fluorescence signal is amplified.  
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Figure 56. Mechanistic principle of the fluorometric detection of Pd and Pt oxidation state 
5.1.2 Importance of Palladium and Platinum Speciation 
As previously discussed, Pd- and Pt-catalyzed reactions are very powerful in synthetic organic 
chemistry.8−10 Each of these reactions requires a palladium or platinum catalyst at a specific 
oxidation state, mostly at (0), (II) or (IV). However, since Pd0 is prone to oxidation to form the 
more stable PdII, Pd0 reagents are often gradually oxidized to PdII while stored. Because of this 
oxidation process, many synthetic chemists experience — although not often reported in the 
literature — that attempts to perform Pd0-catalyzed reactions fail or result in poor and non-
reproducible yields. Thus, identification of catalyst oxidation could greatly aid in understanding 
failed reactions. Moreover, such techniques would also facilitate studies on palladium materials 
including polymer-bound catalysts. 11−13 
 In addition to identifying the oxidation state of palladium catalysts, determination of the 
oxidation state of palladium in contaminated active pharmaceutical ingredients (API) is also 
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important. In fact, it is well known that metal speciation can further complicate the removal of 
such metal impurities.14−16 As such, since Pd0 and PdII bind to scavengers differently, these 
synthetic compounds are often purified differently to remove palladium species. For example, a 
Japanese group developed a method in which polymer-supported trimercaptotriazine was used to 
effectively scavenge Pd0, while a polymer-supported ethylenediamine was used to scavenge 
PdII.16 This difference in scavenging may be attributed to the fact that Pd0 is tetrahedral while 
PdII is square planar. 
 With respect to environmental and biological samples, the mobility, bioavailability and 
toxicological properties of metals are highly dependent on their oxidation state. For palladium, 
the World Health Organization’s published document from 2002 for palladium explicitly states 
that there are currently no reliable analytical methods for differentially determining Pd0 and 
PdII.17 However, much work has been devoted to determination of platinum speciation because 
of the extensive research on cisplatin-based anticancer drugs.18−21 In addition, Pt0 is added to 
drinking water for health benefits, but PtII and particularly PtIV are toxic.22−24 This commercially 
available Pt0 nanocolloid-containing health water is typically made via the reduction of PtIV 
species. Once reduced, the Pt0 species are stable; and thus, monitoring of this reduction process 
is an important step in making safe platinum water. Therefore, determination of metal oxidation 
state in biological and environmental samples is important. In addition, metal speciation studies 
also allow for quality control in industrial processes.  
5.1.3 Current Detection Methods for Palladium and Platinum Speciation 
Current methods for speciation analysis of metals rely on gas chromatography (GC), high 
performance liquid chromatography (HPLC) or capillary electrophoresis (CE).18,25 Each of these 
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methods requires expensive instrumentation and involves sample injection that can cause cross-
contamination. Further descriptions of each of these methods follow below. 
 GC, HPLC and CE are chromatographic methods, which are based on dynamic 
partitioning of an analyte carried by a mobile phase through a stationary phase between these 
two phases, followed by detection using a specific analytical read-out, typically AAS in GC; UV, 
AAS or ICP-MS in HPLC; and UV, fluorescence or ICP-MS in CE. For GC, one major 
limitation is the fact that all metal samples must be pre-derivatized to enable the metal to become 
volatile.25 Typically derivatization methods include hydride formation and alkylation with 
alkylborate or Grignard reagents.  
 Because of these deficiencies with GC, HPLC is becoming more popular in 
chromatographic metal speciation.25 In HPLC, metal ion-containing samples can be analyzed 
without derivatization. In addition, this method is becoming more sensitive because it is often 
used in conjunction with ICP-MS.  
 CE is also on the rise as an analytical measurement technique for metal speciation.18 
Separation by CE is based on differential migration of charged analytes along a capillary filled 
with a suitable conducting analyte. This migration takes place uder the combined effects of 
electrophoretic and electroosmotic flows generated by applying an electric field across the 
capillary.  
 In addition to chromatographic techniques, electrochemical methods, such as ion-
selective electrode potentiometry (ISEP) and spectroelectrochemical sensing, have also been 
utilized but often lack the sensitivity and selectivity needed to analyze trace analytes in complex 
samples.26,27 In ISEP, some additional problems include: electrode fouling due to sample matrix 
components, electrode drift (poor reproducibility), electrode dissolution, electrode carry-over 
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(cross-contamination), and electrode instability. In spectroelectrochemical sensing, another 
major drawback is the requirement for preconcentration into a chemically selective film. 
 With respect to the detection of PdII contamination in APIs, to date there are no reliable 
methods with which to accurately detect this oxidation state specifically. For example, 
electrochemical methods require chromatographic separation, during which Pd0 is likely oxidized 
to PdII. In addition, concentrated acid treatments are required with ICP-MS and a fluorescent 
method developed by Anslyn, which again can oxidize Pd0.28 As a result, it is difficult, if not 
impossible, to accurately address palladium oxidation states in APIs. 
 A fluorescent method that does not require acid treatment or chromatographic separation 
would be more desirable because detection can be observed with an inexpensive fluorometer or 
UV lamp and sample integrity should be high. Moreover, the samples in fluorescent methods are 
not cross-contaminated because disposable cuvettes are available, also facilitating high 
throughput analysis. 
5.2 RESULTS AND DISCUSSION 
5.2.1 Detection of Palladium Oxidation State in Buffer 
Although numerous metal species, including PdII, catalyze the aromatic Claisen rearrangement in 
organic solvent, only in rare examples have metal species been shown to perform this 
transformation in aqueous solvent.  As such, various metal ions were screened for the conversion 
of 34 to 36 in 1:4 DMSO/pH 10 buffer at 50 °C for 4 h. As Figure 57a shows, among the metal 
reagents tested, only PdCl2 (and later PtIV) promoted this rearrangement. Although Pd0 should 
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afford 35 rather than 36, this needed to be confirmed.29 Toward this end, palladium reagents with 
various oxidation states (0, II, IV) were screened. As Figure 57b shows, the detection method is 
oxidation state-specific and each PdII reagent and a PdIV reagent successfully performed the 
conversion while Pd0 and insoluble Pd species did not.  
              
                  (a)                                                    (b)   
 
                                 (c)                                   (d) 
  
Figure 57. Fluorescence analysis of PdII  
In these graphs, the y-axis is fluorescence intensity (a. u. × 105) at 535 nm. In all cases, [34] = 12.5 µM and the 
assays were performed in 1:4 DMSO/pH 10 buffer for 4 h at 50 °C. (a) Metal specificity. [Metal] = 10 µM. A = no 
metal, B = PdCl2, C = PtCl2, D = LiCl, E = FeCl3, F = AgNO3, G = NiCl2, H = Pb(NO3)2, I = MnCl2, J = CdCl2, K, L 
= AuCl and AuCl3, M = RhCl(PPh3)3, N, O = CuCl and CuCl2, P = MgSO4, Q = KCl, R = CrCl3, S = CoCl2, T = 
HgCl2, U = RuCl3, V = ZnCl2. (b) Fluorescence induction by various Pd species and oxidation states. In all cases, 
[Pd] = 5.0 µM. A = no Pd, B = Pd black, C = Pd2(dba)3, D = Pd(PPh3)4,  E = PdCl2, F = Pd(PPh3)2Cl2, G = 
Pd(MeCN)2Cl2, H = Pd(acac)2, I = Pd(OAc)2, J = K2PdCl6. (c) Initial rate analysis for Claisen rearrangement of 34 
in the presence of PdCl2 (20 mol %) in 1:1 DMSO/pH 10 buffer. y = 3.83x – 1.40; R2 = 0.997. (a) Correlation 
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between fluorescence intensity and [PdII/IV]. ♦ = Pd2+.  = Pd4+.  = Pd2+ in 1:4 DMSO/pH 10 buffer (11.4 mM 
salt).  
  
 The initial rate, catalytic efficiency and sensitivity of our PdII/IV detection method were 
next examined. The initial rate was measured in 1:1 DMSO/pH 10 buffer using PdCl2 (Figure 
57c). The turnover frequency (TOF) was calculated as 0.3 h-1 (or 7.2 d-1) in pH 10 buffer under 
the high dilution and salt conditions. This could be increased to 0.75 h-1 by decreasing the buffer 
salt concentration ten-fold. Using PdCl2 and K2PdCl6, it was determined that the fluorescence 
intensity is correlated to the concentration of PdII/IV in the 500 nM−100 µM (50 ppb−10 ppm) 
range for each (Figure 57d). The detection limits for PdII and PdIV using these conditions were 
calculated as 3.9 µM (390 ppb) and 11.1 µM (1.1 ppm), respectively, with S/B of 3. While 
decreasing the buffer salt concentration ten-fold did not increase the detection limit, the S/B 
dramatically increased using these dilute buffer conditions (Figure 57d).  
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No Reaction
ligand-free
Pd0 or Pt0
 
Figure 58. Dual sensor for detecting Pd and Pt in various oxidation states 
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With these results, it is clear that sensor 34 is a dual probe and can be used in applications of 
determining both total metal and the amount of oxidized metal in a sample (Figure 58). Thus, 
using two simple chemical principles, the different states of palladium (Pd black, soluble Pd0, 
PdII/IV) can easily be distinguished.  
5.2.2 PdII Detection in Functionalized Compounds 
To address the challenging problem of palladium speciation in the pharmaceutical 
industry, the detection of PdII contamination in the presence of Pd0 in synthetic samples was next 
examined. Since this process requires the detection of PdII species in the presence of a large 
excess of synthetic compound (500, 50, 5 ppm = 2000, 20000, 200000 equiv of compound with 
respect to PdII), I was skeptical that the metal would effectively bind and promote the Claisen 
rearrangement of 34. 
Thioanisole, cholesterol, 2-carboxy-7-hydroxycoumarin, morpholine, indole and N-
methylephedrine were chosen as model structures that represent some of the typical functional 
groups and pharmacophores in many drugs. Each compound (12.5 mg/mL) was spiked with Pd0 
(<2.25 µmol/mL) and varying amounts of PdII (5−500 ppm relative to each compound), treated 
with 34 and heated at 50 °C for 4 h in 1:4 DMSO/pH 10 buffer. Figure 59a shows that, although 
the absolute fluorescence values are variable to a degree depending on excess organic 
compounds, the progress of palladium scavenging can be rapidly monitored to prioritize 
scavenging methods and optimize the protocol in a high throughput manner. Indole quenches the 
fluorescence signal of 36, but the relative PdII concentrations can still be monitored during 
palladium scavenging because the relative fluorescence signal decreases as the palladium content 
decreases (Figure 59b). With a substituted indole (see Figure 43a), however, quenching was not 
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observed and PdII was successfully detected (Figure 59c). Despite the overall weaker signal 
presumably due to the competitive binding of N-methylephedrine to PdII (Figure 59b), progress 
in metal scavenging in such an excellent metal ligand can still be monitored. It should be noted 
here that this method is less sensitive than the total palladium detection method; however, in 
terms of monitoring the relative PdII values throughout the simulated scavenging in this proof-of-
concept experiment, this can easily be accomplished for all compounds tested. Lesser amounts of 
PdII can be detected by increasing the incubation time due to the method’s catalytic nature or by 
the use of more organic compound (PdII concentration with respect to the sample will be the 
same, but the PdII concentration in solution will increase). 
 
(a)                (b)                    (c) 
   
Figure 59.  PdII detection in functionalized organic compounds  
Each assay was performed in the presence of 34 (12.5 µM) for 4 h at 50 °C.  (a) PdII detection in compounds. The y-
axis is log10(fluorescent intensity (a. u. × 105)) at 535 nm The data are normalized so that the fluorescence signal of 
500 ppm PdII is the same for each. Pd0 in samples is Pd black (<2.25 µmol/mL). The first set of bars for each sample 
is 60 µM (500 ppm) PdII; the second set of bars is 6 µM (50 ppm) PdII; the third set of bars is 600 nM (5 ppm) PdII.  
A = no Pd, B = PdII, C = Pd0, D = PdII + Pd0. All synthetic samples contain both PdII and Pd0: E = thioanisole, F = 
cholesterol, G = 2-carboxy-7-hydroxycoumarin, H = morpholine, I = indole, J = N-methylephedrine. In (b) and (c), 
the y-axis is fluorescent intensity (a. u. × 105) at 535 nm. (b) Effect of indole and N-methylephedrine on 
fluorescence intensity of varying concentrations of 36. The first set of bars is 36  (no compound). The second set of 
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bars is 36 + indole. The third set of bars is 36 + N-methylephedrine. (c) PdII detection in substituted indole. Left = no 
Pd; middle = standard (PdCl2; 10 µM); right = synthetic sample. 
5.2.3 Detection of Palladium Oxidation State in Organic Solvent 
In our laboratory, Sami Osman recently failed to reproduce a previously successful Suzuki 
coupling using Pd(PPh3)4 (unpublished results). It was suspected that the Pd reagent was fully 
oxidized to PdII, accounting for the failure. In order to test the quality of the reagent, presumably 
Pd(PPh3)4 (0.2 equiv) was added to a solution of the sensor 34 in CH2Cl2 at 24 °C for 24 h, but 
deallylation did not proceed to give the green fluorescent compound 35. Instead, the Claisen 
rearrangement proceeded smoothly to produce the green yellow fluorescent compound 36, as it 
was visible with naked eyes and by TLC analysis. This PdII-catalyzed aromatic Claisen 
rearrangement was confirmed with a positive control experiment using PdCl2 (0.2 equiv) for the 
conversion of 34 to 36.  Thus, the lack of 35 and the presence of 36 enabled us to conclude 
easily, without time-consuming analysis, that the "Pd(PPh3)4" reagent was indeed oxidized. 
 To determine the generality of this dual probe in organic solvent, additional sources of Pd 
at each oxidation state were tested (Table 1). Each Pd reagent (0.2 equiv) was treated with a 
solution of sensor 1 in CH2Cl2 at 24 °C for 24 h. For all PdII reagents and PdIV reagent (Table 1, 
entries 1−5), exclusive formation of the Claisen rearrangement product 36 was observed by TLC 
analysis. For Pd0 reagent, Pd2(dba)3 (Table 1, entry 7), deallylation to 35 was observed.  
 
Table 1. Generality of Fluorogenic Probe 34 
Entry Pd reagent Product 
1 PdCl2 36 
2 PdCl2(PPh3)2 36 
3 PdCl2(MeCN)2 36 
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4 Pd(acac)2 36 
5 Pd(OAc)2 36 
6 K2PdCl6 36 
7 Pd2(dba)3 35 
8 Pd black No reaction 
 
5.2.4 Determination of Palladium Oxidation State After a Reaction Stalls 
Br B(OH)2
Pd(PPh3)4 
K2CO3
+
 
Figure 60. Suzuki-Miyaura cross-coupling reaction 
 
Next, this fluorescent method was applied for the detection of palladium oxidation state after a 
stalled reaction. The reaction that was examined was the Suzuki cross-coupling (Pd0-catalyzed) 
between phenylboronic acid (1.5 equiv) and bromobenzene in the presence Pd(PPh3)4 (1 mol %) 
and K2CO3 (3.0 equiv) as a base (Figure 60). As is often the case with such a small amount of Pd 
catalyst, conversion to biphenyl began to stall after approximately 3 h and the reaction did not 
proceed to completion at 65 °C after 24 h. To determine if the reaction stalled due to catalyst 
oxidation, the reaction mixture was cooled to 50 °C after 24 h (reaction no longer occurring) and 
sensor 34 was added. After 2 h, conversion of 34 to 36 was observed by TLC with no detection 
of 35 indicating that the Pd was indeed oxidized accounting for the halt in reaction.  
5.2.5 Determination of Platinum Oxidation State 
Based on the similar π-electrophilicity between cationic palladium and platinum species, it was 
desirable to extend this method to Ptn+ detection. Pt0 has been shown to be beneficial for human 
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health due to its ability to catalytically quench reactive oxygen species to less toxic materials and 
is used in many health-related products including commercially bottled-drinking water.22 Despite 
such benefits, a major concern in manufacturing these products is the contamination of PtIV 
because Pt0 nanocolloid-containing drinking water is produced through the reduction of the more 
stable PtIV species and PtIV is highly toxic.23,24 Current analytical methods are instrument 
intensive requiring highly trained personnel. Thus, for high throughput analysis of the safety of 
such Pt0-containing products a better method for PtIV-specific detection is needed. 
 
                (a)            (b) 
  
Figure 61. Fluorescence analysis for PtIV  
In these graphs, the y-axis is fluorescence intensity (a. u. × 105) at 535 nm. In all cases, [34] = 12.5 µM and the 
assays were performed in water for 2 h at 80 °C. (a) Monitoring of PtIV (1 mM) reduction to Pt0. A = 0 min, B = 10 
min, C = 20 min, D = 30 min. (b) Detection of PtIV in Pt0-containing drinking water. In all cases, [Pt0] = 250 µM (50 
ppm) and the following amounts of PtIV were in the samples: A = Pt0 water, B = 0.5 nM (0.0975 ppb), C = 5 nM 
(0.975 ppb), D = 50 nM (9.75 ppb), E = 500 nM (97.5 ppb). 
 
Although in the metal screening studies PtII did not produce fluorescence signal, it was 
hypothesized that PtIV would be a more efficient catalyst because it is presumably more π-
electrophilic.30 Indeed, unlike Pt0/II, PtIV catalyzed the Claisen rearrangement in water, which was 
also confirmed in organic solvent. These conditions were then used to monitor the progress of 
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the electrochemical reduction of PtIV to Pt0 in water. As Figure 61a shows, this detection method 
was successful for fluorescently monitoring this reduction. This fluorescence method was next 
used to detect PtIV contamination in a Pt0-containing drink. As Figure 61b shows, PtIV was 
successfully detected by fluorescence in a concentration-dependent manner with a detection limit 
of 0.54 nM (0.11 ppb) with S/B of 3 in the presence of Pt0 at 250 µM. In addition, in the absence 
of buffer salts, the PtIV-catalyzed Claisen rearrangement proceeds much more efficiently and 
low-ppb detection can be achieved easily.  
5.3 CONCLUSION 
In summary, it has been demonstrated that fluorogenic probe 34 can selectively detect PdII and 
PtIV via Claisen rearrangement to 36. This method is capable of detecting these metal species in 
aqueous solvent in the presence of functionalized compounds and Pt0-water and in organic 
solvent in reaction mixtures. In combination with the Pd0/Pt0 detection method, it is now possible 
to distinguish PdII and total Pd contamination. This method should find applications in the 
pharmaceutical industry, the environment and Pd/Pt quality control. 
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5.4 EXPERIMENTAL 
5.4.1 General Information 
All reactions were carried out with dry, freshly distilled solvents under anhydrous conditions, 
unless otherwise noted.  Methylene chloride (CH2Cl2) was distilled from calcium hydride.  All 
reactions were monitored by thin-layer chromatography (TLC) carried out on 0.25-mm EMD 
silica gel plates (60F-254) using UV light (254 nm or 365 nm). 
PdCl2, PdCl2(PPh3)4, PtCl2, and H2PtCl6•6H2O were purchased from Alfa Aesar and used 
as received. Pd(PPh3)4, Pd(acac)2, PdCl2(MeCN)2 and K2PdCl6 were purchased from Strem and 
used as received. Pd(OAc)2 was purchased from TCI and used as received. Platinum water and 
spiked samples were obtained from APt Co. Buffers were purchased from J. T. Baker (pH 10, 
borate ([K+] = 94−114 mM), catalog number 5609-01) and used as received. 
5.4.2 Oxidation State Detection in Organic Solvent 
PdII/IV-catalyzed Claisen rearrangement. A dry, 10-mL round bottom flask was charged with 
34 (10.0 mg, 23.4 µmol) and PdII or PdIV catalyst (20 mol %; 4.7 µmol; see table below) at 24 
°C. The flask was evacuated and purged with nitrogen, and CH2Cl2 (234 µL) was added. The 
reaction mixture was stirred at 24 °C for 24 h. TLC analysis (50% EtOAc in hexanes; Rf = 0.59) 
indicated complete conversion to the Claisen-rearranged product 36.  
Pd Reagent Quantity 
Pd(acac)2 1.4 mg 
PdCl2(PPh3)2 3.3 mg 
PdCl2(MeCN)2 1.2 mg 
PdCl2 1.0 mg 
Pd(OAc)2 1.0 mg 
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K2PdCl6 1.8 mg 
 
PtIV-catalyzed Claisen rearrangement. A dry, 10-mL round bottom flask was charged with 34 
(10.0 mg, 23.4 µmol) and H2PtCl6•6H2O (2.4 mg; 4.7 µmol) at 24 °C. The flask was evacuated 
and purged with nitrogen and DCE (234 µL) was added. The reaction mixture was stirred at 80 
°C for 24 h. TLC analysis (50% EtOAc in hexanes; Rf = 0.59) indicated complete conversion to 
the Claisen-rearranged product 36.  
 
Detection of Pd oxidation state in a reaction mixture. A dry, 10-mL round bottom flask was 
charged with bromobenzene (17.0 µL, 162 µmol) and THF (2.43 mL). Subsequently, 
phenylboronic acid (30.0 mg, 162 µmol), K2CO3 (67.2 mg, 486 µmol), and Pd(PPh3)4 (2.8 mg, 
2.4 µmol) were added and the reaction mixture was stirred at 65 °C under nitrogen. After 3 h, the 
reaction progress began to stall and the reaction was left at 65 °C for 24 h. After this period, the 
reaction mixture was cooled to 50 °C and treated with compound 34 (10.0 mg, 23.4 µmol). The 
resulting reaction mixture was stirred at 50 °C for 24 h (initial observation of 36 after 2 h) and 
TLC analysis (50% EtOAc in hexanes; Rf = 0.59) indicated complete conversion of 34 to the 
Claisen-rearranged product 36. 
5.4.3 Fluorescence Spectroscopy 
Preparation of parent stock solutions used for fluorescence study in aqueous solvent. 
Solution Reagent Quantity Solvent (10 mL) Conc. of stock 
solution 
A compound 1 42.7 mg (0.10 mmol) DMSO 10.0 mM 
B PdCl2 9.0 mg (50 µmol) 3:1 Brine/MeOH 5.0 mM 
C Pd(OAc)2 2.2 mg (10 µmol) 3:1 Brine/MeOH 1.0 mM 
D Pd(acac)2 3.0 mg (10 µmol) DMSO 1.0 mM 
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E PdCl2(PPh3)2 7.0 mg (10 µmol) DMSO 1.0 mM 
F PdCl2(MeCN)2 2.6 mg (10 µmol) 3:1 Brine/MeOH 1.0 mM 
G K2PdCl6 19.9 mg (50 µmol) 3:1 Brine/MeOH 5.0 mM 
Notes: See previous experimentals 
 
Fluorescence spectroscopy. Fluorescence spectra were recorded in a 1 × 1-cm disposable 
cuvette (VWR; catalog number 58017-880) on a Jobin Yvon FluoroMax-3 spectrometer under 
the control of a Windows-based PC running FluorEssence software. The samples were excited at 
497 nm and the emission intensities were collected at 535 nm. All spectra were corrected for 
emission intensity using the manufacturer supplied photomultiplier curves.  
 
Initial rate determination. PdCl2 stock solution B (200.0 µL, 470 nmol) and 34 (10.0 mg, 23.4 
µmol) were added to DMSO/pH 10 buffer (1:1) solution (20 mL)  at 24 °C. The experiment was 
performed in triplicate. At t = 0.5, 1, 2 and 4 h, 200 µL aliquots were taken from each reaction 
mixture and diluted to 4.0 mL with 1:4 DMSO/pH 10 buffer for fluorescence measurement. 
Notes: No difference was noted between the reaction in 1:1 and 1:4 DMSO/pH 10 buffer. A pH 
10 buffer was chosen because a pH study revealed that this was the optimal pH for the 
rearrangement. 
 
Turnover frequency (TOF). To determine the TOF, a solution containing PdCl2 ([PdII]final = 
500 nM) and solution A (5.0 µL, [34]final = 12.5 µM) was prepared in DMSO/pH 10 buffer (1:4). 
The intensity of this sample was compared to a standard solution containing 36 ([36]final = 500 
nM) in DMSO/pH 10 buffer (1:4). The intensity of the PdII-containing sample was 7.3 × 105 after 
24 h at 50 °C and the intensity of the standard solution of 36 was 1.0 × 105. The turnover 
frequency is 7.3 × 105 /1.0 × 105 = 7.3/24 h = 0.3 h-1. 
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Preparation of analytic samples for fluorescence detection. Pd solutions B−G (40.0 µL of 1.0 
mM stock, [PdII]final = 10 µM) were added to DMSO/pH 10 buffer solution (1:4) (4.0 mL). To 
the mixture was added solution A (5.0 µL, [34]final = 12.5 µM), and the samples were incubated 
for 24 h at 50 °C in a water bath before fluorescence measurement. Each experiment was 
performed in triplicate. 
 
Concentration dependence of PdII/IV detection in aqueous solvent. Varying amounts of Pd 
solution B/G were added to DMSO/pH 10 buffer solution (1:4) (4.0 mL). Solution A (5.0 µL, 
[34]final = 12.5 µM) was added to the mixture, and the samples were incubated for 24 h at 50 °C 
in a water bath before fluorescence measurement. Each experiment was performed in triplicate. 
 
Determination of PdII in functionalized organic compounds. A solution of compound (50 mg) 
in DMSO (800 µL) was treated with Pd black (<2.25 µmol/mL) and varying amounts of PdCl2 
(600 nM−60 µM; 5−500 ppm in the compound) and the sample was allowed to sit for 30 min. 
pH 10 Buffer ([buffer salt] = 1.14 mM; 3.2 mL) and solution A (5.0 µL, [34]final = 12.5 µM) were 
then added to the mixture, and the samples were heated for 4 h at 50 °C in a water bath before 
fluorescence measurement. 
For comparison, the following control experiments were conducted: 
(1) Negative control (Background): Solution A (5.0 µL, [1]final = 12.5 µM) was added to DMSO 
(800 µL) and pH 10 buffer ([buffer salt] = 1.14 mM; 3.2 mL), and the samples were heated for 4 
h at 50 °C in a water bath before fluorescence measurement. 
(2) Positive control (PdII only): Varying amounts of PdCl2 (0.6−60 µM in solution; 5−500 ppm 
in the compound) were added to DMSO (800 µL), and the sample was allowed to sit for 30 min. 
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pH 10 buffer ([buffer salt] = 1.14 mM; 3.2 mL) and solution A (5.0 µL, [1]final = 12.5 µM) were 
then added to the mixture, and the samples were heated for 4 h at 50 °C in a water bath before 
fluorescence measurement. 
(3) Negative control (Pd0 only): Pd black (<2.25 µmol/mL) was added to DMSO (800 µL), and 
the sample was allowed to sit for 30 min. pH 10 buffer ([buffer salt] = 1.14 mM; 3.2 mL) and 
solution A (5.0 µL, [1]final = 12.5 µM) were then added to the mixture, and the samples were 
heated for 4 h at 50 °C in a water bath before fluorescence measurement. 
(4) Positive control (PdII + Pd0): Pd black (<2.25 µmol/mL) and varying amounts of PdCl2 (600 
nM−60 µM in solution; 5−500 ppm in the compound) were added to DMSO (800 µL), and the 
sample was allowed to sit for 30 min. pH 10 buffer ([buffer salt] = 1.14 mM; 3.2 mL) and 
solution A (5.0 µL, [1]final = 12.5 µM) were then added to the mixture, and the samples were 
heated for 4 h at 50 °C in a water bath before fluorescence measurement. 
Normalization procedure. The data are normalized for 500 ppm PdII analogously to ICP-MS 
analysis, in which a standard curve is generated for Pd in each organic molecule separately. 
 
Monitoring of PtIV reduction. PtIV reduction mixture (0.5 mL) was treated with solution A (5.0 
µL, [34]final = 12.5 µM) and the samples were heated at 80 °C for 2 h. Prior to fluorescence 
measurement, each sample was diluted to 1.0 mL with pH 7 buffer. 
 
PtIV detection in platinum-containing drink. PtIV containing Pt0 water (0.5 mL) was treated 
with solution A (5.0 µL, [34]final = 12.5 µM) and the samples were heated at 80 °C for 2 h. Prior 
to fluorescence measurement, each sample was diluted to 1.0 mL with pH 7 buffer. In this case, 
the negative control was the commercially-available Pt0 nanocolloid-containing water. 
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6.0  FLUOROMETRIC DETECTION OF OZONE 
6.1 RESEARCH DESIGN 
The study of reactive oxygen species (ROS) in biology is quite extensive. Although selective 
fluorescent sensors exist for many ROS (singlet oxygen, superoxide, hydroxyl radical, nitric 
oxide, etc.), no such sensor had been previously reported for ozone.1 As such, it was speculated 
that a selective, fluorescent “turn-on” probe for ozone could be designed based on ozone’s 
reactivity with alkenes (Figure 62). 
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Figure 62. Ozonolysis of homoallyl ether to convert a nonfluorescent molecule to a fluorescent molecule 
6.1.1 Importance of Ozone Detection 
Ozone exposure is a signficant global health problem, especially in urban areas. While ozone in 
the stratosphere protects the earth from damaging ultraviolet light, tropospheric or ground level 
ozone is toxic resulting in damage to the respiratory tract.2 In fact, the Environmental Protection 
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Agency recently lowered the allowable ozone level from 84 ppb/8 h to 75 ppb/8 h.3 Aside from 
outdoor ozone exposure, indoor exposure to ozone is on the rise, which is largely due to outdoor 
ozone being trapped indoors and electrical equipment that can produce ozone such as 
photocopiers (1.3−7.9 mg ozone/h), laser printers (<0.02−6.5 mg ozone/h) and electrostatic air 
filters.4,5 In addition to ozone itself as a pollutant, the products of ozone reactions are also toxic. 
Such ozone-reactive compounds are found in common items such as wood flooring, carpet, 
paints, cleaning products and perfumes. 
 In terms of ozone biology, the exact mechanism by which ozone damages the respiratory 
system is poorly understood.6−11 It is speculated that ozone is much too reactive to reach and 
permeate the epithelial cells of the lung. Once ozone is breathed into the respiratory system, it is 
known to react with many biomolecules including unsaturated fatty acids and antioxidants in the 
nasal and lung lining fluid. In fact, the antioxidants uric acid, ascorbic acid and glutathione are 
the first line of defense against ozone.10,11  While the time for ozone to cross the lung lining was 
estimated as 2 × 10-6 s, the half-life of ozone was estimated as 7 × 10-7 s. This is due to the fact 
that the rates of reaction with these antioxidants are 5.83 × 104 M-1s-1 (uric acid), 5.5 × 104 M-1s-1 
(ascorbic acid), and 57.5 × 104 M-0.75s-1 (glutathione).12 Thus, ozone preferentially reacts with 
antioxidants to prevent damage to the lung tissue. 
 Although ozone has a negative impact on human health, there are a number of industrial 
applications for ozone.13 For example, ozone plays a critical role in wastewater treatment, 
disinfection and fumigation. In addition, although prohibited in the United States, intravenous 
ozone therapy is believed to have health benefits. Thus, ozone plays many roles in today’s 
society and selective detection of this toxic, but useful gas is an important challenge. 
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6.1.2 Endogenous Ozone Controversy 
Reactive oxygen species (ROS) have had a rather controversial history.14 The existence of singlet 
oxygen and superoxide was first proposed in the late 1960s; however, due to the lack of sensitive 
and specific probes, these results were met with skepticism and the observations were only 
confirmed in the late 1980s. Recently, ozone has received its time in the spotlight. It has been 
proposed that ozone is produced endogenously from singlet oxygen in both neutrophils and 
atherosclerotic plaque (Figure 63b) implicating ozone in inflammatory responses.15−17 This 
conclusion was drawn from the premise that the colorimetric dye, indigo carmine (68; Figure 
63a),18 differentially reacted with ozone as opposed to other ROS through incorporation of an 
18O label . However, similar to the singlet oxygen/superoxide story, 68 has since been proven to 
not only react with ozone but also with superoxide in a similar manner, thus, calling into 
questions these findings of endogenous ozone.19−21  
 Aside from this ozone controversy, chemiluminescent methods, including the use of 68, 
are also used to measure ozone in ambient air;22,23 however, other atmospheric compounds are 
known to also absorb in this region of the electromagnetic spectrum and false-positive ozone 
readings are often reported.24,25 In addition, many of these methods are sensitive to humidity. We 
reasoned that if a specific probe were available then ozone detection in air and biological 
systems would be achieved more reliably. 
 There are several problems associated with the use of 68 as a specific sensor for ozone. 
First, the dye readily undergoes oxidative cleavage, which is most likely responsible for the lack 
of specificity.26 Additionally, the reaction of blue 68 with ROS yields compound 69 (Figure 63), 
which is colorless and cannot be directly visualized without the use of a spectrometer. In 
biological samples, HPLC or mass spectrometry are often required in combination with such 
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spectroscopic techniques because the signal for 69 (UV: λmax = 245 and 298 nm) overlaps with 
many other bioorganic compounds. 
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Figure 63. Nonselective indigo carmine sensor for ROS 
  
A similar approach has recently been reported and commercialized for the simultaneous 
detection of ozone and carbonyls in air.27 Although this system was shown to be resistant to 
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humidity, it requires extensive extraction and derivatization prior to HPLC analysis, and its 
stability in the presence of other oxidizing agents was not reported. 
6.1.3 Other Ozone Detection Methods 
In addition to colorimetric ozone detection methods, other common ozone detection methods 
include chemiluminescence (noncolorimetric), UV photometry, electrochemical, differential 
optical absorption spectrometry (DOAS) and light detection and ranging (LIDAR).22,28,29 There 
are two chemiluminescent methods commonly used for ozone: reaction of ozone with ethylene 
or reaction of ozone with NO. Although this method is sensitive (detection limit = 2−5 ppbv), a 
known interference is water vapor; and thus, false positive ozone readings are often observed.28  
 The UV photometry method is based on ozone’s ability to absorb UV light. Similar to 
indigo carmine, one major drawback is the fact that other gaseous hydrocarbons such as aromatic 
hydrocarbons often overlap with ozone’s signal (254 nm). The detection limit for this method is 
2−5 ppbv.28 
The most common electrochemical method is based on the reaction of ozone with 
potassium iodide.22 In fact, this is one of the oldest methods for ozone detection. Major problems 
with this method are interferences with other oxidants and insufficient reproducibility, especially 
at low ozone concentrations.22,28,29 Nonetheless, this method is still used for calibration. 
DOAS and LIDAR are both remote ozone detection methods and the most sensitive to 
date.24 Since both of these methods are based on light paths (white light vs. laser), a major 
interference is any object that interrupts the path of the laser. The detection limit for DOAS and 
LIDAR are <1.5 ppbv.28 
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6.2 RESULTS AND DISCUSSION 
6.2.1 Mechanistic Design and Synthesis of Fluorescent Ozone Sensor 
As was previously discussed, fluorescein compounds display fluorescence signal only when the 
phenolic hydroxy group is deprotonated.30 Thus, it was proposed that if Pittsburgh Green 35 
were functionalized as a nonfluorescent homoallyl ether, after reaction with ozone the resulting 
aldehyde would undergo β-elimination to yield fluorescent fluorescein and acrolein (Figure 64). 
This terminal alkene sensor should be specific for ozone because it contains a less electron-rich, 
isolated (non-conjugated) olefin, which should not react with other ROS to yield a fluorescence 
signal.31−33 
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Figure 64. Synthesis and mechanistic design of ozone sensor 67 
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 Based on this hypothesis, homoallyl ether 67 was designed and synthesized in two steps 
from commercially available 2’,7’-dichlorofluorescein (DCF) in 64% yield (Figure 64). Ozone 
was bubbled through a solution of 67 in 19:1 acetone/water and fluorescent compound 35 was 
obtained in quantitative yield presumably through intermediates 71 and 72, thus, providing 
positive feedback for the sensor design.  
6.2.2 Ozone Detection in Aqueous Media 
In order to develop a fluorescent method amenable to both biological and atmospheric detection, 
pH 7 buffer was chosen to perform the conversion of 67 to 35. A solution of 67 in 1:19 
MeOH/pH 7 buffer at 24 °C was exposed to ozone, and following incubation at 37 °C for 1 h to 
facilitate β-elimination, formation of 35 was observed (signal-to-background (S/B) = 80) (Figure 
65a). A time-dependence study for conversion of 67 to 35 revealed that 1 h is sufficient time for 
this process to occur (Figure 65b). Presumably, the β-elimination is the rate-determining step 
because the formation and fragmentation of molozonides are extremely rapid.34 Because this 
detection method may be performed in the presence of cells, ozonolysis was also performed in a 
mixture of pH 7 buffer and RPMI-1640 cell culture media (3:1). Indeed, the method is 
compatible with components of the cell culture media (S/B = 104; not shown) indicating that this 
method should be amenable for in vitro and possibly in vivo studies. 
With these successful results with ozone in hand, the ROS-specificity of the sensor was 
next determined. Sensor 67 was tested against singlet oxygen and superoxide; singlet oxygen 
was generated in situ from sodium molybdate and hydrogen peroxide and potassium superoxide 
was used as a source of superoxide. To confirm the production of these ROS species, indigo 
carmine was used as a positive control. No reaction or fluorescence signal was observed with 
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either of these ROS (Figure 65a). Hydrogen peroxide and hydroxyl radical were also examined 
because peroxide35 is a by-product of the aqueous ozonolysis reaction, hydroxyl radical22 is a 
product of ozone decomposition in aqueous solution and both are endogenous ROS species. For 
each, no reaction was observed (Figure 65a). Thus, sensor 67 is specific for ozone and can be 
used to unambiguously detect ozone even in the presence of other ROS. 
The sensitivity of this fluorescent method for ozone detection was next examined. The 
fluorescence intensity correlated to the concentration of ozone in the 50 nM−12.5 µM (2.4−600 
ppbv) range (Figure 65c) with S/B of 2.6−310 after 10-fold dilution of the original samples 
(0−500 nM shown in Figure 65d). The level of detection is 59 nM (2.9 ppbv; S/B = 3) and the 
level of quantitation is 340 nM (16 ppbv; S/B = 10), which is comparable to other known ozone 
measurement techniques. 
(a)          (b)                      (c) 
 
 (d)                           (e)                                            (f)        (g) 
 
Figure 65. Ozone detection in aqueous and biological media  
In (a)−(e), the y-axis is fluorescence intensity (a. u. × 105) at 523 nm. In all cases, [67] = 12.5 µM and ozone was 
generated by feeding high purity oxygen into a Welsbach T-series ozone generator. (a) ROS specificity. A = no 
ROS, B = ozone, C = singlet oxygen, D = superoxide, E = hydrogen peroxide, F = hydroxyl radical. Ozone samples 
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were incubated in 1:19 MeOH/pH 7 buffer at 37 °C for 1 h after ozone exposure at 24 °C. Singlet oxygen was 
generated from NaMoO4•2H2O (1.0 mM) and 30% H2O2 (25 mM) in pH 10 borate buffer and samples were 
incubated at 24 °C for 30 min. Superoxide was generated from KO2 (250 µM) and samples were incubated in pH 7 
phosphate buffer at 37 °C for 30 min. Samples containing only 30% H2O2 (25 mM) were incubated in pH 7 
phosphate buffer at 37 °C for 30 min. Hydroxyl radical was generated from FeSO4•7H2O (250 µM) and 30% H2O2 
(250 µM) and samples were incubated at 37 °C for 30 min. (b) Time-dependence of the conversion from 67 to 35. 
(c) Correlation between fluorescence intensity and [ozone] in 1:19 MeOH/pH 7 buffer. (d) Correlation between 
fluorescence intensity and [ozone] in 1:19 MeOH/pH 7 buffer after ten-fold dilution of original samples. y = 
0.000900x + 0.0467; R2 = 0.987; average standard deviation = 0.00844. (e) Ozone detection in the presence of 
antioxidants. A = no ozone, B = ozone only, C = ozone with ascorbic acid (50 µM), D = ozone with glutathione (100 
µM), E = ozone with uric acid (100 µM), F = ozone with all antioxidants. (f) Ozone detection in human pleural  
fluid. Left: 67, no ozone; Right: 67, + ozone. (g) Ozone detection in human serum. Left: 67, no ozone; Right: 67, + 
ozone. 
   
6.2.3 Ozone Detection: Biological Applications 
Because many questions exist in ozone’s role in damaging human health, there is necessity for a 
biomedical probe to better understand the localization of this highly reactive species. Cellular 
effects of ozone exposure have been observed; however, it is speculated that ozone is much too 
reactive to reach and permeate the epithelial cells.10,11 Thus, to examine the utility of this sensing 
method in such biological samples, ozone detection was attempted first in the presence of 
antioxidants that are found in the epithelial lining fluid. Ascorbic acid, glutathione, and uric acid 
are the most predominant antioxidants present,9,10,12 and as Figure 65e shows, this sensor method 
is operational even in the presence of physiologically relevant antioxidants. This method was 
then tested with human pleural fluid to accurately mimic the epithelial lining fluid of the lung.36 
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Indeed, fluorescence signal was produced (S/B = 92; Figure 60f) indicating that sensor 67 should 
provide a tool to directly visualize this reactive gas in the study of ozone and the respiratory 
system.  
 As further demonstration of the robustness of sensor 67, detection of ozone in human 
serum was examined. As Figure 65g shows, sensor 67 is capable of detecting ozone even in the 
presence of other potentially reactive species in serum (S/B = 92). It is interesting to note that 
although the maximum emission wavelength red-shifted to 531 nm, the observed color was blue. 
This observation proved to be general for this fluorophore scaffold as both DCF and 35 behaved 
in a similar manner in serum (not shown). One possible explanation may be due to the small 
Stokes shift that is found in fluorescein and its derivatives, which makes these fluorophores more 
prone to influences of scattering and interference.37 
6.2.4 Ozone Detection: Atmospheric Application 
In addition to ozone detection in biological samples, the application of sensor 67 for ozone 
detection in ambient air was also desired. Solutions of 67 in 5:95 MeOH/pH 7 buffer were 
prepared and exposed to ambient air in various locations throughout a city on a hot, sunny day 
(~32 °C) for 8 h. A negative control was prepared in the same manner but incubated at 37 °C in a 
closed vial for 8 h.     
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           (a)              (b) 
  
Figure 66. Ozone detection in ambient air  
In both graphs, the y-axis is fluorescence intensity (a. u. × 105) at 523 nm. In all cases, [67] = 12.5 µM and all ozone 
assays were performed in 1:19 MeOH/pH 7 buffer. (a) Ozone detection in outdoor air for 8 h. A = negative control, 
B−E = outdoor air samples at various locations. (b) Ozone specificity against other air pollutants. A = no additive, B 
= ozone, C = HNO3, D = H2SO4, E = Pb, F = Pd, G = Pt. [Acid] = 250 µM. [Metal] = 100 nM. The acid samples 
were incubated in pure water for 30 min at 37 °C. The metal samples were incubated in pH 7 buffer for 30 min at 37 
°C. 
 
Ozone detection was successful with S/B values of 10−17 (Figure 66a), which correlates to 
13−22 ppb based on linear regression. To ensure that ozone was selectively detected, a number 
of other pollutants were screened. Nitrogen dioxide and sulfur dioxide will convert to their 
corresponding acids in aqueous solution so nitric acid and sulfuric acid were screened. Lead, 
palladium and platinum, which are known pollutants emitted from automobiles, were also 
screened.38 As Figure 66b shows, none of these species produced a fluorescence signal. Aside 
from the specificity, it is important to note here that my sensing method is performed in aqueous 
media and will not be impacted by humidity. Thus, sensor 67 may be used as a sensitive probe 
for ozone in the atmosphere.  
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6.3 CONCLUSION 
A specific and robust fluorescent sensor for ozone has been developed. This method is capable of 
fluorescently detecting ozone in biological samples, including nasal fluid and serum. In addition, 
detection of ozone in ambient air has also been demonstrated. The key benefits of this method 
are resistance to oxidants other than ozone, specificity against other known atmospheric 
pollutants, water compatibility and ease of measurement. This method should be a valuable tool 
in better understanding ozone’s role in human health and the atmosphere. Additionally, due to 
the simplicity of the method, it may be possible for the general public to monitor their exposure 
to ozone at home, especially for those who suffer from respiratory diseases using an inexpensive 
hand-held fluorometer. 
6.4 EXPERIMENTAL 
6.4.1 General Information 
Ozone was generated by feeding high purity oxygen into a Welsbach T-series ozone generator. 
RPMI-1640 medium (without L-glutamine and phenol red) is a product of HyClone® and was 
used as received. Human pleural fluid was purchased from Lee Biosolutions and used as 
received. Human serum (off-the-clot, type AB) was purchased from PAA Laboratories, Inc. and 
used as received. Buffers were purchased from J. T. Baker (pH 7, phosphate ([PO43-] = 46−50 
mM, [K+] = 23−25 mM, [Na+] = 50−56 mM), J. T. Baker, Catalog Number 5608-01) and used 
after dilution with ARISTAR® ULTRA Water. 
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All reactions were carried out under a nitrogen atmosphere with dry, freshly distilled 
solvents under anhydrous conditions, unless otherwise noted. Tetrahydrofuran (THF) was 
distilled from sodium-benzophenone, and methylene chloride (CH2Cl2) was distilled from 
calcium hydride. Yields refer to chromatographically and spectroscopically (1H NMR) 
homogenous materials, unless otherwise stated. 
All reactions were monitored by thin-layer chromatography (TLC) carried out on 0.25-
mm EMD silica gel plates (60F-254) using UV light (254 nm). TSI silica gel (230−400 mesh) 
was used for flash column chromatography. 
NMR spectra were recorded on AM300 (Bruker) instruments and calibrated using a 
solvent peak as an internal reference. The following abbreviations are used to indicate the 
multiplicities: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad. Mass spectra 
were obtained from a Micromass Autospec double focusing instrument. 
6.4.2 Synthesis 
Compound 70. A 100-mL round bottom flask was charged with 
2’,7’-dichlorofluorescein (2.4 g, 5.89 mmol), DMF (20 mL), K2CO3 
(2.5 g, 17.7 mmol) and 4-bromobutene (1.8 mL, 17.7 mmol) at 24 
°C. The reaction mixture was stirred at 70 °C for 8 h and then 
poured into 750 mL water. The resulting precipitate was washed with water and dried in vacuo to 
yield 70 as a red-orange solid (2.4 g; 80%). 
Data for 70: mp = 184−185 °C; Rf = 0.34 (70% EtOAc in hexanes); IR (KBr pellet): 1725 
(C=O), 1593, 1521, 1278, 997 cm-1; 1H NMR (300 MHz, CDCl3, 293K): δ 8.32 (dd, J = 7.5, 1.2 
Hz, 6-H), 7.82−7.68 (m, 2H, 4-H, 5-H), 7.26−7.30 (br d, J = 7.5 Hz, 1H, 3-H), 7.04 (s, 1H, Ar), 
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7.03 (s, 1H, Ar), 6.95 (m, 1H, Ar), 6.60 (s, 1H, Ar), 5.93 (ddt, J = 16.9, 10.3, 6.6 Hz, 1H, 3′′′-H), 
5.60 (ddt, J = 16.5, 9.9, 6.6 Hz, 1H, 3′′-H), 5.24 (ddt, J = 17.1 , 3.3, 1.5 Hz, 1H, 4′′′-Htrans), 5.18 
(ddt, J = 10.2 , 3.3, 1.5 Hz, 1H, 4′′′-Hcis), 5.02 (ddt, J = 17.1, 3.3, 1.5 Hz, 1H, 4′′-Htrans), 4.97 
(ddt, J = 10.2, 3.3, 1.5 Hz, 1H, 4′′-Hcis), 4.20 (t, J = 6.7 Hz, 2H, 1′′′-H), 4.13 (t, J = 6.7 Hz, 2H, 
1′′-H), 2.68 (q, J = 6.6 Hz, 2H, 2′′′-H), 2.23 (q, J = 6.6 Hz, 2H, 2′′-H); 13C NMR (75 MHz, 
CDCl3, 293K): δ 177.7, 169.4, 158.6, 157.8, 152.5, 149.8, 135.2, 133.5, 133.3, 133.2, 133.1, 
131.6, 130.4, 130.3, 130.2, 128.0, 127.4, 120.5, 118.1, 117.6, 117.4, 114.9, 105.7, 100.7, 69.2, 
64.5, 33.0, 32.6;  HRMS (ESI) m/z calcd. for C28H23Cl2O5 [M+H]+ 509.0923, found 509.0876. 
 
Compound 67.  A solution of compound 70 (200 mg, 0.392 mmol) in 
CH2Cl2 (1.32 mL) was treated with DIBALH (1.4 mL, 1.0 M in hexanes, 
1.4 mmol) dropwise over 15 min at -78 °C under a nitrogen atmosphere. 
The mixture was stirred for 5 min at the same temperature and then was warmed to 24 °C. After 
2 h, the reaction mixture was quenched with saturated aqueous NH4Cl (700 µL) and diluted with 
Et2O (2.9 mL) at 0 °C. DDQ (2.50 g, 11.0 mmol) was then added to the mixture at 0 °C.  After 
stirring 15 min, the mixture was filtered through Celite® and washed with Et2O. The filtrate was 
dried over Na2SO4 and the solvents were evaporated under reduced pressure. Silica gel flash 
chromatography of the residue (5 → 10 % EtOAc in hexanes) afforded compound 67 as a light 
orange solid (134 mg, 80%).  
Data for 67: mp = 167−168 °C; Rf = 0.69 (50% EtOAc in hexanes); IR (KBr pellet): 3387 
(br O-H), 3080, 2925, 2857, 1608, 1480, 1416, 1035 cm-1; 1H NMR (300 MHz, CDCl3, 293K): δ 
7.39−7.45 (m, 2H, Ar), 7.28−7.30 (m, 1H, Ar), 6.91 (s, 1H, Ar), 6.90 (s, 1H, Ar), 6.88 (s, 1H, 
Ar), 6.85 (s, 1H, Ar), 6.76 (s, 1H, Ar), 5.94 (ddt, J = 17.1, 10.5, 6.6 Hz, 1H, 3”-H), 5.26 (ddt, J = 
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17.1, 3.3, 1.5 Hz, 1H, 4′′-Htrans), 5.17 (ddt, J = 10.2, 3.3, 1.5 Hz, 1H, 4′′-Hcis), 5.34 (s, 2H, 1′′′-
H), 4.11 (t, J = 6.7 Hz, 2H, 1”-H), 2.63 (ddd, J = 6.6, 6.6, 1.5 Hz, 2H, 2”-H); 13C NMR (75 MHz, 
CDCl3, 293K): δ154.9, 151.9, 150.1, 149.6, 143.9, 138.6, 133.8, 129.5, 128.7, 128.6, 128.3, 
123.7, 121.0, 118.2, 118.1, 117.5, 117.1, 115.5, 103.6, 101.1, 83.1, 72.3, 68.6, 33.2;  HRMS 
(ESI) m/z calcd. for C24H19Cl2O4 [M+H]+ 441.0660, found 441.0683. 
 
Compound 35. A solution of 67 (34.2 mg, 0.0775 mmol) was prepared in 95:5 acetone/water39 
(585 µL total, 0.15 mM). The solution was cooled to 0 °C and ozone was bubbled through the 
sample for 2 min. Following ozonolysis, a small amount of KI (<5 mg) was added and the 
solution was stirred at 24 °C for 1 min. TLC analysis (50% EtOAc in hexanes) indicated 
complete conversion to 35.  
6.4.3 Fluorescence Spectroscopy 
Preparation of parent stock solutions used for this study. 
Entry Reagent Quantity Solvent (10 mL) Conc. of stock 
solution 
A compound 67 44.1 mg (0.10 mmol) DMSO 10.0 mM 
B NaMoO4•2 H2O 206.0 mg (1.00 mmol) pH 10 buffer 100 mM 
C KO2 71.1 mg (1.00 mmol) DMSO 100 mM 
D FeSO4•7 H2O 278.0 mg (1.00 mmol) pH 7 buffer 100 mM 
E L-Ascorbic acid sodium 
salt 
19.8 mg (0.1 mmol) pH 7 buffer 10.0 mM 
F Glutathione, reduced 30.7 mg (0.1 mmol) pH 7 buffer 10.0 mM 
G Uric acid 16.8 mg (0.1 mmol) pH 7 buffer 10.0 mM 
H Pb(NO3)2 16.6 mg (50 µmol) MeOH 5.0 mM 
I PdCl2 9.0 mg (50 µmol) 3:1 Brine/MeOH 5.0 mM 
J PtCl2 13.3 mg (50 µmol) DMSO 5.0 mM 
Notes:  
(1) All the solutions were stored at 24 °C. 
(2) Solution A was stored in the dark as precaution. 
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(3) All solutions for testing the ROS specificity were prepared and used immediately to 
prevent decomposition. 
(4) All solutions for testing detection in the presence of antioxidants were prepared and 
used immediately to prevent decomposition. 
 
Fluorescence spectroscopy. Fluorescence spectra were recorded in a 1 × 1-cm disposable 
cuvette (VWR; catalog number 58017-880) on a Jobin Yvon FluoroMax-3 spectrometer under 
the control of a Windows-based PC running FluorEssence software. The samples were excited at 
497 nm and the emission intensities were collected at 523 nm. All spectra were corrected for 
emission intensity using the manufacturer supplied photomultiplier curves. 
 
ROS specificity: 
Ozone: Solution A (5.0 µL, [67]final = 12.5 µM) was added to 1:19 MeOH/pH 7 buffer 
([PO43-] = 5 mM) solution (4.0 mL), and the samples were exposed to ozone for 2 min at 24 °C 
(flow rate = 1 mL/min) followed by 1 h incubation at 37 °C before fluorescence measurement. 
Singlet oxygen: Solution A (5.0 µL, [67]final = 12.5 µM), solution B (40.0 µL, 
[NaMoO4•2H2O]final = 1.0 mM)40 and 30% H2O2 (10 µL, [H2O2]final = 25.0 mM) were added to 
1:19 MeOH/pH 10 buffer solution (4.0 mL), and the samples were incubated for 30 min at 24 
°C. 
Superoxide: Solution A (5.0 µL, [67]final = 12.5 µM) and solution C (10.0 µL, [KO2]final = 
250 µM) were added to 1:19 MeOH/pH 7 buffer solution (4.0 mL), and the samples were 
incubated for 30 min at 37 °C. 
 138 
Hydrogen peroxide: Solution A (5.0 µL, [67]final = 12.5 µM) and 30% H2O2 (10 µL, 
[H2O2]final = 25.0 mM) were added to 1:19 MeOH/pH 7 buffer solution (4.0 mL), and the 
samples were incubated for 30 min at 37 °C. 
Hydroxyl radical: Solution A (5.0 µL, [67]final = 12.5 µM), solution D (10.0 µL, 
[FeSO4•7H2O]final = 250 µM) and 30% H2O2 ([H2O2]final = 250 µM) were added to 1:19 
MeOH/pH 7 buffer solution (4.0 mL),41 and the samples were incubated for 30 min at 37 °C. 
 
Time dependence of the conversion from 67 to 35. Solution A ([67]final = 12.5 µM) was added 
to 1:19 MeOH/pH 7 buffer ([PO43-] = 5 mM) solution, and the sample was exposed to ozone for 
5 min at 24 °C (flow rate = 1 mL/min) followed by incubation at 37 °C. Aliquots of the reaction 
mixture were taken out at various time for fluorescence measurement. 
 
Concentration dependence. Ozone solutions were prepared in pH 6 buffer and the 
concentrations were determined by UV absorption (λmax = 258 nm; ε = 2900 l mol-1 cm-1.42,43 To 
1:19 MeOH/pH 7 buffer ([PO43-] = 5 mM) solution (4.0 mL) was added solution A (5.0 µL, 
[67]final = 12.5 µM), and the samples were exposed to varying amounts of ozone at 24 °C 
followed by 1 h incubation at 37 °C. The samples were diluted 10-fold before fluorescence 
measurement to maintain linearity with respect to fluorescence signal. 
 
Ozone detection in the presence of antioxidants. Solution A (5.0 µL, [67]final = 12.5 µM) and 
solutions E−G (E: 20.0 µL, [Ascorbic acid]final = 50.0 µM; F, G: 40.0 µL, [Glutathione/Uric 
acid]final = 100.0 µM) were added to 1:19 MeOH/pH 7 buffer ([PO43-] = 5 mM) solution (4.0 
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mL), and the samples were exposed to ozone for 2 min at 24 °C followed by 1 h incubation at 37 
°C before fluorescence measurement. 
 
Ozone detection in human pleural fluid. Human pleural fluid (1.0 mL) was diluted in pH 7 
buffer ([PO43-] = 5 mM) (3.0 mL). Solution A (5.0 µL, [67]final = 12.5 µM) was added to the 
pleural fluid solution, and the samples were exposed to ozone for 2 min at 24 °C followed by 1 h 
incubation at 37 °C before fluorescence measurement. 
 
Ozone detection in human serum. Human serum (1.0 mL) was diluted in pH 7 buffer ([PO43-] 
= 5 mM) (3.0 mL). Solution A (5.0 µL, [67]final = 12.5 µM) was added to the serum solution, and 
the samples were exposed to ozone for 2 min at 24 °C followed by 1 h incubation at 37 °C before 
fluorescence measurement. 
 
Ozone detection in ambient air. Solution A (5.0 µL, 674]final = 12.5 µM) was added to 1:19 
MeOH/pH 7 buffer ([PO43-] = 5 mM) solution (4.0 mL), and the samples were placed in 4 
outdoor areas throughout University of Pittsburgh campus for 8 h on June 6, 2008 (high 
temperature = 32.2 °C; AQI = 43; PM2.5 = 64) (data from http://www.airnow.gov. AQI = air 
quality index. PM2.5 = particulate matter less than 2.5 µm.). Care was taken to ensure the 
samples were not hit by direct sunlight.  
 
Sample Location (See the map: http://maps.google.com/?ie=UTF8&ll=40.444612,-
79.955739&spn=0.00783,0.009527&t=h&z=17&layer=t) 
A Corner of Forbes Avenue* (3 lane road) and South Bouquet Street (2 lane road) next to a lane of traffic frequently 
traveled by cars and buses  
B Corner of Fifth Avenue* (4 lane road) and Bigelow Boulevard (4 lane road) next to a lane of traffic frequently traveled by 
cars and buses 
C In a tree ~200 m from Fifth Avenue (University Drive/Parkman Avenue) 
 140 
D Outside a 12th floor window of Chevron Science Center, which is ~200 m from Fifth Avenue (the corner between 
University Drive and Parkman Avenue) 
* Forbes and Fifth Avenues are two of the most heavily traveled streets in Pittsburgh, Pennsylvania 
 
 A negative control was prepared in the same manner but incubated at 37 °C in a closed 
vial for 8 h. Following 8 h incubation, the fluorescence of each sample was measured. 
 
Air pollutant specificity: 
Acids: HNO3 or H2SO4 (10 µL of 0.1 M solution; [Acid]final = 250 µM) and solution A 
(5.0 µL, [67]final = 12.5 µM) were added to 1:19 MeOH/pure water solution (4.0 mL), and the 
samples were  incubated at 37 °C for 30 min before fluorescence measurement. 
Metals: Pb, Pd or Pt solution (40 µL of 10 µM solution; [Metal]final = 100 nM) and 
solution A (5.0 µL, [67]final = 12.5 µM) were added to 1:19 MeOH/pH 7 buffer ([PO43-] = 5 mM) 
solution (4.0 mL), and the samples were incubated at 37 °C for 30 min before fluorescence 
measurement. 
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7.0  INTRODUCTION: SMALL MOLECULE LIBRARY SYNTHESIS 
Small molecules are powerful tools for the study of biological systems.1 For instance, such 
compounds provide rapid and conditional modulation of biological function, can alter an 
individual function of a multifunctional target and can help to identify new therapeutic targets. 
As such, processes that generate diverse arrays of small molecules are fundamental to the further 
understanding of biological pathways. 
7.1 DIVERSITY ORIENTED SYNTHESIS  
Diversity-oriented synthesis (DOS) has emerged as an important approach in generating vast 
arrays of compounds for biological screening.1−5 The key tenet of DOS is the development of 
divergent synthetic pathways that efficiently lead to collections or libraries of functionally, 
stereochemically and skeletally diverse small molecules. The methodology is dependent on 
tandem and complexity generating reactions and driven by advances in solid-phase organic 
synthesis. Thus, DOS aims to create vast arrays of small molecules in an attempt to occupy all 
realms of chemical space. By examining some examples of DOS, the power this method of 
library synthesis has in generating diverse small molecules is quite obvious. 
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7.1.1 Functional Diversity 
The simplest method of generating diversity is based on the principles of combinatorial 
chemistry, that is, functional group transformations at various reactive sites, such as OH, NH, 
and SH.1−5 A major goal in natural product-based library synthesis is to discover molecules that 
exhibit biological activity beyond that of the natural product in consideration, not to simply 
improve upon the activity of the parent scaffold. Thus, transformations at these types of reactive 
sites may provide new avenues to biologically active small molecules compared to the traditional 
alkyl-substitutions of combinatorial chemistry. 
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 An example of library synthesis demonstrating a functional diversity generating strategy 
is from the Shair group in the synthesis of galanthamine-like molecules 73 (Figure 67).6 The 
synthesis followed a biomimetic approach toward the key skeleton of the galanthamine-like core 
with four opportunities for functional diversity: (1) Mitsunobu chemistry at the phenol position 
with various alcohols, (2) conjugate addition into the α,β-unsaturated ketone with sulfur 
nucleophiles, (3) acylation or alkylation at the secondary amine and (4) formation of imines with 
hydrazines and hydroxylamines at the newly formed ketone. After the respective functional 
 146 
group transformations and cleavage with HF•pyridine, 2527 galanthamine-like small molecules 
were successfully synthesized. One compound was identified as a potent inhibitor of the 
secratory pathway at 2 µM. 
7.1.2 Stereochemical Diversity 
In addition to the diversity generated at the appendages of a library of small molecules, the 
molecular shape of a scaffold is also a variable in DOS. It is known that the complementarity of 
a small molecule and its target is necessary for biological activity, although not exclusively.7 
Thus, the stereochemical diversity and the spatial arrangement of such appendages must also be 
a significant factor in a library’s bioactivity.   
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 An example of DOS illustrating stereochemical diversity is the synthesis of non-peptidic 
analogues of endomorphin-2 74, a potent agonist of mu-opiod receptor, by the Verdine group.8,9 
The analogues were derived from two stereochemically rich terminal olefins coupled via olefin 
cross-metathesis (Figure 68). The synthesis generated four stereochemically diverse isomers.  
Remarkably, each isomer was found to exhibit vastly different binding affinities with the (S, S, S, 
R) isomer having activity closest to that of endomorphin-2.  
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7.1.3 Skeletal Diversity 
Although particularly effective, generating libraries of small molecules containing distinct 
molecular skeletons remains a difficult task. Two such strategies have been adopted to 
accomplish this feat. The first relies on pluripotent substrates, which may be treated with an 
array of reagents to create skeletal diversity.10 In contrast to the reagent-based approach, a 
second strategy relies on treating a collection of substrates containing different appendages, or σ-
elements, with common reagents to produce distinct molecular skeletons.11   
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 An example of a library based upon this σ-element approach to skeletal diversity was 
completed by the Schreiber group where they examined the idea of appendage stereochemistry to 
pre-encode skeletal diversity.11 The pathways began with a tandem, diversity-generating Ugi 
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four-component reaction followed by an intramolecular Diels-Alder reaction to form various 
tricyclic compounds (Figure 69).  Following allylation, hydrolysis, and acylation, the key σ-
element containing intermediates were generated and capable of undergoing the final ring-
closing metathesis step. The Schreiber group discovered an interesting phenomenon: if the σ-
element was on the α-face, the product contained a bridged molecular skeleton (75) following 
ring-closing metathesis; however, if the σ-element was on the β-face, then the fused product 76 
was isolated. Unfortunately, no known biological testing was reported. 
7.2 CHEMICAL SPACE 
Chemical space, defined as the total number of possible small organic molecules within a 
molecular weight of less than 500, is often estimated at ~1030-200 structures.1,12,13 One question 
that remains with respect to drug discovery concerns the known regions of chemical space, more 
specifically, are the known regions of chemical space the best for discovering biologically-active 
small molecules. Unfortunately, there is no answer to this question; however, DOS aims at 
answering this crucial question by synthesizing libraries of small molecules that occupy all 
regions of chemical space.1−5  
 Besides traditional combinatorial library design, DOS typically relies on two major 
library design strategies: the design of drug-like or natural product-like libraries.1,13 These 
structures are known to more effectively occupy chemical space than their combinatorial 
counterparts.14  
Drug-like libraries are traditionally based on nitrogen-containing heteroaromatic 
scaffolds of appropriate size to effectively occupy the active site binding pocket of its 
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target.1,14,15 A good example of such a library is Ellman’s benzodiazepine-based library, which is 
one of the earliest DOS contributions (Figure 70a).16 Additional examples of these “privileged” 
structures are shown in Figure 70a.1 It is important to note that these compounds often have few 
to no stereogenic centers, which greatly eases their synthesis. 
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Figure 70. Examples of drugs and natural products 
 
On the other hand, natural product-like libraries can be based on the core scaffold of a 
natural product, structural motifs found in a class of natural products or generally emulate the 
structural characteristics of natural products.1 These molecular types typically have large 
molecular weight, greater structural complexity, electrophilic sites and a significant number of 
stereogenic centers.14,15 Because of this complexity, natural products are known to exhibit high 
binding specificity for their receptors and highly selective modes of action. As such, libraries 
based on these scaffolds are highly profitable. Some examples of natural products containing key 
electrophilic moieties (in red) in addition to molecular recognition sites are shown in Figure 70b. 
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7.3 CONCLUSION 
Diversity-oriented synthesis is a useful approach for generating vast arrays of potentially 
bioactive small molecules. A survey of the literature reveals three main methods for generating 
diversity: functional group transformation, diversity at stereochemical centers and the synthesis 
of diverse molecular skeletons. Through these diversity-generating elements, libraries emulating 
natural products and drug-like structure are readily attainable. Thus, the development of new 
methods that can further this approach may be highly profitable toward the goal of examining 
chemical space through synthesis. 
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8.0  EFFORTS TOWARD CONVERGENT SOLID-PHASE ORGANIC SYNTHESIS 
Solid-phase organic synthesis is an enabling technology and its automation has had profound 
impact. For example, automated solid-phase oligonucleotide1 and peptide2 syntheses have 
advanced many scientific areas. However, to date, the structural diversity of the molecules 
derived from this technology is limited3 because current solid-phase methods are linear. 
Convergent synthetic approaches are far more versatile and amenable to highly complex 
molecules due to the ability to functionalize each fragment separately. While solution-phase 
target- and diversity-oriented syntheses4 have been greatly aided by such convergency,5 solid-
phase organic synthesis has been limited by its inherent linearity.6,7 Thus, new technologies for 
convergency are needed to advance solid-phase organic synthesis for complex molecules.  
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 As such, I set out to develop an enabling resin-to-resin transfer technology that unites two 
spatially separated, functionalized fragments to form highly complex small molecules in a 
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convergent manner (Figure 71). Such technology should allow for the synthesis of small 
molecules possessing natural product- and drug-like functionalities that are not readily accessible 
by conventional linear approaches. 
8.1 RESEARCH DESIGN 
8.1.1 Convergent Solid-Phase Organic Synthesis 
Examples of “convergent” solid-phase organic synthesis in the literature are limited. However, 
one aspect that all examples have in common is that one of the fragments is coupled with a 
second fragment on solid support only after synthesis using solution-phase or solid-phase 
synthesis after cleavage. This cleave-and-couple method is depicted in Figure 72. 
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Figure 72. Convergent, cleave-and-couple solid-phase organic synthesis 
 
The first example of convergent solid-phase organic synthesis was demonstrated by 
Nielsen, who termed the method “double combinatorial chemistry”.8,9 The concept of Nielsen’s 
work was to couple two peptide libraries to a biaryl linker in the synthesis of actinomycin 
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analogs 77 (Figure 73). Nielsen synthesized a total of 9 library compounds isolated as mixtures, 
and no biological testing was reported. 
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A second example of a convergent solid-phase library strategy was not reported until 
2004 by Raveglia in the synthesis of a 48-member benzimidazolone library 78 (Figure 74).10 The 
Raveglia group synthesized 3 carboxylic acids on solid support, which were subsequently 
cleaved, purified, and coupled with 16 amines. Again, no biological testing was reported. 
 
O
O
NO2
NHR1
N
N
HO
O
O
R2
R1
N
H
O
O
R3
OH N
H
O
O
R3
N
H
R4
Couple and
Cleave
N
N
N
O
O
R2
R1
R3
R4
H2N3 carboxylic acids
16 amines
78
48 Benzimidazolones  
Figure 74. Raveglia library 
 155 
A final example was demonstrated by Schreiber in the synthesis of small molecule 
hybrids.11 The library synthesis makes use of both types of convergent solid-phase synthesis: the 
coupling of sublibraries I and II demonstrates the reaction of a solid-supported component with a 
solution-phase component while the coupling of sublibraries II and III demonstrates the cleave-
and-couple strategy with both components in solution. The Schreiber group coupled the 3 highly 
functionalized sublibraries through esterification to generate libraries of 480 (79) and 384 (80) 
compounds, respectively, shown in Figure 75. Similar to the previous library syntheses, no 
biological testing has yet been reported. 
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Figure 75. Schreiber library 
 
 Although each of these examples validates convergent synthesis partially on the solid 
support, each coupling requires three steps: (1) initial cleavage from the resin, (2) purification of 
the intermediate and (3) coupling with an additional fragment. A better and more efficient 
method of convergent solid-phase library synthesis would be the coupling of both components 
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on the solid support, thereby eliminating the need for pre-coupling cleavage and purification. 
This may seem feasible, however, there are some critics. In a recent paper, such an approach was 
described as, “…conventional convergent synthetic strategy…can only be conveniently 
conducted using solution-phase, not solid-phase, techniques and avoids the more repetitive 
independent linear synthesis of each analogue.” While this may be the accepted notion, this type 
of resin-to-resin transfer chemistry has been documented in the literature.  
8.1.2 Resin-to-Resin Transfer Chemistry 
Resin-to-resin transfer chemistry dates back to the 1970’s with Rebek’s studies on the “three-
phase test” or triphasic reactions.12−15 The set-up consists of a precursor and trap molecule each 
on solid support in the same reaction vessel. A cleaving reagent in solution then reacts with the 
precursor to form an intermediate in solution, which subsequently reacts with the trap to form the 
adduct or product remaining on the resin (see the following examples in Figures 76 and 77 for 
more mechanistic detail). Despite the fact that this method could have potential in synthesis, the 
chemistry was only used to study reaction mechanisms at this time.  
 Using Rebek’s initial studies, two research groups have explored the idea of employing 
resin-to-resin transfer for synthetic purposes. The first example is acyl- and aminoacyl-transfer 
reactions using oxime supports from the DeGrado group, which is similar to the reactions 
examined by Rebek.16 The mechanistic scheme for acyl-transfer is shown in Figure 76. The 
mechanism follows a similar pathway to that described by Rebek with the acylated oxime resin 
serving as the precursor, N-hydroxysuccinimide as the shuttling agent between the precursor and 
trap, and the amine containing resin serving as a trap. 
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Figure 76. Resin-to-resin acyl transfer reaction 
 
The second example illustrates the first resin-to-resin carbon-carbon bond forming 
reaction by the Hall group, namely resin-to-resin transfer Suzuki coupling.17,18 The pathway of 
the Hall method is shown in Figure 77.  The first step involves the release of the boronic acid 
from the resin in the presence of water. This intermediate is then able to react with the solid-
supported aryl iodide in the presence of palladium to complete the Suzuki reaction in 100% yield 
for the reaction shown. This method has also been more recently applied to Sonogashira 
chemistry.19 
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Figure 77. Resin-to-resin Suzuki cross-coupling reaction 
 158 
           By examining each of these resin-to-resin transfer reactions, several benefits are clearly 
identified. First of all, these reactions allow for convergent fragment coupling with both 
components on the resin. Secondly, they share a common benefit with typical solid-phase 
organic synthesis, namely simple purification of intermediates by washing with organic solvents. 
Finally, resin-to-resin transfer reactions provide vast opportunity for library synthesis whereby 
many diverse fragments can be coupled to form many small molecules. 
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Figure 78. Resin-to-resin transfer approach 
 
 Along with these inherent benefits, there are also limitations to the previously described 
resin-to-resin reactions. Similar to solid-phase organic synthesis, all reactions must be driven to 
completion to ensure all starting materials are consumed, which is especially important in 
convergent library synthesis with no intermediate purification steps. Additionally, any by-
products formed during the reaction would also be isolated along with the product(s) and 
remaining starting materials (Figure 78). Each of these limitations can be attributed to one flaw 
in the reaction set-up – both precursor and trap beads are contained in the same vessel with no 
separation. Thus, allowing separation of each of these components would provide ease in 
separating any remaining precursor beads that may not have reacted and any by-products that 
may have formed on the precursor side of the vessel, thereby greatly simplifying the final 
purification of library compounds.20 
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8.1.3 Olefin Cross-Metathesis 
Carbon-carbon double bond formations are important in organic synthesis. Among these 
reactions is olefin metathesis, which is a very powerful method for the construction of complex 
alkenes.21 Olefin metathesis has been used in the syntheses of a variety of molecules in solution 
phase.22 In solid-phase synthesis, although ring-closing olefin metathesis has been widely 
used,23−26 olefin cross-metathesis has been rarely used despite its potential for the convergent 
synthesis of complex alkenes.27−30 A few notable examples are shown below. 
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Figure 79. Examples of solid-phase olefin cross-metathesis 
 
 A simple example comes from the Chang group, who reported the synthesis of hydroxy 
(E)-stilbenoids 81 using a solid-supported hydroxystyrene (Figure 79a).29 In a more recent 
example, Testero and Mata showed that β-lactam analogues 82 could be prepared on solid 
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support using olefin cross-metathesis between simple alkenes in solution and solid-supported 
vinyl lactams (Figure 79b).28 
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Figure 80. Example of intrabead homodimerization using olefin cross-metathesis 
 
 In addition to the synthesis of heterodimers on solid support using olefin cross-
metathesis, the synthesis of intrabead homodimers has also been reported.31−34 The Schreiber 
group first reported this approach for the synthesis of simple peptidomimetics 83 (Figure 80).34 
This approach has since been used in more complex molecule synthesis and in the synthesis of 
solid-supported ligands. 
 In terms of mechanism, olefin cross-metathesis is the combination of two olefins via a 
ruthenium alkylidene catalyst (84, 85a-b)35−39  (Figure 81a).21 Ideally, each R1-containing olefin 
and each R2-containing olefin react selectively to give the appropriate R1-R2 dimer; however, 
experimentally, not only is the appropriate dimer isolated but also a mixture of the R1 and R2 
homodimers and a mixture of regioisomers (Figure 81b). These particular problems are the 
primary cause of the limited usage of this synthetic method in both solution- and solid-phase 
synthesis. A generic mechanism for this transformation is shown in Figure 81c. For a more 
detailed discussion, please see the following section. 
 
 161 
NNMes Mes
Ru
Cl
Cl
Ph
PCy3
NNMes Mes
Ru
Cl
Cl
O R
84 85
R = H, 85a
R = NO2, 85b
(a)
R1 + R2
[Ru]
Ar
R1 R2
+ R1 R1
R2 R2
+
R1 + [Ru]
Ar
R1
[Ru] Ar
R1 [Ru] + Ar
R1 [Ru] R2+ R1 R2
R1
[Ru]
R2
+ [Ru]
Undesired homodimers
(b)
(c)
 
Figure 81. Olefin cross-metathesis catalysts and mechanism 
 
In 2003, Grubbs published a general model for selectivity in olefin cross-metathesis.40 In 
this work, several types of olefins were ranked based on their ability to homodimerize. Type I 
olefins are the most reactive leading to rapid homodimerization; however, the homodimers can 
additionally participate in a second metathesis reaction. Type II olefins are more electron 
deficient or sterically bulky, and as a result, undergo slow homodimerization and the 
homodimers are sparingly consumed. Finally, type III olefins are the least reactive due to 
extreme steric bulk or electron-deficiency. Examples of each of these types of olefins are shown 
in Figure 82. 
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Figure 82. Types of olefins based on reactivity in olefin cross-metathesis reactions 
 
Grubbs found that if two olefins of the same type were coupled, the result is a statistical mixture 
of hetero- and homodimers (Figure 83a); however, if two olefins of different types were coupled, 
selective heterodimerization could be obtained (Figure 83b). As a result of Grubbs’ study, many 
selective cross-olefin metathesis reactions have been accomplished and the reaction has seen 
increased use in synthesis. 
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Figure 83. Selective olefin cross-metathesis 
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8.2 RESULTS AND DISCUSSION 
8.2.1 Resin-to-Resin Olefin Cross-Metathesis – First Generation 
Thus, the model cross-coupling reaction chosen for this study was olefin cross-metathesis. In 
addition to its convergency, olefin cross-metathesis is also a mild transformation and well-
tolerant of many functional groups.21,22 Also, olefins themselves are stable for long-term storage 
and compatible with many synthetic transformations such as carbonyl addition reactions, 
epoxidation, etc.  
 In initial experiments, resin-to-resin olefin cross-metathesis was attempted by mixing the 
two resin-bound substrates A and B (see Figure 78) as previously described for the three-phase 
test type reactions. This procedure, however, gave intractable mixtures because desired products 
were contaminated with starting materials and their derivatives as expected. Furthermore, a large 
excess of undesired resin after the coupling prohibits the continuation of synthesis (see Figure 
84). Alternatively, employing the use of two different linkers further complicates multiple step 
synthesis on solid support because a method must be developed to easily cleave one resin in the 
presence of another. After considerable efforts, it was hypothesized that the two solid-supported 
substrates A and B did not need to be in the same vessel and could be spatially separated to ease 
in isolation of the desired cross-coupling product. 
 
 164 
R
1
A
(substrate)
R
1
R2
[Ru]
X R
2
B 
(substrate)
D
[Ru] R
2
Y
[Ru]
X
[Ru] R
2
Y
frit
C
(product)
R
1
A
R2
B
[Ru]
R
X
D
R1
R
2
C
+ +
 
Figure 84. Resin-to-resin olefin cross-metathesis between spatially separated substrates 
 
 The strategy for resin-to-resin olefin cross-metathesis is illustrated in Figure 84. First, the 
polystyrene-bound terminal alkene A (acceptor) and the polystyrene-bound internal alkene B 
(donor) are placed in each side of the reaction vessel separated by a frit. This frit keeps the two 
types of alkene resins separated during reactions, but allows small molecules in solution to 
traverse between the two vessels. Ruthenium catalyst X can react with both alkenes reversibly; 
however, only when the catalyst reacts with the internal alkene B, will the resulting intermediate 
Y form. This ruthenium complex would then react with the terminal alkene A to form the 
coupling product C, catalyst X, and by-product D. Catalyst X will then shuttle between the two 
vessels to transfer the R2-unit from A to B, producing predominantly the desired heterodimer C. 
It is envisioned that this process can be automated by placing a frit in the middle of each well of 
a commercially available 96-well reaction block. Some additional benefits of the above system 
include: (1) by-products on the donor resin and in solution can easily be removed because the 
two coupling partners are not mixed; and (2) donor and acceptor compounds are synthesized 
independently allowing many functional group transformations to be employed with little 
concern about chemoselectivity. 
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Figure 85. Proof of principle experiments for resin-to-resin olefin cross-metathesis 
 10 equiv B used in each reaction. A = 86,87; catalyst 84. A = 88; catalyst 85b. A = 89; catalyst 85a. 
 
To test the above hypothesis, resin-to-resin olefin cross-metathesis was first investigated 
with several model substrates of varying electronics (Figure 85). Although 10 equivalents of 
each internal alkene were used for the initial model study, 3 equivalents were found to be 
sufficient as demonstrated later. The choice of a ruthenium catalyst was based on the electron-
density of each alkene acceptor 86–89; the relatively electron-rich 86 and 87 required mildly 
active catalyst 84.35 The most electron-deficient substrate 88 required the most active catalyst 
85b,38,39 although catalyst 85a was also effective in some cases. For the slightly less electron-
deficient substrate 89, catalyst 85a was used.36,37  
First, the aliphatic alkene 90 was coupled with each of 86–89 in the presence of the 
respective ruthenium catalyst. At temperatures below 60 °C, little cross-coupling products were 
observed, indicating that the kinetic ruthenium alkylidene products on each acceptor resin do not 
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undergo the desired retro [2+2] reaction at these temperatures. After 7 h at 60 °C in 1,2-
dichloroethane, all of these cross-couplings were effective and trans selective, affording the 
expected products 95–98 in 73% to quantitative yield upon cleavage of the products from the 
trityl resin with 2% TFA/5% Et3SiH in CH2Cl2 at 24 °C. Encouraged by this result, each of the 
four cinnamyl alcohol derivatives 91–94 was cross-coupled with each of 86–89. As Figure 85 
shows, all of the reactions proceeded smoothly to afford the corresponding coupling products in 
68% to quantitative yields in a highly trans-selective manner.40 Although the trityl ethers of 90–
94 are not essential, the readily cleavable linker provided a handle for analysis upon cleavage to 
characterize compounds synthesized on the polymer.  
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Figure 86. Epoxide openings and couplings between spatially separated resins 
 
 With these successes, resin-to-resin transfer technology was then applied in complex 
molecule synthesis (Figure 86). Epoxides and 1,2-aminoalcohols were used in this study for 
several reasons: (1) these functional groups are ubiquitous in biologically active compounds, (2) 
enantiomerically pure epoxides are readily available and (3) epoxide-openings with amines yield 
1,2-aminoalcohols with multiple hydrogen-bonding sites. Although the cross-coupling between 
115 and 117 did not proceed in these preliminary experiments, products containing more 
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hydrogen-bonding sites with a possible electrophilic functionality (119−121; Figure 86) were 
more interesting. These highly functionalized compounds with potential electrophiles and 
hydrogen-bonding sites are not readily accessible by a classical linear approach in the solid phase 
since one cannot easily distinguish multiple electrophiles, unprotected amines and hydroxy 
groups. Moreover, compound 121 and its derivatives may mimic positively charged peptides 
such as lethal factor of Bacillus anthracis.41 
8.2.2 Solid-Phase Olefin Cross-Metathesis Promoted by a Linker42 
Despite the success with my initial studies, a lack of reproducibility was observed, which is not 
uncommon in solid-phase organic synthesis. As such the cross coupling of 115 with solution-
phase olefin substrates was examined.  
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Figure 87. Solid-phase olefin cross-metathesis with epoxide 
 
As a complex olefin in solution, quinine was chosen because it presents high functionality, is 
commercially available and has been used as an anti-malarial drug.43 Unexpectedly, treatment of 
115 with quinine (5.0 equiv) and 85b (5 mol %) at 40 °C did not yield the desired alkene 122 as 
determined by crude 1H NMR analysis (Figure 87). It was speculated that the ruthenium 
alkylidene complex of 115 might be catalytically inactive due to chelation with the epoxide 
oxygen atom. Based on this speculation, the above reaction of 115 and quinine was employed in 
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the presence of Ti(OiPr)4 (20 mol %),44 which proceeded but to less than 20%, which was still 
unsatisfactory.  No intrabead homodimerization was observed in either of these experiments. 
In light of these poor results and the lack of systematic studies in the literature, cross-
metathesis reactions using model systems on solid support were studied in order to further the 
use of this method in solid-phase organic synthesis. It was noted that the olefin in 115 was much 
closer to the polymer than those substrates reported in the literature.28 Although change in linker 
length has been shown to be non-essential in other solid-phase reactions,45−47 the proximity of the 
olefin to the solid support could impact cross-metathesis because the steric bulk of the polymer 
may block the catalyst’s access to the olefin and the steric bulk of the catalyst may prevent it 
from entering further into the polymer to react with shorter carbon chains. Conversely, too long 
of a carbon chain would facilitate the formation of undesired homodimers on the same bead as 
previously shown by others.31−34  
To study the distance-dependent solid-phase olefin cross-metathesis, compounds 
123a−123d (Table 2) were prepared. For these model studies, alkene 126 was chosen as a 
symmetrical alkene in solution.48,49 Metathesis reactions were performed between alkenes 123a–
123d and alkene 126 (5.0 equiv) using pre-catalyst 85b (5 mol %) in DCE at 24 °C for 22 h. 
Following cleavage with TFA, alcohols 127a−127d were isolated (entries 1–4). All reaction 
yields were quantified based on an external standard method. Indeed, reaction yields were 
strongly influenced by the carbon chain length; ether 123a (n = 1) afforded alcohol 127a in 12% 
yield (entry 1) while ether 123d (n = 4) gave alcohol 127d in quantitative yield. The low yield of 
123a is not due to the steric hindrance imposed by the trityl group because a control cross-
coupling between allyl trityl ether and 126 (5 equiv) catalyzed by 85b (5 mol %) afforded the 
corresponding metathesis product in 61% yield.46,50 Also, no intra-bead homodimerization was 
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observed for each carbon chain length. I found that catalyst 85b consistently gave higher yields 
than catalyst 84 (entries 1–4), which is reminiscent of a previous report by the Schreiber group.51 
Thus, it was concluded that 85b was superior to 84 in solid-phase olefin cross-metathesis. 
 
Table 2. Proximity effect on solid-supported olefin cross-metathesis 
RO n
+ BzO OBz
126 (5 equiv)
1. 85b (5 mol %), DCE
     24 °C, 22 h
2. cleavage
HO n
OBz
Tr
: polystyrene resin
123: R = 125: R =
123–125 127
(CH2)3
124: R =
Si
 
Entry Substrate n % yield 
1 123a 1 12 (<10a) 
2 123b 2 62 (48a) 
3 123c 3 70b (52a) 
4 123d 4 >95c (60a) 
5 124a 1 37 
6 124b 2 52 
7 124c 3 80b 
8 124d 4 83c 
9 125a 1 37 
10 125b 2 42 
11 125c 3 50b 
12 125d 4 70c 
a Yield using 84 instead of 85b. b Yield, 6:1 E:Z. c Yield, 5:1 E:Z. 
 
To determine the generality of this proximity effect, each alkenyl alcohol was also loaded 
onto alkylsilyl resin52 and Merrifield resin to generate compounds 124a−124d and 125a−125d,  
respectively. Metathesis reactions were performed in a similar manner as described above, and 
products 127a−127d were isolated after cleavage. These experiments revealed a similar 
proximity effect; silyl ethers 124a–124d produced the corresponding alcohols 127a–127d in 
37% (entry 5), 52% (entry 6), 80% (entry 7), and 83% yield (entry 8), respectively. Benzyl ethers 
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125a–125d produced alcohols 127a–127d in 37% (entry 9), 42% (entry 10), 50% (entry 11), and 
70% (entry 12), respectively. Again, intra-bead homodimerization did not occur. These solid-
phase experiments showed that increasing the distance between the reacting olefin and the resin 
improved the efficiency of olefin cross-metathesis. 
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Figure 88. Cross-metathesis with a linker 
 
While these studies provided insight, the addition of unnecessary carbons in the substrate 
and product is not desirable in organic synthesis. Therefore, on the basis of the proximity effect 
and the necessity for a traceless linker, attention was turned to the commercially available trityl 
alcohol 128 (Figure 88). Although 128 contains a chlorotrityl moiety instead of trityl, the 
chlorine atoms should have no effect on the olefin’s reactivity. This alcohol was loaded onto 
aminomethyl polystyrene resin via a standard amide forming method, and the resulting 
compound was converted to trityl chloride 129 by the action of acetyl chloride. This trityl 
chloride was reacted with alkenyl alcohols to form trityl ethers 130a–130c (n = 1–3). To my 
delight, metathesis of 130a with 126 (5.0 equiv) using 85b followed by cleavage (5% TFA in 
CH2Cl2) provided the desired product 127a in 62% yield. Similar yields were observed with 
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130b and 130c with the linker (55 and 57% yield). These data indicate that with an additional 
linker between the trityl moiety and polymer, more consistent yields can be obtained (cf. Table 2, 
entries 1–3). 
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Figure 89. Cross-metathesis with substituted alcohols 
 
More substituted alcohols on solid support were next investigated. With trityl ethers 131, 
134 and 137 without the linker and trityl ethers 132, 135 and 138 with the linker (Figure 89), 
metathesis reactions were carried out using 126 (5 equiv) and 85b (5 mol %). In general, raising 
the temperature from 24 to 40 °C increased isolated yields by approximately two-fold, thus the 
yields at 40 °C are shown here. With the substituted homoallylic ethers 131 and 132, the reaction 
was again more efficient with the linker (25% vs 47% yield). With the substituted allylic ether 
134 without the linker, the reaction essentially did not proceed. In contrast, the allylic ether 135 
with the linker underwent olefin metathesis with 126 to form 136 in 41% yield. This coupling 
could be improved to 53% yield when the reaction mixture was heated to 60 °C. In the case of 
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type III40 olefins, 137 and 138, the reaction was also more efficient with the linker (<5% vs 20% 
yield). Similar to 135 the coupling was further improved to 38% yield when the reaction mixture 
was heated to 60 °C. With these more substituted allylic and homoallylic alcohols, the linker 
effect is prominent. 
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Figure 90. Cross-metathesis with solid-supported epoxide 
 
Having established the olefin cross-metathesis technology on solid support, the initial 
problem depicted in Figure 87 was revisited. The epoxyalcohol was loaded onto linker resin 129 
to generate trityl ether 140. Metathesis of 140 with quinine (5 equiv) was performed using 85b 
and Ti(OiPr)4 at 40 °C for 24 h. 1H NMR analysis of the crude material cleaved from the resin 
revealed that the quinine derivative 122 was formed in 60% yield (Figure 90). In the absence of 
Ti(OiPr)4, the reaction again did not proceed validating our initial claim of catalyst inactivation 
by the epoxide. These results clearly demonstrate the merit of linker 128 in performing 
metathesis reactions on solid support. Moreover, the quinine example illustrates that the solid-
phase olefin cross-metathesis could be applied to the synthesis of morphed drugs/natural 
products with new properties. 
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8.2.3 Resin-to-Resin Olefin Cross-Metathesis – Second Generation 
The linker technology was next applied to the challenging resin-to-resin olefin cross-metathesis 
problem. As a model study, the synthesis of the simple and more substituted alkenes synthesized 
in the linker model studies were examined since authentic samples were in hand. The results for 
these experiments are shown in Figure 91.  
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Figure 91. Resin-to-resin olefin cross-metathesis using a linker 
 
Metathesis reactions were performed between acceptor alkenes 130b, 132, 135 and 138 
and donor alkene 141 (5.0 equiv) using pre-catalyst 86b (10 mol %) in DCE at 80 °C for 24 h. 
Following cleavage with TFA, alcohols 127b, 133, 136 and 139 were isolated. In general, these 
reactions were ~25% less efficient than the respective couplings of the solid-phase acceptors 
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with 126 in solution. This was expected since the reaction is dependent upon the retro [2+2] 
reaction of the donor olefin.  
Despite the success of our model studies described above, all attempts at resin-to-resin 
olefin cross-metathesis with more functionalized substrates failed (not shown). Although 
increased equivalency of the donor could have been attempted, it is not practical to require such 
a large excess of the donor fragment, especially with highly functionalized donor substrates. As a 
result, it seems that the proximity effect is not the sole culprit in our preliminary failures. 
Reproducibility problems are well noted in the literature in solid-phase organic 
synthesis.53,50 In fact, most of these problems are linked to inhomogeneities in the cross-linked 
polystyrene resin, which are likely due to differences in cross-linking reactivities (meta- and 
para-divinylbenzenes differ in their reactivity with styrene).53 Moreover, these differences in 
reactivity lead to differences in cross-linking topography throughout the resin (variable dense 
and lightly cross-linked areas). As the swollen polymer matrix is the solvent in the case of solid 
phase reactions and >99% of the sites of attachment are inside the resin, these parameters are 
critical for reaction reproducibility.50,53 As such, resin purification techniques have been 
developed to improve reproducibility; however, the generality of these methods are not known.54 
More specific to this case, I learned through personal communication (Professor Philip Dawson, 
The Scripps Research Institute) that aminomethylpolystyrene resin is particularly prone to many 
differences between batches and vendors because the synthetic process is often different between 
companies. As such, these potential differences in resin matrix may limit the reproducibility of 
this reaction. 
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Figure 92. Potential pitfalls in resin-to-resin olefin cross-metathesis 
 
In addition to the distance-dependence issue and potential differences between resin 
batches, there are a number of more fundamental challenges in performing resin-to-resin olefin 
cross-metathesis. Firstly, the likelihood for the ruthenium intermediate (Y in Figure 84) to escape 
the polymer matrix, traverse the barrier and react with an acceptor olefin is unclear, especially 
under thermal conditions and in the presence of many potential olefin substrates within the donor 
matrix.  
Secondly, in terms of reactivity, there are two potential problems. The first potential 
pitfall is if the ruthenium catalyst preferentially reacts with the terminal olefin, which could 
result in two outcomes: transfer of the ligand from the catalyst to form an on-bead dimer or 
transfer of the ruthenium to form a solid-supported alkylidene, each of which kills the catalyst 
(Figure 92a). The second potential pitfall is if the ruthenium catalyst reacts with the donor resin 
but with the opposite regiochemistry, which results in a solid-supported ruthenium intermediate 
again killing the catalyst (Figure 92b). A similar catalyst killing effect was also observed in the 
case of a resin-to-resin Sonogashira coupling.19 In this case, Pd0 initially cleaves the allylic 
substrates from the resins prior to coupling in solution; however, the most successful examples 
required equimolar or higher loadings of palladium presumably indicating loss of the catalyst 
either on the resin or due to oxidation. As such, although I may have solved olefin cross-
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metathesis between a solid-supported substrate and a substrate in solution, resin-to-resin olefin 
cross-metathesis remains an unsolved yet challenging problem. 
8.3 CONCLUSION 
The challenging resin-to-resin olefin cross-metathesis has been investigated as a convergent 
approach to library synthesis on solid support. Although unsuccessful, these initial failings led to 
the development of a general protocol for solid-phase olefin cross-metathesis using a traceless 
long linker. This model study should enhance the utility of olefin cross-metathesis in solid-phase 
organic synthesis. 
8.4 EXPERIMENTAL 
8.4.1 General Information 
All reactions were carried out under laboratory atmosphere, unless otherwise noted. 
Tetrahydrofuran (THF) was distilled from sodium-benzophenone, and methylene chloride 
(CH2Cl2) was distilled from calcium hydride. Yields refer to chromatographically and 
spectroscopically (1H NMR) homogenous materials, unless otherwise stated.   
All reactions were monitored by thin layer chromatography (TLC) carried out on 0.25- 
mm E. Merck silica gel plates (60F-254) using UV light (254 nm) with 2.4% phosphomolybdic 
acid/5% sulfuric acid/1.4% phosphoric acid in water, anisaldehyde in ethanol, or 0.2% ninhydrin 
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in ethanol and heat as developing agents. TSI silica gel (230−400 mesh) was used for flash 
column chromatography. 
NMR spectra were recorded on AM300 (Bruker) instruments and calibrated using a 
solvent peak or tetramethylsilane (TMS) as an internal reference. The following abbreviations 
are used to indicate the multiplicities: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, 
broad. Mass spectra were obtained from a Micromass Autospec double focusing instrument. 
HPLC/MS data was recorded using an Agilent HP 1100 series LC-MSD instrument with 
purities determined by a UV-Vis detector. HPLC analyses were performed with a reverse-phase 
Eclipse XDB-C18 (4.6 X 750 mm, 3.5 µm) column using 5→30% MeCN in H2O/0.1% HCO2H 
as a solvent system. The flow rate was 0.4 mL/min. UV detection was performed at 254 and 280 
nm. 
Bio-Rad Poly-Prep® chromatography columns and Bio-Rad Bio-Spin® chromatography 
columns are a product of Bio-Rad Laboratories.  
The following apparati were used for solid-phase reactions: reaction spinner (Tube 
Rotator, Scientific Equipment Products, this instrument has only one speed), incubator (Lab-
Line® Incubator-Shaker) and reaction shaker (VWR Analog Vortex Mixer). 
8.4.2 Resin-to-Resin Olefin Cross-Metathesis – First Generation 
Preparation of 86. A 10-mL Bio-Rad Poly-Prep® chromatography column was charged with 
500 mg of trityl chloride resin (Advanced ChemTech, 100−200 µm, 1.5 mmol/g) and 5.0 mL of 
CH2Cl2 at 24 °C. The mixture was gently agitated on a reaction spinner for 10 min to swell the 
resin.  The solvent was removed by vacuum filtration and a fresh 5.0 mL portion of CH2Cl2 was 
added at 24 °C followed by allyl alcohol (510 µL, 7.5 mmol), Et3N (1.78 mL, 13.5 mmol) and 
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DMAP (45.8 mg, 0.375 mmol). After gentle agitation at 24 °C for 12 h on a reaction spinner, the 
solution was filtered via vacuum filtration and the yellow resin was washed with CH2Cl2 (3×5 
mL), THF (3×5 mL), DMF (3×5 mL), and CH2Cl2 (3×5 mL). Loading was assumed to be 
quantitative (1.4 mmol/g) due to the volatility of allyl alcohol.    
 
Preparation of 87. Homoallyl-alcohol acceptor 87 was loaded in a similar fashion as was used 
in the preparation of 86.  Loading was assumed to be quantitative due to volatility (quant, 1.4 
mmol/g, yellow resin). 
   
Preparation of 88. Acrylic acid (329 µL) was loaded onto Wang resin (Nova Biochem, 
100−200 µm, 0.96 mmol/g) according to literature precedent55 to prepare 500 mg of 88 as white 
beads. Theoretically, the quantitative loading level of 88 is 0.90 mmol/g. Resin 88 (20.0 mg, 
0.018 mmol) was swelled in a 1.0-mL Bio-Rad Bio-Spin® chromatography column with CH2Cl2, 
filtered via vacuum filtration, and treated with 0.5 mL of a 1:10:9 Et3SiH/TFA/CH2Cl2 solution 
for 30 min at 24 °C. The beads were filtered via gravity filtration with CH2Cl2 and the resulting 
liquid was concentrated in vacuo yielding 15.3 mg (0.212 mmol, 85%, 0.82 mmol/g) of acrylic 
acid as a colorless oil. 1H NMR spectrum was consistent with that of the starting material. 
 
Preparation of 89. A 20-mL Bio-Rad chromatography column was charged with 4-
methylbenzhydrylamine resin hydrochloride salt (300 mg, 0.18 mmol, Nova Biochem, 0.62 
mmol/g, 100−200 µm), and the salt was washed with 5% diisopropylethylamine in CH2Cl2 
(2×5.0 mL for 2 min at 24 °C followed by washing with CH2Cl2) to yield the free amine. Rink 
amide linker (Nova Biochem) was then coupled to this amine resin according to the literature56 
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followed by Fmoc deprotection with 1:1 piperidine/DMF and additional coupling with acrylic 
acid to afford 89. All reactions were monitored by the Kaiser ninhydrin test.57 Loading was 
assumed to be quantitative (0.60 mmol/g) based on the negative result in the Kaiser test. 1H 
NMR spectrum was consistent with that of the starting material.  
  
Preparation of 90. cis-But-2-en-1,4-diol was loaded onto trityl chloride resin (500 mg) in a 
similar manner as that used to prepare acceptor 86. The resin was then carried on to acetylation 
using acetic anhydride (3.5 mL, 37.5 mmol) in pyridine (5.0 mL) at 24 °C for 2 h to prepare 90 
as pale yellow beads. The resin was washed with CH2Cl2 (3×5 mL), THF (3×5 mL), DMF (3×5 
mL) and CH2Cl2 (3×5 mL) and dried under vacuum overnight. A small portion of 90 was 
cleaved for analysis. A portion of 90 in a 1.0-mL Bio-Rad Bio-Spin® chromatography column 
was swelled with CH2Cl2, filtered via vacuum filtration, and treated with 0.5 mL of a 1:2.5:46 
TFA/Et3SiH/CH2Cl2 solution for 3 min at 24 °C. The beads were filtered via gravity filtration 
with CH2Cl2 and the resulting solution was concentrated in vacuo yielding a colorless oil (quant, 
1.3 mmol/g). 1H NMR spectrum consistent with that of the known compound: 1H NMR (300 
MHz, CDCl3, 20 ºC): δ 5.91−5.64 (m, 2H); 4.69 (d, J = 6.8 Hz, 2H); 4.29 (d, J = 6.8 Hz, 2H); 
2.08 (s, 3H).58 
 
Preparation of 91. Donor 91 (cinnamyl alcohol) was loaded onto trityl chloride resin in a 
similar fashion as that used to prepare 86 (quant, 1.3 mmol/g). 1H NMR spectrum was consistent 
with that of cinnamyl alcohol: 1H NMR (300 MHz, CDCl3, 20 ºC): δ 7.4 (m, 5H); 6.6 (d, J = 
16.0 Hz, 1H); 6.40 (dt, J = 16.0, 5.5 Hz, 1H); 4.30 (d, J = 5.5 Hz, 2H). 
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Preparation of 92. (E)-3-(4-Methoxyphenyl)prop-2-en-1-ol was loaded onto trityl chloride resin 
(Advanced ChemTech, 100−200 µm, 1.5 mmol/g) in an analogous fashion as that used to 
prepare 86 to produce 92 as yellow beads. A portion of 92 was cleaved by treatment with a 
1:2.5:46 TFA/Et3SiH/CH2Cl2 solution to yield a white solid (quant., 1.2 mmol/g). 1H NMR 
spectrum was consistent with that of the known compound: 1H NMR (300 MHz, CDCl3, 20 ºC): 
δ 7.32 (d, J = 8.7 Hz, 2H); 6.85 (d, J = 8.7 Hz, 2H); 6.55 (d, J = 15.9 Hz, 1H); 6.23 (dt, J = 15.9, 
6.0 Hz, 1H); 4.78 (br s, 1H); 4.28 (dd, J = 6.0, 1.1 Hz, 2H); 3.80 (s, 3H).59 
 
Preparation of 93. (E)-3-(4-Dimethylaminophenyl)prop-2-en-1-ol was loaded onto trityl 
chloride resin (Advanced ChemTech, 100−200 µm, 1.5 mmol/g) in an analogous fashion as that 
used to prepare 86 to produce 93 as yellow beads (79%, 0.95 mmol/g). 1H NMR spectrum was 
consistent with that of the known compound: 1H NMR (300 MHz, CDCl3, 20 ºC): δ 7.37 (d, J = 
8.7 Hz, 2H); 6.77 (d, J = 8.7 Hz, 2H); 6.61 (d, J = 15.8 Hz, 1H); 6.26 (dt, J = 15.8, 5.9 Hz, 1H); 
4.35 (d, J = 5.9 Hz, 2H); 3.05 (s, 6H).60 
 
Preparation of 94. (E)-3-(3-Hydroxypropenyl)phenol was loaded onto trityl chloride resin 
(Advanced ChemTech, 100−200 µm, 1.5 mmol/g) in an analogous fashion as that used to 
prepare 86 to produce 94 as yellow beads (90%, 1.3 mmol/g). 1H NMR spectrum was consistent 
with that of the known compound: 1H NMR (300 MHz, CD3OD, 20 ºC): δ 7.19 (dd, J = 7.5, 7.5 
Hz, 1H), 6.95 (d, J = 7.5 Hz, 1H), 6.87 (d, J = 7.5 Hz, 1H), 6.73 (s, 1H), 6.46 (d, J = 15.9 Hz, 
1H), 6.23 (dt, J = 15.9, 5.6 Hz, 1H), 4.25 (d, J = 5.6 Hz, 2H).61 
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Reaction Vessel for Resin-to-Resin Metathesis Reactions. Two Bio-Rad Micro Biospin® 
chromatography columns were cut at the frit. Removal of one frit followed by coupling of the 
two columns with a Teflon connector (prepared by cutting a piece of Teflon tubing to XX in) 
provided the reaction vessel for resin-to-resin metathesis reactions (see photo below). Each 
column was capped with the cap sold together with the chromatography column. 
 
 
 
Metathesis of Acceptors (86−89) and Donors (90−94). To one half of the reaction vessel was 
added Donor resin (10.0 equiv), ruthenium catalyst (5−10 mol %) and 1.0 mL DCE at 24 °C. 
The vessel was capped, and to the other side was added Acceptor resin (1.0 equiv) and another 
1.0 mL portion of DCE. In a typical experiment, 75 mg of the Acceptor resin is coupled with 
the appropriate amount of the Donor resin based on the 1:10 molar ratio using the appropriate 
amount of the ruthenium catalyst. The vessel was then placed into a shaking incubator and 
allowed to vigorously shake at 60 °C for 7 h. Following reaction, the resin from the acceptor side 
of the vessel was transferred to a new column using a disposable plastic pipet and the resin was 
washed with CH2Cl2 (3×2 mL), THF (3×2 mL), DMF (3×2 mL) and CH2Cl2 (3×2 mL) and dried 
under vacuum overnight. The acceptor beads were then swelled with CH2Cl2 and treated with the 
respective cleavage solution. The beads were filtered via gravity filtration with CH2Cl2 and the 
resulting liquid was concentrated in vacuo. 
 
Metathesis of Acceptor 86 and Donors (90−94): Ruthenium catalyst 84 (5 mol %); Cleavage 
with 1:2.5:46 TFA/Et3SiH/CH2Cl2 solution for 3 min at 24 °C. 
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Data for 95: Colorless oil (96%); 1H NMR spectrum was consistent with that of 90. 
Data for 99: Colorless oil (94%); 1H NMR spectrum was consistent with that of 91. 
Data for 103: Yellow oil (quant.); 1H NMR spectrum was consistent with that of 92. 
Data for 107: Green oil (quant.); 1H NMR spectrum was consistent with that of 93. 
Data for 111: White solid (74%); 1H NMR spectrum was consistent with that of 94. 
 
Metathesis of Acceptor 87 and Donors (90−94): Ruthenium catalyst 84 (5 mol %); Cleavage 
with 1:2.5:46 TFA/Et3SiH/CH2Cl2 solution for 3 min at 24 °C. 
Data for 96: Colorless oil (quant.); 1H NMR spectrum was consistent with that of the 
known compound: 1H NMR (300 MHz, CDCl3, 20 ºC): δ 5.79 (dt, J = 15.4, 6.6 Hz, 1H); 5.65 
(dt, J = 15.4, 5.9 Hz, 1H); 4.52 (d, J = 5.9 Hz, 2H); 3.66 (t, J = 6.6 Hz, 2H); 3.28 (br s, 1H); 2.32 
(q, J = 6.5 Hz, 2H); 2.06 (s, 3H).62 
Data for 100: (quant.); 1H NMR spectrum was consistent with that of the known 
compound: 1H NMR (300 MHz, CDCl3, 20 ºC): δ 7.40−7.12 (m, 5H); 6.48 (d, J = 15.9 Hz, 1H); 
6.19 (dt, J = 15.9, 7.2 Hz, 1H); 3.72 (t, J = 6.3 Hz, 2H); 2.46 (dt, J = 7.2, 6.3 Hz, 2H); 2.01 (br s, 
1H).63 
Data for 104: Yellow oil (90%); 1H NMR spectrum was consistent with that of the known 
compound: 1H NMR (300 MHz, CDCl3, 20 ºC): δ 7.19 (d, J = 8.5 Hz, 2H); 6.72 (d, J = 8.5 Hz, 
2H); 6.38 (d, J = 16.0 Hz, 1H); 6.18 (dt, J = 16.0, 6.5 Hz, 1H); 3.82 (s, 3H); 3.53 (t, J = 6.5 Hz, 
2H); 2.45 (q, J = 6.5 Hz, 2H).64 
Data for 108: Yellow oil (93%); 1H NMR spectrum was consistent with that of the known 
compound: 1H NMR (300 MHz, CDCl3, 20 ºC): δ 7.12 (d, J = 8.6 Hz, 2H); 6.54 (d, J = 8.6 Hz, 
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2H); 6.41 (d, J = 15.9 Hz, 1H); 6.06 (dt, J = 15.9, 6.5 Hz, 1H); 3.57 (t, J = 6.5 Hz, 2H); 2.85 (s, 
6H); 2.15 (q, J = 6.5 Hz, 2H).64 
Data for 112: Colorless oil (72%); 1H NMR spectrum was consistent with that of the 
known compound: 1H NMR (300 MHz, CD3OD, 20 ºC): δ 7.04 (t, J = 7.5 Hz, 1H); 6.86 (d, J = 
7.5 Hz, 1H); 6.77 (s, 1H); 6.61 (d, J = 7.5 Hz, 1H); 6.46 (d, J = 15.9 Hz, 1H); 6.15 (dt, J = 15.9, 
6.4 Hz, 1H); 3.55 (t, J = 6.4 Hz, 2H); 2.27 (q, J = 6.4 Hz, 2H).64 
 
Metathesis of Acceptor 88 and Donors (90−94): Ruthenium catalyst 85b (10 mol %) prepared 
from Grubbs II catalyst; Cleavage with 1:10:9 Et3SiH/TFA/CH2Cl2 solution for 30 min at 24 °C. 
Data for 97: Colorless oil (90%); 1H NMR spectrum was consistent with that of the 
known compound: 1H NMR (300 MHz, CD3OD, 20 ºC): δ 7.30 (dt, J = 15.8, 6.3 Hz, 1H); 6.21 
(d, J = 15.8 Hz, 1H); 4.75 (d, J = 6.3 Hz, 2H); 2.01 (s, 3H).65 
Data for 101: Colorless oil (quant.); 1H NMR spectrum was consistent with that of 
cinnamic acid: 1H NMR (300 MHz, CD3OD, 20 ºC): δ 12.1 (s, 1H); 7.73−7.25 (m, 6H); 6.41 (d, 
J = 16.0 Hz, 1H).64 
Data for 105: Colorless oil (75%); 1H NMR spectrum was consistent with that of the 
known compound: 1H NMR (300 MHz, CDCl3, 20 ºC): δ 10.2 (br s, 1H); 7.67 (d, J = 8.6 Hz, 
2H); 7.57 (d, J = 16.0 Hz, 1H); 6.99 (d, J = 8.6 Hz, 2H); 6.41 (d, J = 16.0 Hz, 1H); 3.84 (s, 
3H).66 
Data for 109: Yellow oil (78%); 1H NMR spectrum was consistent with that of the known 
compound: 1H NMR (300 MHz, CD3OD, 20 ºC): δ 7.72 (d, J = 8.7 Hz, 2H); 7.65 (d, J = 16.0 
Hz, 1H); 6.91 (d, J = 8.7 Hz, 2H); 6.50 (d, J = 16.0 Hz, 1H); 3.08 (s, 6H).66 
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Data for 113: Colorless oil (quant.); 1H NMR spectrum was consistent with that of the 
known compound: 1H NMR (300 MHz, CD3OD, 20 ºC): δ 7.56 (d, J = 16.0 Hz, 1H); 7.21 (dd, J 
= 7.9, 7.9 Hz, 1H); 7.04 (d, J = 7.9 Hz, 1H); 6.99 (dd, J = 2.3, 1.2 Hz, 1H); 6.82 (ddd, J = 7.9, 
2.3, 1.2 Hz, 1H); 6.40 (d, J = 16.0 Hz, 1H).67 
 
Metathesis of Acceptor 89 and Donors (90−94): Ruthenium catalyst 85a (10 mol %); Cleavage 
with 1:2.5:46 TFA/Et3SiH/CH2Cl2 solution for 3 min at 24 °C. 
Data for 98: Colorless oil (73%); 1H NMR spectrum was consistent with that of the 
known compound: 1H NMR (300 MHz, CDCl3, 20 ºC): δ 7.30 (dt, J = 15.8, 6.3 Hz, 1H); 6.21 (d, 
J = 15.8 Hz, 1H); 4.75 (d, J = 6.3 Hz, 2H); 2.01 (s, 3H).68 
Data for 102: Colorless oil (72%); 1H NMR spectrum was consistent with that of the 
known compound: 1H NMR (300 MHz, CDCl3, 20 ºC): δ 7.73−7.25 (m, 6H); 6.41 (d, J = 16.0 
Hz, 1H).68  
Data for 106: Colorless oil (81%); 1H NMR spectrum was consistent with that of the 
known compound: 1H NMR (300 MHz, CDCl3, 20 ºC): δ 7.50 (d, J = 8.7 Hz, 2H); 7.36 (d, J = 
15.9 Hz, 1H); 6.97 (d, J = 8.7 Hz, 2H); 6.46 (d, J = 15.9 Hz, 1H); 3.79 (s, 3H).69 
Data for 110: Colorless oil (84%); 1H NMR spectrum was consistent with that of the 
known compound: 1H NMR (300 MHz, CDCl3, 20 ºC): δ 7.72 (d, J = 8.7 Hz, 2H); 7.55 (d, J = 
16.0 Hz, 1H); 6.91 (d, J = 8.7 Hz, 2H); 6.50 (d, J = 16.0 Hz, 1H); 3.08 (s, 6H).69   
Data for 114: Colorless oil (68%); 1H NMR spectrum was consistent with that of the 
known compound: 1H NMR (300 MHz, CDCl3, 20 ºC): δ 7.56 (d, J = 16.0 Hz, 1H); 7.21 (dd, J = 
7.9, 7.9 Hz, 1H); 7.04 (d, J = 7.9 Hz, 1H); 6.99 (dd, J = 2.3, 1.2 Hz, 1H); 6.82 (ddd, J = 7.9, 2.3, 
1.2 Hz, 1H); 6.40 (d, J = 16.0 Hz, 1H).69  
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Preparation of 115 and 140. Diene 142 was prepared according to the literature.70 A stirred 
suspension of activated 4Å molecular sieves (19.24 g) in CH2Cl2 (200 mL) was treated with (+)-
diisopropyl tartrate (1.2 mL, 5.71 mmol) at 24 °C under an argon atmosphere. The reaction 
mixture was cooled to -20 oC, then titanium isopropoxide (1.4 mL, 4.7 mmol) was added, 
followed by tert-butyl hydroperoxide (5−6 M in isooctane, 22.2 mL, 111.3−133.2 mmol). The 
mixture was stirred for 1 h at -20 oC to allow the catalyst to form, then 142 (5.9 g, 60.1 mmol) in 
CH2Cl2 (40 mL) was added over 15 min. The reaction was stirred for 12 h at -20 oC, then was 
quenched with 3 N NaOH (20 mL) and vigorously stirred for 1 h at 24 °C. Celite, solid NaCl and 
anhydrous Na2SO4 was then added to the resulting reaction mixture. The mixture was filtered 
through a pad of Celite, eluting with 60% EtOAc in hexanes (500 mL), and concentrated under 
reduced pressure. The residue was purified by flash chromatography (20→40% EtOAc in 
hexanes) on silica gel to afford 143 (5.1 g, 73%) as a colorless oil.  
Data for 143: colorless oil; Rf = 0.30 (30% EtOAc in hexanes); IR (neat): νmax  3421 (br, 
O-H), 2926, 1550, 1445, 1048 cm-1; [α]D22 -36.5 (c 1.0, CHCl3); 1H NMR (300 MHz, CDCl3, 
293 K): δ 5.87 (dddd, J = 16.9, 10.1, 7.4, 7.4 Hz, 1H; C4-H), 5.19−5.11 (m, 2H; C5-H), 3.79 (dd, 
J = 12.3, 4.5 Hz, 1H; C1-H), 3.65 (dd, J = 12.3, 8.4 Hz, 1H; C1-H’), 2.90 (d, J = 4.7 Hz, 1H; C6-
H), 2.71 (d, J = 4.7 Hz, 1H; C6-H’), 2.52 (dd, J = 14.6, 7.4 Hz, 1H; C3-H), 2.31 (dd, J = 14.6, 7.4 
Hz, 1H; C3-H’), 1.73 (dd, J = 8.4, 4.5 Hz, 1H; OH); 13C NMR (75 MHz, CDCl3, 20 °C): δ 133.1, 
117.3, 63.3, 60.4, 49.1, 35.9; MS (EI) m/z calcd. for C5H7O M-43 83.0497, found 83.0505. 
Epoxyalcohol 143 was subsequently loaded onto trityl chloride resin (Advanced 
ChemTech, 100−200 µm, 1.0 mmol/g) or resin 129 to generate resins 115 or 140, respectively. A 
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10-mL Bio-Rad Poly-Prep® chromatography column was charged with 500 mg of trityl chloride 
resin (Advanced ChemTech, 100−200 µm, 1.0 mmol/g) or resin 129 and 8.0 mL of CH2Cl2 at 24 
°C. The mixture was gently agitated for 10 min on a reaction spinner to swell the resin. The 
solvent was removed via vacuum filtration and a fresh portion of CH2Cl2 (5.0 mL; 1.00 mL/100 
mg resin) was added at 24 °C followed by 143 (1.25 mmol, 2.5 equiv) and pyridine (2.5 mmol, 5 
equiv). After gentle agitation at 24 °C for 24 h on a reaction spinner, the solution was filtered via 
vacuum filtration and the resin was washed with CH2Cl2 (3×5 mL), DMF (3×5 mL), and CH2Cl2 
(3×5 mL). The resin was dried under high vacuum for at least 8 h. Loading was quantitative 
(0.93 mmol/g).   
 
Preparation of 116. A 10-mL Bio-Rad Poly-Prep® chromatography column was 
charged with 115 (150 mg, 0.19 mmol) and 5.0 mL toluene at 24 °C, and the 
resulting mixture was gently agitated for 10 min at 24 °C on a reaction spinner. 
The resin was then filtered via vacuum filtration, and a new 3.0 mL portion of toluene and (S)-2-
amino-3-methylbutan-1-ol (433 mg, 4.2 mmol) was added. The resulting mixture was heated in a 
sand bath at 80 ºC for 12 h. The resulting resin was washed with CH2Cl2 (3×5 mL), THF (3×5 
mL), DMF (3×5 mL), and CH2Cl2 (3×5 mL) and dried under vacuum overnight to form 116. A 
small portion of 116 was cleaved for analysis. Theoretically, the quantitative loading level of 116 
is 1.0 mmol/g. Resin 116 (5.3 mg, 5.3 µmol) was swelled in a 1.0-mL Bio-Rad Bio-Spin® 
chromatography column with CH2Cl2, filtered via vacuum filtration, and treated with 0.5 mL of a 
1:2.5:46 TFA/Et3SiH/CH2Cl2 solution for 3 min at 24 °C. The beads were filtered via gravity 
filtration with CH2Cl2 and the resulting liquid concentrated in vacuo yielding a single product 
116’ (1.1 mg, quant, 1.0 mmol/g) as a colorless oil. 
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 Data for 116’: Rf = 0.10 (60% EtOAc in hexanes); IR (neat): νmax 3630 (br, O-H), 3321 
(N-H), 2926, 1645 (C=C), 1220 cm-1; 1H NMR (300 MHz, CD3OD, 20 °C): δ 5.82 (dddd, J = 
15.6, 11.1, 7.5, 5.8 Hz, 1H; C4-H), 5.13−5.07 (m, 2H; C5-2H), 3.86−3.50 (m, 5H; C1-2H, C7-2H, 
C8-H), 3.25−3.11 (m, 2H; C6-H), 2.98−2.86 (m, 1H; C9-H), 2.06 (dd, J = 14.2, 7.5 Hz, 1H; C3-
H), 1.93 (dd, J = 14.2, 5.8 Hz, 1H; C3-H’), 1.23 (br s, 6H); 13C NMR (75 MHz, CDCl3, 20 °C): δ 
130.6, 117.6, 67.3, 64.4, 58.2, 55.6, 51.0, 39.5, 27.4, 16.9, 16.6; MS (ESI) m/z calcd. for 
C11H24NO3 [M+H]+ 218.1756, found 218.1745. 
 
Preparation of 144. A 250-mL round-bottom flask was charged with 10% 
palladium on carbon (20.0 mg, 1.69 mmol) and EtOAc (71 mL) at 24 °C. 
Subsequently, 143 (1.00 g, 8.76 mmol) in EtOAc (17 mL) was added and the solvent was 
degassed and put under a hydrogen atmosphere (1 atm) at 24 °C. The mixture was allowed to stir 
at the same temperature for 12 h then filtered through filter paper and the filter was washed with 
CH2Cl2.  The crude residue was purified by flash chromatography (20→40% EtOAc in hexanes) 
on silica gel to afford 144 (940 mg, 92%) as a colorless liquid.   
 Data for 144: Rf = 0.25 (30% EtOAc in hexanes); IR (neat): νmax  3421 (br, O-H), 2926, 
1048, 890 cm-1; [α]D22 -36.8 (c 1.0, CHCl3); 1H NMR (300 MHz, CDCl3, 20 °C): δ 3.79 (d, J = 
12.3 Hz, 1H; C1-H), 3.65 (d, J = 12.3 Hz, 1H; C1-H’), 2.90 (d, J = 4.7 Hz, 1H; C6-H), 2.68 (d, J 
= 4.7 Hz, 1H; C6-H’), 1.52−1.33 (m, 2H; C3-H), 1.33−1.20 (m, 2H; C4-H), 0.95 (t, J = 7.1 Hz, 
3H; C5-H); 13C NMR (75 MHz, CDCl3, 20 °C): δ 63.3, 60.4, 49.8, 33.7, 17.9, 13.5; MS (EI) m/z 
calcd. for C5H9O M-31 85.0653, found 85.0651. 
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Preparation of 117. A 10-mL Bio-Rad Poly-Prep® chromatography 
column was charged with 200 mg of 94 (0.266 mmol) and 3.0 mL of 
THF at 24 °C, and the resulting mixture was gently agitated for 10 min at 24 °C on a reaction 
spinner. The resin was then filtered via vacuum filtration, and triphenylphosphine (472 mg, 1.8 
mmol) in 1.8 mL of THF, 144, and diisopropyl azodicarboxylate (175 µL) in 430 µL of THF 
were added. The resulting solution was gently agitated for 1.5 h at 24 °C on a reaction spinner. 
The resulting resin was washed with CH2Cl2 (3×5 ml), THF (3×5 mL), DMF (3×5 mL), and 
CH2Cl2 (3×5 mL) and dried under vacuum overnight. A small portion of 117 was cleaved for 
analysis. Theoretically, the quantitative loading level of 117 is 1.0 mmol/g. Resin 117 (5.5 mg, 
5.7 µmol) was swelled in a 1.0-mL Bio-Rad Bio-Spin® chromatography column with CH2Cl2, 
filtered via vacuum filtration and treated with 0.5 mL of a 1:2.5:46 TFA/Et3SiH/CH2Cl2 for 3 
min at 24 °C. The beads were filtered via gravity filtration with CH2Cl2 and the resulting liquid 
was concentrated in vacuo yielding a single product 117’ (1.4 mg, quant, 1.05 mmol/g) as a 
colorless oil.  
 Data for 117’: Rf = 0.17 (30% EtOAc in hexanes); IR (neat): νmax 3108 (br, O-H), 3050, 
1670 (C=C), 1251, 1224 cm-1; 1H NMR (300 MHz, CD3OD, 20 °C): δ 6.91 (dd, J = 7.8, 7.8 Hz, 
1H; C6-H), 6.67 (d, J = 7.8 Hz, 1H; C5-H or C7-H), 6.65 (d, J = 7.8 Hz, 1H; C5-H or C7-H), 6.54 
(s, 1H; C9-H), 6.33 (d, J = 15.9 Hz, 1H; C3-H), 6.11 (ddd, J = 15.9, 5.6, 5.6 Hz, 1H; C2-H), 4.16 
(apparent dd, J = 5.6, 1.5 Hz, 2H; C1-H), 4.07−3.98 (br m, 2H; C10-H), 3.32 (d, J = 4.3 Hz, 1H; 
C15-H), 3.24 (d, J = 4.3 Hz, 1H; C15-H’), 1.13−1.05 (m, 2H; C12-H), 0.96−0.91 (m, 2H; C13-H), 
0.57−0.51 (m, 3H; C14-H); 13C NMR (75 MHz, CDCl3, 20 °C): δ 157.5, 130.6, 129.4, 128.7, 
123.7, 117.9, 114.0, 112.8, 89.3, 80.2, 62.5, 53.2, 30.1, 22.3, 21.1;  MS (ESI) m/z calcd. for 
C15H20O3 [M+H]+ 249.1491, found 249.1518. 
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Preparation of 118. 118’ was prepared in a similar manner as that 
used to prepare 116 using benzylamine. (quant., 0.76 mmol/g)   
  
Data for 118’: Rf = 0.34 (100% EtOAc); IR (neat): νmax 3540 (OH), 3230 (NH), 3110, 3072, 
1673 (C=C), 1227 cm-1; 1H NMR (300 MHz, CD3OD, 20 °C): δ 7.28 (m, 5H), 6.93 (dd, J = 7.8 
Hz, 7.8 Hz, 1H; C6-H), 6.70 (d, J = 7.8 Hz, 1H; C5-H or C7-H), 6.67 (d, J = 7.8 Hz, 1H; C5-H or 
C7-H), 6.51 (s, 1H; C9-H), 6.36 (d, J = 15.9 Hz, 1H; C3-H), 6.14 (ddd, J = 15.9, 5.8, 5.8 Hz, 1H; 
C2-H), 4.18 (apparent dd, J = 5.8, 1.7 Hz, 2H; C1-H), 4.07−3.96 (br m, 2H; C10-H), 3.63−3.35 
(m, 4H; C15-H, C16-H), 1.21−1.07 (m, 7H); 13C NMR (75 MHz, CDCl3, 20 °C): δ 157.2, 138.1, 
133.2, 130.3, 129.1, 128.8, 128.5, 125.5, 123.4, 117.7, 115.1, 114.3, 114.1, 112.5, 70.1, 69.1, 
62.2, 48.4, 46.7, 42.9, 20.8, 20.4; MS (ESI) m/z calcd. for C22H30NO3 [M+H]+ 356.2226, found 
356.2242. 
 
Metathesis of Acceptors (115, 116) and Donors (117, 118). For each donor and acceptor 
containing an amine (116 and 118), these resins were initially treated with p-TsOH (1.1 equiv) in 
THF (0.01 M) at 24 °C for 3 min to afford the solid supported amine salts. The amine salts were 
subsequently used in metathesis reactions.  
To one half of the reaction vessel (described above with the model studies) was added 
Donor resin (3.0 equiv), ruthenium catalyst 85b (10 mol %), and 1.0 mL DCE at 24 °C. The 
vessel was capped, and to the other side Acceptor resin (1.0 equiv) and another 1.0 mL portion 
of DCE were added. In a typical experiment, 75 mg of the Acceptor resin is coupled with the 
appropriate amount of the Donor resin based on the 1:3 molar ratio using the appropriate 
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amount of the ruthenium catalyst. The vessel was then placed into a shaking incubator and 
allowed to shake at 60 ºC for 7 h. Following reaction, the resin from the acceptor side of the 
vessel was transferred to a new column with a disposable plastic pipet and washed with CH2Cl2 
(3×2 mL), THF (3×2 mL), DMF (3×2 mL), and CH2Cl2 (3×2 mL) and dried under vacuum 
overnight. The acceptor beads were then swelled with CH2Cl2 and treated with 0.5 mL of a 
1:2.5:46 TFA/Et3SiH/CH2Cl2 solution for 3 min at 24 °C. The beads were filtered via gravity 
filtration with CH2Cl2 and the resulting liquid was concentrated in vacuo. All crude residues 
were initially analyzed by LC-MS and purified by reverse-phase C18 column (5→50% MeOH in 
H2O/0.1% HCO2H). Following purification, all 1H NMR peaks were greatly obscured resulting 
in poor spectra. All crude 1H NMR and HPLC data are described. 
 
 
 
 
Data for 119: 10.3 mg, 79%:  Rf = 0.44 (4:1:1 
iPrOH/H2O/AcOH); tR (5→30% MeCN in H2O/0.1% HCO2H, 
0.4 mL/min, 254 and 280 nm) = 6.549 min; 1H NMR (300 
MHz, CD3OD, 20 °C): δ 7.48-7.33 (m, 5H), 6.91 (dd, J = 7.8, 
7.8 Hz, 1H; C9-H), 6.66 (d, J = 7.8 Hz, 1H; C8-H or C10-H), 6.59 (d, J = 7.8 Hz, 1H; C8-H or C10-
H), 6.47 (s, 1H; C12-H), 6.34 (d, J = 16.0 Hz, 1H; C5-H), 6.12 (ddd, J = 16.0, 5.8, 5.8 Hz, 1H; C4-
H), 4.17−4.14 (br m, 2H; C1-H), 4.04−4.00 (br m, 2H; C13-H), 3.48−3.27 (m, 4H; C18-H, C19-H), 
3.06 (d, J = 4.3 Hz, 1H; C6-H), 2.99 (d, J = 4.3 Hz, 1H; C6-H’), 2.07 (d, J = 5.8 Hz, 2H; C3-H), 
1.14−1.10 (m, 4H; C15-H, C16-H), 0.73−0.66 (m, 3H; C17-H). 
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In an attempt to further verify the structure of 119, the 
compound was acetylated in a similar manner as 90. 5.7 mg, 
86%:  Rf = 0.47; tR (5→30% MeCN in H2O/0.1% HCO2H, 0.4 
mL/min, 254 and 280 nm) = 7.141 min; LC-MS (ESI) m/z: C31H40NO7 [M+H]+ 537.3.  
 
Data for 120. 8.6 mg, 61%:  Rf = 0.53 (4:1:1 
iPrOH/H2O/AcOH); tR  (5→30% MeCN in H2O/0.1% 
HCO2H), 0.4 mL/min, 254 and 280 nm) = 6.582 min; 1H NMR 
(300 MHz, CD3OD, 20 °C): δ 7.54 (d, J = 8.0 Hz, 2H; OTs), 7.07 (d, J = 8.0 Hz, 2H; OTs), 6.94 
(dd, J = 7.9, 7.9 Hz, 1H; C14-H), 6.77 (d, J = 7.9 Hz, 1H; C13-H or C15-H), 6.69 (d, J = 7.9 Hz, 
1H; C13-H or C15-H), 6.66 (s, 1H; C17-H), 6.35 (d, J = 15.9 Hz, 1H; C5-H), 6.14 (ddd, J = 15.9, 
5.5, 5.5 Hz, 1H; C4-H), 4.11 (d, J = 14.0 Hz, 1H; C1-H), 4.07−3.98 (br m, 2H; C18-H), 3.88 (d, J 
= 14.0 Hz, 1H; C1-H’), 3.72−3.34 (m, 3H; C7-2H, C8-H), 3.29 (d, J = 4.7 Hz, 1H; C23-H), 2.92 
(d, J = 4.7 Hz, 1H; C23-H’), 2.86−2.77 (m, 2H; C6-H), 2.20−2.10 (m, 2H; C3-H), 1.99−1.75 (m, 
1H; C9-H), 1.12 (br s, 6H), 0.94−0.79 (m, 4H; C20-H, C21-H), 0.52−0.34 (m, 3H; C22-H); LC-MS 
(ESI) m/z: C30H45NO8S [M+H]+ 579.2. 
 
In an attempt to further verify the structure of 120, the 
compound was derivatized via acetylation. A solution of 120 
(7.3 mg, 0.018 mmol) in CH2Cl2 (200 µL) was treated with 
acetic anhydride (170 µL, 1.8 mmol), dimethylaminopyridine (1.1 mg, 0.009 mmol), and 
triethylamine (240 µL, 1.8 mmol) at 24 °C. The resulting solution was allowed to stir for 12 h at 
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room temperature. The crude mixture was purified by preparative TLC (0.25-mm in thickness) 
using 60% EtOAc in hexanes. 7.0 mg, 73%:  Rf = 0.32; tR (5→30% MeCN in H2O/0.1% 
HCO2H, 0.4 mL/min, 254 and 280 nm) = 5.886 min; 1H NMR analysis was obscured presumably 
due to acyl migrations at elevated temperatures; LC-MS (ESI) m/z: C29H42NO8 [M+H]+ 532.3.   
 
Data for 121. 8.1 mg, 64%:  Rf = 0.50 (4:1:1 
iPrOH/H2O/AcOH); tR (5→30% MeCN in H2O/0.1% HCO2H, 
0.4 mL/min, 254 and 280 nm) = 6.400 min; 1H NMR (300 
MHz, CD3OD, 20 °C): δ 7.48-7.33 (m, 5H), 6.94 (dd, J = 7.8, 
7.8 Hz, 1H; C14-H), 6.72 (d, J = 7.8 Hz, 1H; C13-H or C15-H), 6.67 (d, J = 7.8 Hz, 1H; C13-H or 
C15-H), 6.50 (s, 1H; C17-H), 6.36 (d, J = 15.9 Hz, 1H; C5-H), 6.14 (ddd, J = 15.9, 5.6, 5.6 Hz, 
1H; C4-H), 4.13 (d, J = 14.9 Hz, 1H; C1-H), 4.06−4.02 (br m, 2H; C18-H), 3.87 (d, J = 14.9 Hz, 
1H; C1-H’), 3.75−3.21 (m, 9H; C6-H, C7-H, C8-H, C23-H, C24-H), 2.17−2.11 (m, 3H; C3-H, C9-
H), 1.13 (br s, 6H), 0.85−0.77 (m, 4H; C20-H, C21-H), 0.51−0.35 (m, 3H; C22-H);  LC-MS (ESI) 
m/z: 481.2 (C29H42N2O4; [M–OCH3+H]+; 6%), 437.3 (C24H40N2O5; [M–C6H5+H]+; 14%), 393.2 
(C22H36NO5; [M–CH2NBn+H]+; 30%), 349.1 (C19H29NO5; [M–C3H7+2H]+; 49%). 
8.4.3 Solid-Phase Olefin Cross-Metathesis Promoted by a Linker 
General procedure for the loading of simple and substituted alkenyl alcohols onto trityl 
chloride resin and 129. A 10-mL Bio-Rad Poly-Prep® chromatography column was charged 
with 300 mg of trityl chloride resin (Advanced ChemTech, 100−200 µm, 1.0 mmol/g) or 129 and 
5.0 mL of CH2Cl2 at 24 °C. The mixture was shaken for 10 min at 24 °C on a reaction shaker to 
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swell the resin. The solvent was removed via vacuum filtration and a fresh portion of CH2Cl2 
(3.0 mL; 1.00 mL/100 mg resin) was added at 24 °C followed by the respective alcohol (1.5 
mmol, 5 equiv) and pyridine (3.0 mmol, 10 equiv). After agitation at 24 °C for 24 h on a reaction 
shaker, the solution was filtered via vacuum filtration and the resin was washed with CH2Cl2 
(3×5 mL), DMF (3×5 mL), and CH2Cl2 (3×5 mL). The resin was dried under high vacuum for at 
least 8 h. Loading was assumed to be quantitative (0.98−0.94 mmol/g) due to the volatility of the 
alkenyl alcohols.   
 
General procedure for the loading of simple alkenyl alcohols onto alkylsilyl resin. Alkenyl 
alcohols were loaded onto (4-methoxyphenyl)diisopropylsilylpropyl polystyrene resin according 
to the literature.52  
 
General procedure for the loading of simple alkenyl alcohols onto Merrifield resin. A 5.0-
mL silanized vial was charged with the respective alcohol (1.275 mmol, 5 equiv) and NaH 
(1.402 mmol, 5.5 equiv) in DMF (3.0 mL; 1.0 mL/100 mg resin) at 24 °C. 300 mg of Merrifield 
HL resin (Novabiochem, 100−200 mesh), 0.85 mmol/g) was then added and the mixture was 
heated to 60 °C in an oil bath. After gently stirring at 60 °C for 16 h, the resin was transferred to 
a 10-mL Bio-Rad Poly-Prep® chromatography column with a disposable plastic pipet and the 
solution was filtered via vacuum filtration. The resin was washed with DMF (3×5 mL), 1:1 
DMF/CH2Cl2 (3×5 mL), DMF (3×5 mL), CH2Cl2 (3×5 mL), and MeOH (3×5 mL). The resin 
was dried under high vacuum for at least 8 h. Loading was assumed to be quantitative (0.83−0.81 
mmol/g) due to the volatility of the alkenyl alcohols.   
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Preparation of resin 129. A 10-mL Bio-Rad Poly-Prep® chromatography column was charged 
with 300 mg of aminomethylated polystyrene HL resin (Novabiochem, 100−200 mesh, 0.78 
mmol/g) and 5.0 mL of DMF at 24 °C. The mixture was shaken for 10 min at 24 °C on a reactio 
shaker to swell the resin. The solvent was removed via vacuum filtration and a fresh portion of 
DMF (3.0 mL; 1.00 mL/100 mg resin) was added at 24 °C followed by linker 128 (0.47 mmol, 2 
equiv), 1-hydroxybenzotriazole monohydrate (0.47 mmol, 2 equiv), N,N’-
dicyclohexylcarbodiimide (0.23 mmol, 1 equiv), and DMAP (0.023 mmol, 0.1 equiv). After 
agitation at 24 °C for 24 h on a reaction shaker, the solution was filtered via vacuum filtration 
and the resin was washed with CH2Cl2 (3×5 mL), DMF (3×5 mL), and CH2Cl2 (3×5 mL). 
Loading was assumed to be quantitative (0.53 mmol/g). 
The above resin in the same 10-mL Bio-Rad Poly-Prep® chromatography column at 24 
°C was then treated with 10% AcCl in CH2Cl2 (3.0 mL). After agitation at 24 °C for 3 h on a 
reaction shaker, the solution was filtered via vacuum filtration and the resin was washed with 
CH2Cl2 (5×5 mL). The resin was dried under high vacuum for at least 8 h. Loading was assumed 
to be quantitative (0.52 mmol/g).   
 
General procedure for olefin cross-metathesis reactions with solid-supported simple and 
substituted alkenyl alcohols. A 2-mL Bio-Rad Micro Bio-Spin chromatography column was 
charged with solid-supported alcohol (25−75 mg resin, 0.035−0.049 mmol) and 500 µL of DCE 
at 24 °C. The mixture was shaken for 10 min at 24 °C on a reaction shaker to swell the resin. The 
solvent was removed via vacuum filtration and a fresh portion of DCE (500 µL) was added at 24 
°C followed by 126 (0.175−0.245 mmol, 5 equiv) and ruthenium catalyst (0.002 mmol, 0.05 
equiv). After agitation at 24 °C for 22 h on a reaction shaker, the solution was filtered via 
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vacuum filtration and the resin was washed with CH2Cl2 (3×2 mL), DMF (3×2 mL), and CH2Cl2 
(3×2 mL). The resin was dried under high vacuum for at least 4 h and cleaved according to resin 
type. 
 
General procedure for the cleavage of trityl-linked metathesis products. A 2-mL Bio-Rad 
Micro Bio-Spin chromatography column containing the solid-supported metathesis product was 
charged with 1.0 mL of 1:19 TFA/CH2Cl2 at 24 °C. After agitation at 24 °C for 1 h on reaction 
shaker, the liquid was gravity filtered with CH2Cl2 and concentrated in vacuo. Because of the 
volatility of the starting alkenyl alcohols, drying under high vacuum yielded pure metathesis 
products.  
 
General procedure for the cleavage of alkylsilyl-linked metathesis products. Metathesis 
products were cleaved from alkylsilyl resin according to the literature.52 
General procedure for the cleavage of Merrifield-linked metathesis products. A 2-mL Bio-
Rad Micro Bio-Spin chromatography column containing the solid-supported metathesis product 
was charged with 1.0 mL of 4:1:15 TFA/Et3SiH/CH2Cl2 solution at 24 °C. After agitation at 24 
°C for 1 h on a reaction shaker, the liquid was gravity filtered with CH2Cl2 and concentrated in 
vacuo. Because of the volatility of the starting alkenyl alcohols, drying under high vacuum 
yielded pure metathesis products.  
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 Data for 127a matches that of the known compound71: colorless oil; 1H NMR (300 MHz, 
293K, CDCl3) δ 8.05 (d, J = 7.5 Hz, 2H; C7, C11-H), 7.57 (dd, J = 7.5, 7.5 Hz, 1H; C9-H), 7.44 
(dd, J = 7.5, 7.5 Hz, 2H; C8, C10-H), 6.03 (ddd, J = 15.7, 4.7, 4.7 Hz, 1H; C2-H), 5.93 (ddd, J = 
15.7, 4.7, 4.7 Hz, 1H; C3-H), 4.84 (d, J = 4.7 Hz, 2H; C4-H), 4.20 (d, J = 4.7 Hz, 2H; C1-H).  
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 Data for 127b matches that of the known compound72: colorless oil; 1H NMR (300 MHz, 
293K, CDCl3) δ 8.05 (d, J = 7.5 Hz, 2H; C8, C12-H), 7.56 (dd, J = 7.5, 7.5 Hz, 1H; C10-H), 7.44 
(dd, J = 7.5, 7.5 Hz, 2H; C9, C11-H), 5.87 (ddd, J = 15.3, 6.0, 6.0 Hz, 1H; C3-H), 5.82 (ddd, J = 
15.3, 4.8, 4.8 Hz, 1H; C4-H), 4.80 (d, J = 4.8 Hz, 2H; C5-H), 3.73 (t, J = 6.0 Hz, 2H; C1-H), 2.38 
(q, J = 6.0 Hz, 2H; C2-H), 1.60 (br s, 1H; OH). 
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 Data for 127c: colorless oil; Rf = 0.17 (30% EtOAc in hexanes); IR: 3397 (br, O-H), 
2924, 2852, 2360, 1716 (C=O), 1272 cm-1; 1H NMR (300 MHz, 293K, CDCl3) δ 8.07 (d, J = 7.5 
Hz, 2H; C9, C13-H), 7.57 (dd, J = 7.5, 7.5 Hz, 1H; C11-H), 7.46 (dd, J = 7.5, 7.5 Hz, 2H; C10, C12-
H), 5.90 (ddd, J = 15.6, 6.3, 6.3 Hz, 1H; C4-H), 5.75 (ddd, J = 15.6, 6.0, 6.0 Hz, 1H; C5-H), 4.79 
(d, J = 6.0 Hz, 2H; C6-H), 3.69 (t, J = 6.3 Hz, 2H; C1-H), 2.22 (q, J = 6.3 Hz, 2H; C3-H), 1.72 
(quint, J = 6.3 Hz, 2H; C2-H), 1.58 (br s, 1H; OH); 13C NMR (75 MHz, 293K, CDCl3) δ 166.6, 
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135.5, 132.9, 129.6, 129.6, 128.4, 128.4, 124.5, 124.3, 65.5, 62.4, 31.8, 28.6; MS (EI) m/z calcd. 
for C13H16O3 M+· 220.1099, found 220.1103. 
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Data for 127d: colorless oil; Rf = 0.20 (30% EtOAc in hexanes); IR: 3392 (br, O-H), 
2932, 2860, 1717 (C=O), 1272 cm-1; 1H NMR (300 MHz, 293K, CDCl3) δ 8.05 (d, J = 7.5 Hz, 
2H; C10, C14-H), 7.57 (dd, J = 7.5, 7.5 Hz, 1H; C12-H), 7.45 (dd, J = 7.5, 7.5 Hz, 2H; C11, C13-H), 
5.85 (ddd, J = 15.3, 6.3, 6.3 Hz, 1H; C5-H), 5.71 (ddd, J = 15.3, 6.0, 6.0 Hz, 1H; C6-H), 4.77 (d, 
J = 6.0 Hz, 2H; C7-H), 4.36 (t, J = 6.3 Hz, 2H; C1-H), 2.13 (q, J = 6.3 Hz, 2H; C2-H), 1.67−1.40 
(m, 4H; C3, C4-H); 13C NMR (75 MHz, 293K, CDCl3) δ 166.5, 136.0, 135.2, 132.9, 129.6, 129.6, 
128.3, 128.3, 124.2, 65.7, 62.7, 32.2, 32.0, 25.6; MS (EI) m/z calcd. for C14H17O3 M+· 233.1178, 
found 233.1179. 
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Data for 133: colorless oil; Rf = 0.27 (30% EtOAc in hexanes); IR: 3433 (br, O-H), 2925, 
1717 (C=O), 1272 cm-1; 1H NMR (300 MHz, 293K, CDCl3) δ 8.05 (d, J = 7.5 Hz, 2H; C9, C13-
H), 7.56 (dd, J = 7.5, 7.5 Hz, 1H; C11-H), 7.44 (dd, J = 7.5, 7.5 Hz, 2H; C10, C12-H), 5.80 (dd, J = 
15.6, 5.8 Hz, 1H; C3-H), 5.73 (ddd, J = 15.6, 4.8, 4.8 Hz, 1H; C4-H), 4.81 (d, J = 4.8 Hz, 2H; 
C5-H), 3.52 (dddd, J = 6.9, 6.9, 5.8, 5.8 Hz, 2H; C1-H), 2.45 (septet, J = 6.9 Hz, 1H; C2-H), 1.63 
(br s, 1H; OH), 1.05 (d, J = 6.9 Hz, 3H; C6-H); 13C NMR (75 MHz, 293K, CDCl3) δ 166.2, 
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137.7, 132.9, 130.5, 129.6, 129.6, 128.4, 128.4, 125.3, 67.1, 65.4, 39.4, 16.1; MS (EI) m/z calcd. 
for C13H16O3Na M+23 243.0997, found 243.0999. 
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 Data for 136: colorless oil; Rf = 0.23 (30% EtOAc in hexanes); IR: 3431 (br, O-H), 2971, 
2926, 1718 (C=O), 1272 cm-1; 1H NMR (300 MHz, 293K, CDCl3) δ 8.06 (d, J = 7.2 Hz, 2H; C8, 
C12-H), 7.56 (dd, J = 7.2, 7.2 Hz, 1H; C10-H), 7.44 (dd, J = 7.2, 7.2 Hz, 2H; C9, C11-H), 6.03 
(ddd, J = 15.7, 4.9, 4.9 Hz, 1H; C4-H), 5.93 (dd, J = 15.7, 6.3 Hz, 1H; C3-H), 4.81 (d, J = 4.9 Hz, 
2H; C5-H), 4.37 (dq, J = 6.3 Hz, 1H; C2-H), 1.60 (br s, 1H; OH), 1.30 (d, J = 6.3 Hz, 3H; C1-H); 
13C NMR (75 MHz, 293K, CDCl3) δ 166.3, 138.4, 133.0, 130.1, 129.7, 129.7, 128.4, 128.4, 
123.7, 68.1, 64.7, 23.2; MS (EI) m/z calcd. for C12H14O3 M+· 206.0943, found 206.0937.  
 
O
139
HO
O
10
1
4
8
3
2
5
6
9
12
11
O
1. 126 (5.0 equiv)
85b (5 mol %)
2. Cleavage
 
 Data for 139 match those in the literature73: colorless oil; 1H NMR (300 MHz, 293K, 1% 
CD3OD in CDCl3) δ 8.13 (d, J = 7.5 Hz, 2H; C8, C12-H, cis), 8.05 (d, J = 7.5 Hz, 2H; C8, C12-H, 
trans), 7.73−7.43 (m; C9, C10, C11-H, cis and trans), 5.77 (t, J = 6.3 Hz, 1H; C3-H, cis), 5.56 (t, J 
= 6.3 Hz, 1H; C3-H, trans), 4.92 (d, J = 6.3 Hz, 2H; C4-H, cis), 4.90 (d, J = 6.3 Hz, 2H; C4-H, 
trans), 4.26 (br s, 2H; C1-H, cis), 4.09 (br s, 2H; C1-H, trans), 1.89 (br s, 3H; C5-H), 1.80 (br s, 
3H; C5-H).  
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Control experiment with trityl ether. 
O O
O
O
1
4
3
5
7
8
9
10
112
126 (5.0 equiv)
85b (5 mol %)
145  
A solution of the trityl ether of allyl alcohol (34.6 mg, 0.115 mmol) in DCE (1.15 mL) 
was treated with 126 (171 mg, 0.576 mmol) and 85b (3.8 mg, 0.005 mmol) at 24 °C. The 
resulting solution was stirred at 24 °C for 5 h, then pushed through a plug of silica with 30% 
EtOAc in hexanes.  The crude residue was purified by flash column chromatography 
(Hexanes→1% EtOAc in hexanes) on silica gel to afford 145 (30.6 mg, 61%) as a colorless oil. 
  Data for 145: off-white solid; 1H NMR (300 MHz, 293K, CDCl3) δ 8.06 (d, J = 7.2 Hz, 
2H; C7, C11-H), 7.56 (dd, J = 7.2, 7.2 Hz, 1H; C9-H), 7.45 (dd, J = 7.2, 7.2 Hz, 2H; C8, C10-H), 
7.36−7.19 (m, 15H; trityl), 6.07 (ddd, J = 16.2, 5.7, 5.7 Hz, 1H; C2-H), 6.00 (ddd, J = 16.2, 5.7, 
5.7 Hz, 1H; C3-H), 4.83 (d, J = 5.7 Hz, 2H; C4-H), 3.65 (d, J = 5.7 Hz, 2H; C1-H). 
 Further purification of 145 resulted in loss of the trityl group. The 1H NMR spectrum of 
this compound matched that of known compound 127a and no further characterization was 
completed. 
 
Preparation of 122. 
NH
HO
O
N
MeO
OH
O
O
1. quinine (5.0 equiv)
85b (5 mol %)
3'
7 5
8
3
9
2'
6
6" 4"
7'
1" 3"
8'
5"
5'
122
2. Cleavage
2
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 A 2-mL Bio-Rad Micro Bio-Spin chromatography column was charged with 140 (75 
mg resin, 0.0375 mmol) and 500 µL of DCE at 24 °C. The mixture was shaken for 10 min at 24 
°C on a reaction shaker to swell the resin. The solvent was removed via vacuum filtration and a 
fresh portion of DCE (500 µL) was added at 24 °C followed by quinine (0.188 mmol, 5 equiv), 
Ti(OiPr)4 (0.007 mmol, 0.2 equiv), and ruthenium catalyst (0.002 mmol, 0.05 equiv). After 
agitation at 24 °C for 22 h on a reaction shaker, the solution was filtered via vacuum filtration 
and the resin was washed with CH2Cl2 (3×2 mL), DMF (3×2 mL), and CH2Cl2 (3×2 mL). The 
resin was dried under high vacuum for 8 h.  Cleavage with 1:19 TFA/CH2Cl2 afforded 122 as a 
crude residue which was purified by pushing through a reverse-phase C18 silica plug with 1% 
MeOH in CH2Cl2. 
 Data for 122: white solid; Rf = 0.11 (7.5% MeOH in CH2Cl2); 1H NMR (300 MHz, 293K, 
d6-DMSO) δ74,75 11.76 (br s, 1H; NH), 8.86 (d, J = 4.5 Hz, 1H; C2’-H), 8.07 (d, J  = 9.1 Hz, 1H; 
C8’-H), 7.78 (d, J = 4.5 Hz, 1H; C3’-H), 7.70 (s, 1H, C5’-H), 7.54 (d, J = 9.1 Hz, 1H; C7’-H), 6.62 
(br s, 1H; C9 enantiomer), 6.29 (br s, 1H, C9 enantiomer), 5.82 (ddd, J = 17.2, 7.3, 7.3 Hz, 1H; 
C4”), 5.03 (dd, J = 17.2, 9.6 Hz, 1H; C5”), 4.07 (s, 3H; OMe), 3.98 (m, 2H; C6en, C8), 3.55 (m, 
3H; C1”, C2t), 3.22 (m, 4H; C6ex, C2c, C6”), 2.73 (m, 1H, C3), 2.05 (m, 3H; C3”, C4), 1.85 (m, 2H; 
C5), 1.43 (m, 2H; C7);13C NMR (75 MHz, 293K, CDCl3 + 0.1% CD3OD) δ 160.4 (C6’), 152.6 
(C4’), 141.3 (C2’), 136.9 (C10’), 136.1 (C5”), 131.8 (C4”), 126.7 (C8’), 125.5 (C9’), 119.3 (C3’), 
117.6 (C7’), 100.9 (C5’), 67.4 (C9), 66.2 (C1”), 59.9 (C8), 57.8 (C2”), 54.8 (OMe), 44.2 (C3), 36.9 
(C3”), 29.7 (C4), 26.7 (C5), 24.2 (C7); C2, C6, C6” are buried in CD3OD between 50.3−49.176; MS 
(EI) m/z calcd. for C24H30N2O4 M+· 410.2205, found 410.2208. 
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8.4.4 Resin-to-Resin Olefin Cross-Metathesis – Second Generation 
Preparation of 141. cis-But-2-en-1,4-diol was loaded onto resin 129 according to the general 
procedure. The resin was then carried on to benzoylation using benzoyl chloride (650 µL, 5.6 
mmol) and pyridine (910 µL, 11.2 mmol) in CH2Cl2 (20 mL) at 24 °C for 24 h to prepare 141 as 
pale yellow beads. The resin was washed with CH2Cl2 (3×5 mL), THF (3×5 mL), DMF (3×5 
mL) and CH2Cl2 (3×5 mL) and dried under vacuum overnight. A small portion of 141 was 
cleaved for analysis as previously described and the loading was found to be quantitative (100%, 
0.56 mmol/g). 1H NMR spectrum consistent with that of compound 127a. 
 
Metathesis of Acceptors (130b, 132, 135, 138) and Donor (141). The Donor resin (5.0 equiv) 
and ruthenium catalyst 85b (10 mol %) were added to a portion of Kimwipe, which was closed 
by tying with a string (see photo below). The Acceptor resin (1.0 equiv) was then added to a 
scintillation vial with a stir bar. DCE (3.0 mL) and the Kimwipe bag containing the Donor resin 
were then added and the vial was capped (see below for photo of reaction setup). In a typical 
experiment, 75 mg of the Acceptor resin is coupled with the appropriate amount of the Donor 
resin based on the 1:5 molar ratio using the appropriate amount of the ruthenium catalyst. The 
vial was then placed into an oil bath and heated at 80 oC for 24 h. Following reaction, the 
acceptor resin was transferred to a new column with a disposable plastic pipet and washed with 
CH2Cl2 (3×2 mL), THF (3×2 mL), DMF (3×2 mL) and CH2Cl2 (3×2 mL) and dried under 
vacuum overnight. The acceptor beads were then swelled with CH2Cl2 and treated with 1:19 
TFA/CH2Cl2. The beads were filtered via gravity filtration with CH2Cl2 and the resulting liquid 
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was concentrated in vacuo. The formation of products 127b, 133, 136 and 139 was verified by 
comparison to the authentic samples. 
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APPENDIX A 
SYNTHESIS OF PITTSBURGH GREEN AND PITTSBURGH YELLOWGREEN            
A.1 1H NMR AND 13C NMR SPECTROSCOPY 
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1H NMR spectrum of compound 34: CDCl3, 293K, 300 MHz  
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13C NMR spectrum of compound 34: CDCl3, 293K, 75 MHz  
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1H NMR spectrum of compound 35: CD3OD, 293K, 300 MHz  
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13C NMR spectrum of compound 35: CD3OD, 293K, 75 MHz  
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1H NMR spectrum of compound 36: CDCl3, 293K, 300 MHz  
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13C NMR spectrum of compound 36: CD3OD, 293K, 75 MHz  
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APPENDIX B 
SYNTHESIS OF OZONE SENSOR 
B.1 1H NMR AND 13C NMR SPECTRA 
 217 
1H NMR spectrum of compound 70: CDCl3, 293K, 300 MHz 
 
 
13C NMR spectrum of compound 70: CDCl3, 293K, 75 MHz 
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 218 
1H NMR spectrum of compound 67: CDCl3, 293K, 300 MHz 
 
 
 
13C NMR spectrum of compound 67: CDCl3, 293K, 75 MHz 
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APPENDIX C 
RESIN-TO-RESIN OLEFIN CROSS-METATHESIS 
C.1 1H NMR AND 13C NMR SPECTRA AND LC-MS DATA 
 220 
1H NMR spectrum of compound 143: 1% CD3OD in CDCl3, 293K, 300 MHz 
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13C NMR spectrum of compound 143: CDCl3, 293K, 75 MHz 
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1H NMR spectrum of compound 116’: CD3OD, 293K, 300 MHz 
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13C NMR spectrum of compound 116’: CD3OD, 293K, 75 MHz 
 
 224 
1H NMR spectrum of compound 144: CDCl3, 293K, 300 MHz 
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13C NMR spectrum of compound 144: CDCl3, 293K, 75 MHz 
 226 
1H NMR spectrum of compound 117’: CD3OD, 293K, 300 MHz 
 
 227 
13C NMR spectrum of compound 117’: CD3OD, 293K, 75 MHz 
 228 
1H NMR spectrum of compound 118’: CD3OD, 293K, 300 MHz 
 
 229 
13C NMR spectrum of compound 118’: CD3OD, 293K, 75 MHz 
 230 
crude 1H NMR spectrum of compound 119: CD3OD, 293K, 300 MHz 
 
 231 
HPLC, MS, UV data for compound 119 (crude) 
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 232 
crude 1H NMR spectrum of compound 120: CD3OD, 293K, 300 MHz 
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HPLC, MS, UV data for compound 120 (crude) 
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 234 
crude 1H NMR spectrum of compound 121: CD3OD, 293K, 300 MHz 
 
 235 
HPLC, MS, UV data for compound 121 (crude) 
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APPENDIX D 
SOLID PHASE OLEFIN CROSS-METATHESIS WITH A LINKER 
D.1 1H NMR AND 13C NMR SPECTRA 
 237 
1H NMR spectrum of compound 127c (cis and trans): 1% CD3OD in CDCl3, 293K, 300 MHz 
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13C NMR spectrum of compound 127c (cis and trans): CDCl3, 293K, 75 MHz 
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 239 
1H NMR spectrum of compound 127d (cis and trans): 1% CD3OD in CDCl3, 293K, 300 MHz 
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13C NMR spectrum of compound 127d (cis and trans): CDCl3, 293K, 75 MHz 
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 241 
1H NMR spectrum of compound 133: 1% CD3OD in CDCl3, 293K, 300 MHz 
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13C NMR spectrum of compound 133: CDCl3, 293K, 75 MHz 
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 243 
1H NMR spectrum of compound 136: 1% CD3OD in CDCl3, 293K, 300 MHz 
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 244 
13C NMR spectrum of compound 136: CDCl3, 293K, 75 MHz 
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 245 
1H NMR spectrum of compound 136 (cis and trans): 1% CD3OD in CDCl3, 293K, 300 MHz 
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1H NMR spectrum of compound 145: CDCl3, 293K, 300 MHz 
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1H NMR spectrum of compound 122: d6-DMSO, 293K, 300 MHz 
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13C NMR spectrum of compound 122: 1% CD3OD in CDCl3, 293K, 75 MHz 
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